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ABSTRACT 
 
Yessotoxin (YTX) is a disulfated polycyclic polyether, produced by dinoflagellate algae.  
It is known to accumulate in edible shellfish, raising concerns about its potential risk to 
human health.  YTX was initially classified as a diarrhetic shellfish poisoning toxin, due 
to commonly being extracted alongside toxins of this variety.  However, YTX does not 
induce any of the effects characteristic of this group.  A separate category for YTXs was 
established by the European Commission in 2002 and a limit of 1 mg/kg of shellfish 
meat was established. 
YTX has been shown to be an apoptosis inducer in a variety of cell lines in vitro.  It has 
also been shown to be lethal to mice when administered by intra-peritoneal injection.  
However, when administered orally only limited toxicity is observed.  The di-desulfated 
derivative (dsYTX) has also been shown to be lethal to mice following intra-peritoneal 
injection.  However it causes damage mainly to the liver, whereas YTX appears to 
target the heart.  The mechanism of action of YTX is still unknown. 
The goals of this project were to use proteomic techniques, to examine the effects of 
YTX and dsYTX on Saccharomyces cerevisiae and human promyelocytic leukemic blood 
leukocyte (HL60) cells. Young et al. (2009) showed that the major proteins affected by 
YTX in HepG2 cells were heterogeneous ribonucleoproteins (hnRNPs), lamins, 
cathepsins and heat shock proteins.  HnRNPs had not previously been identified as 
possible targets of YTX.  Alterations of hnRNP levels were also seen in HL60 cells 
treated with microtubule stabilising agents, peloruside A or paclitaxel (Wilmes et al., 
2011, 2012). 
No differences in cell morphology or significant changes in protein abundance were 
observed when S. cerevisiae cells were exposed to YTX.  A small number of significant 
changes in abundance were detected when these cells were exposed to dsYTX.  The 
small number of protein changes seen is possibly due to poor toxin entrance into the 
cell through the yeast cell wall, lack of protein targets structurally homologous to 
those found in mammalian cells, or fast removal of the toxin through export pumps.   
v 
 
Twenty-four hour incubation of HL60 cells with YTX resulted in increased cell death but 
no change in cell morphology.  Treatment with dsYTX caused cells to aggregate into 
clusters and a 24% decrease in the number of live cells.  Increases were found in the 
abundance of β-actin, hnRNP A and BiP proteins in response to dsYTX treatment.  
Decreases in these proteins were seen in HepG2 cells treated with YTX for 24 hours.  
As seen in S. cerevisiae cells, dsYTX had a greater effect in HL60 cells compared with 
YTX. 
Overall, the results provide some support for the previously identified effect on 
hnRNPs in mammalian cells exposed to YTX. 
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ABBREVIATIONS 
 
1DE one-dimensional gel electrophoresis 
2DE  two-dimensional gel electrophoresis 
ABC  adenosine triphosphate binding cassette 
BiP binding immunoglobulin protein 
BSA  bovine serum albumin 
b.w. body weight 
CHCA α-cyano-4-hydroxycinnamic acid 
DIGE  differential in gel electrophoresis 
DSP diarrhetic shellfish poisoning 
dsYTX di-desulfoyessotoxin 
DTT  dithiothreitol 
DTX dinophysistoxin 
FCS  fetal calf serum 
FDR false discovery rate 
GRP glucose-regulated protein 
hnRNP heterogeneous nuclear ribonucleoprotein 
HSP heat shock protein 
IAA  iodacetamide 
IEF isoelectric focusing 
i.p. intraperitoneal 
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IPA Ingenuity Pathways Analysis 
LC-MS  liquid chromatography – mass spectrometry 
LSP ladder-shaped polyether 
MALDI-TOF MS matrix assisted laser desorption/ionisation – time of 
flight mass-spectrometry 
MALDI-TOF/TOF MS/MS matrix assisted laser desorption/ionisation - time of flight 
tandem mass spectrometry 
MTX maitotoxin 
OA okadaic acid 
PARP poly(ADP-ribose)polymerase 
PBS phosphate buffered saline 
Pel A peloruside A 
PI propidium iodide 
PTP permeability transition pore 
PTX paclitaxel 
SDS-PAGE  sodium dodecyl sulphate - polyacrylamide gel 
electrophoresis 
TCR T-cell receptor 
TFA trifluoroacetic acid 
YPD yeast peptone dextrose 
YTX  yessotoxin 
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1 INTRODUCTION 
1.1 Yessotoxins  
Yessotoxin (YTX) is a disulfated polycyclic polyether (Fig. 1), produced by dinoflagellate 
algae.  It was first isolated from the digestive glands of the scallops Patinopecten 
yessoensis collected in Japan (Murata et al., 1987).  YTX was originally classed as a 
diarrhetic shellfish poisoning toxin (DSP) as it is often extracted with DSP toxins such as 
okadaic acid (OA) and dinophysistoxin (DTX) (Fig. 2).  Subsequent studies have shown 
that it does not display any of the typical DSP characteristics, such as inducing diarrhea 
(Murata et al., 1987, Ogino et al., 1997) or inhibition of protein phosphatase 2A (PP2A) 
(Ogino et al., 1997).  In 2002 a separate group was established for YTXs by the 
European Commission (directive 2002/225/EC).  The presence of YTX in New Zealand 
mussels was first detected in 1997 (Yasumoto et al., 1997).  The current limit of YTXs 
allowed in shellfish meat for human consumption is 1 mg YTXs/kg of mollusc 
(Regulation (EC) No. 853/2004).  The exact mechanism of action of YTX has yet to be 
determined.   
 
1.2 Algal production and shellfish metabolism 
There are currently three species of dinoflagellate algae confirmed to be producers of 
YTX.  These are: Protoceratium reticulatum, Lingulodinium polyedrum and Gonyaulax 
spinifera.  A phylogenetic analysis found that all YTX producing species of 
dinoflagellate belong to the order Gonyaulacales (Howard et al., 2009).  However, 
there is evidence that some analogues of YTX are produced by metabolism of the toxin 
by the shellfish that feed on toxic algae as opposed to being produced by the algae 
themselves.  Cultures of P. reticulatum have been found to contain YTX, but not 45-
hydroxy-YTX (45-OH-YTX), 45, 46, 47-trinor YTX or homo-YTX (Fig. 1) (Satake et al., 
1997).  Another study using LC-MS found indications of 93 YTXs in extracts from P. 
reticulatum (Miles et al., 2005). 
In contaminated Greenshell™ mussels (Perna canaliculis) collected around the coast of 
the upper South Island of New Zealand in 2001, YTX was found to be the major toxin 
Introduction 
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present.  45-OH-YTX was also detected although at a lesser concentration (Mackenzie 
et al., 2002).  There was also evidence from liquid chromatography work, in the same 
study, for the presence of three other YTXs, thought to be most likely carboxy-YTX, a 
hydroxylated carboxy-YTX analogue and aldehyde metabolite intermediates (Fig. 1).  
YTX was still detectable in the shellfish meat for some time after exposure to toxic 
algae ended, taking approximately 100 days to decline from an initial concentration of 
326 µg/100 g of shellfish meat, to the EU limit of 100 µg/100 g.  This gives an 
estimated half-life of the toxin in Greenshell™ mussels of about 49 days.  Interestingly 
while the amount of YTXs decreased over time, the ratio of 45-OH-YTX to YTX 
remained constant (12.3% ± 3.3%). 
A study of Norwegian Blue mussels (Mytilus edulis) (Aasen et al., 2005), found that the 
main toxin present was carboxy-YTX, with YTX being only a minor component, except 
for the time just after an algal bloom.  Half-lives for the YTXs detected in the mussels 
were determined to be 20 days for YTX, 22 days for 45-OH-YTX, 60 days for carboxy-
YTX and 33 days for 46-OH-carboxy-YTX.  This led to the conclusion that in Norwegian 
Blue mussels, YTX was converted rapidly to carboxy-YTX and, more slowly, to 45-OH-
YTX. 
YTX was found to be the dominant toxin in contaminated French mussels (Mytilus 
galloprovincialis).  The detoxification profile was similar to that of the Norwegian blue 
mussels (Amzil et al., 2008).  Toxicology profiles from the French mussels indicated 
that YTX was being converted to homo-YTX as well, as this analogue had a very low 
initial concentration which increased during the detoxification stage. 
Pacific oysters (Crassostrea gigas) were found to undergo a much faster detoxification 
of YTXs than mussels (M. edulis) (Roder et al., 2011).  Four days after feeding on YTX 
producing algae ended, C. gigas contained only approximately 15% of the initial 
amount of YTX and < 5% of the initial amount of 45-OH-YTX.  Two mono-desulfated 
analogues were detected in both shellfish, one of which was found to increase during 
the feeding and detoxification stages, indicating that it is possibly an end product of 
the metabolism process.  
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Name R1
 R2 R3 n 
Yessotoxin (YTX)
a 
SO3Na SO3Na 
 
1 
Homo-YTX
b
 SO3Na SO3Na 
 
2 
Desulfo-yessotoxin (dsYTX)
c 
H H 
 
1 
Carboxy-YTX
d 
SO3Na SO3Na 
 
1 
Carboxy-homo-YTX
d 
SO3Na SO3Na 
 
2 
1-desulfo-carboxy-homo-YTX
d 
H SO3Na 
 
2 
4-desulfo-carboxy-homo-YTX
d 
SO3Na H 
 
2 
45-hydroxy-YTX (45-OH-YTX)
b 
SO3Na SO3Na 
 
1 
Figure 1 The chemical structure of yessotoxin (YTX), its di-desulfated derivative (dsYTX) and selected other 
naturally occurring derivatives.   
a
 Young et al., 2009; 
b
 Dominguez et al., 2010; 
c
 Inoue et al., 2003; 
d 
Ciminiello et al., 2007 
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Figure 2 Chemical structures of toxic polycyclic polyethers produced by dinoflagellates.  A okadaic acid 
(OA), B brevetoxin B, C pectenotoxin 1, D ciguatoxin, E dinophysistoxin 1 (DTX 1), F yessotoxin (YTX), G 
maitotoxin (MTX), H azaspiracid 1 (AZA 1) 
1
 Dominguez et al., 2010; 
2
 Inoue et al., 2007; 
3
 García et al., 2005; 
4
 Young et al., 2009; 
5
 Nicolau et al, 
2010; 
6
 Evans et al., 2007 
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1.3 Yessotoxin 
1.3.1 In vivo effects 
1.3.1.1 Lethality 
YTX has been found to be lethal over a range of dose levels in murine studies, but only 
when administered by intraperitoneal (i.p) injection (Table 1).  The differences in LD50 
values between these studies may be due to the different strains and sexes of mice 
used (Aune et al., 2008).  LD50 values may also be influenced by mice fasting or 
receiving food ad libitum prior to YTX treatment.  Death following YTX administration 
appears to always occur within 24 h or not at all (Terao et al., 1990; Ogino et al., 1997; 
Aune et al., 2002; Tubaro et al., 2003; Franchini et al., 2004). 
 
Table 1 LD50 values by i.p injection found in mice.  * Doses that are lethal but not necessarily an LD50 
Study Strain Sex LD50 (µg/kg) 
Murata et al., 1987 - - 100* 
Terao et al.., 1990 IRC M 286 (at 3 h) 
Ogino et al., 1997 ddY M 80-100* 
Tubaro et al., 2003 CD-1 F 512 
Aune et al., 2008 ICR (CD-1) F 380 
  M 462 
 Swiss (CFW-1) F 269 
  M 328 
 NMRI F 314 
  M 412 
 
Oral administration of YTX is non-lethal in mice, even at doses as high as 1 - 10 mg/kg 
body weight (b.w) (Ogino et al., 1997; Tubaro et al., 2003 and 2008; Aasen et al., 2011) 
- more than 10 times the i.p. lethal dose.  This may be due to YTX being unable to cross 
membrane barriers and therefore being poorly absorbed following oral ingestion.  
Introduction 
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However YTX has been detected in the blood of mice at a concentration of 3.12 ng/mL, 
following repeated oral administration (Tubaro et al., 2008). 
YTX is structurally similar to brevetoxin B (Fig. 2B) which is lethal to zebra fish 
(Brachydanio rerio) at a concentration of 18 nM (Lin et al., 1981).  YTX was not found 
to be lethal to killifish (Oryzias latipes) at a concentration of 420 nM or 840 nM, within 
24 h (Ogino et al., 1997). 
1.3.1.2 Symptoms 
Mice appeared to behave normally for the first hour or so following i.p administration 
of YTX (Terao et al., 1990).  They then appeared restless, displayed jumping and muscle 
cramps, before dyspnea set in followed by death (Terao et al., 1990, Aune et al., 2002, 
Tubaro et al., 2003, Franchini et al., 2004a). 
No difference in behaviour from controls was observed in mice following oral 
administration of YTX (Ogino et al., 1997, Aune et al., 2002, Tubaro et al., 2003) 
1.3.1.3 Morphological and histological analysis 
In mice, YTX appears to mainly affect the heart (Terao et al., 1990; Aune et al., 2002; 
Tubaro et al., 2003 and 2008), but also causes damage to the intestine and some areas 
of the brain (Franchini et al., 2004a and 2004b).  In the heart it causes rounding and 
swelling of myocardial cells, rounding of the mitochondria and disrupts the 
organisation of myofibrils, particularly in the region around the capillaries.  Little 
morphological or histological changes have been observed in the intestine, other than 
an apparent inflammation response observed in the duodenum (Franchini et al., 
2004b).  YTX does not cause fluid accumulation in the intestine of suckling mice 
(Murata et al., 1987; Ogino et al., 1997), unlike DSP toxins such as OA.   
In the brain, disruption of neuron arrangement and shrinkage and increased 
hematoxylin and eosin staining of the cytoplasm of Purkinje cells was observed 
following i.p administration of a lethal dose of YTX (Franchini et al., 2004a).  An 
increased amount of S-100 protein and a decreased amount of calbindin D-28K, both 
Ca2+ binding proteins, was also observed.  Decreased amounts of β-tubulin, 
Introduction 
7 
 
neurofilaments and neurotubules, and disruption to the organisation of these proteins 
were also detected.  The authors postulated that damage to the cytoskeleton of 
Purkinje cells, was due to the action of increased amounts of S-100 protein.  Changes 
to the cell organisation and an increase in the number of apoptotic cells were also seen 
in the thymus following i.p administration of lethal and sub-lethal doses of YTX 
(Franchini et al., 2004b).  The same study also found an increase in the number of cells 
positive for the cytokines IL-6 and TNF-α, and a decrease in the number of IL-1α AND 
IL-8 positive cells. 
No changes (Ogino et al., 1997, Aasen et al., 2011) or changes similar to, but less 
pronounced than, those seen following i.p injection (Aune et al., 2002, Tubaro et al., 
2008) were observed with oral administration of YTX. 
 
1.3.2 In vitro effects 
1.3.2.1 Anti-microbial action 
YTX inhibits growth of yeast and fungi.  It has no effect on bacterial growth (Ogino et 
al., 1997). 
1.3.2.2 Cell death and morphological changes 
YTX induced cell death has been observed in a range of cell types (Leira et al., 2002, 
Malaguti et al., 2002, Korsnes et al., 2006, Pérez-Gómez et al., 2006, Young et al., 
2009, Pang et al., 2011, Korsnes et al., 2011).  Changes observed accompanying cell 
death include DNA and chromatin fragmentation and chromatin condensation, 
decreased membrane potential of mitochondria, caspase activation and poly(ADP-
ribose)polymerase (PARP) fragmentation. These changes are typically characteristic of 
apoptosis rather than necrosis.  That YTX is inducing apoptosis is supported by Annexin 
V/propidium iodide (PI) staining (Leira et al., 2002, Young et al., 2009).  One of the 
hallmarks of apoptosis is translocation of phosphatidylserine from the inner leaflet to 
the external surface of the cell membrane.  Annexin V preferentially binds to 
phospholipids, such as phosphatidylserine.  The externalisation of phosphatidylserine 
Introduction 
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also occurs in necrotic cells, but is also accompanied by loss of integrity of the cell 
membrane.  The use of PI as a counterstain with Annexin V allows necrotic cells to be 
distinguished from those undergoing apoptosis using flow cytometry, as it can only 
enter cells with damaged membranes (Vermes et al., 1995). 
Paraptosis is a form of programmed cell death which does not meet the criteria for 
apoptosis or necrosis (Sperandio et al., 2000).  It has recently been suggested as the 
form of cell death induced by YTX in myoblast cells (Korsnes et al., 2011).  This is due to 
the observation of rampant cytoplasmic vacuolisation, swelling of the ER and 
mitochondria, lack of DNA fragmentation and increased levels of JNK/SAPK1, which are 
not typically associated with apoptosis or necrosis (Korsnes et al., 2011).   
Alterations to cell shape, both rounding and membrane blebbing, and detachment 
from adhesion surfaces were also observed (Aune et al., 1991, Leira et al., 2002, 
Malaguti et al., 2002, Pang et al., 2011, Korsnes et al., 2011).  Effects appear to be 
concentration and time dependent, with higher concentrations inducing more evident 
damage earlier (Aune et al., 1991, Pérez-Gómez et al., 2006).  The concentration of YTX 
required for an observable alteration in morphology also seems to depend on the type 
of cell used (Aune et al., 1991, Leira et al., 2002, Malaguti et al., 2002, Korsnes et al., 
2006, Pérez-Gómez et al., 2006, Pang et al., 2011). 
1.3.2.3 Immune system 
Yessotoxin has been found to affect cells of the immune system such as macrophages 
(Orsi et al., 2010) and T-lymphocytes (López et al., 2011).  YTX was found to inhibit 
macrophage maturation and their ability to internalise the yeast Candida albicans at 1 
and 10 nM concentrations but not at 0.1 nM (Orsi et al., 2010).  The same study also 
found changes in morphology, with macrophages becoming smaller and more 
rounded.  The organisation of F-actin in the cytoplasm was also disrupted although no 
difference in the level of F-actin was detected.  Production of the cytokines TNF-α, 
MIP-1α and MIP-2 was also found to be increased in response to YTX treatment.   
In T-lymphocytes, a rapid down-regulation of the T cell receptor (TCR) followed by a 
late up-regulation after 48 h incubation with YTX is seen.  YTX was able to induce this 
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effect at a concentration of 1 nM (López et al., 2011).  The expression of TCR returned 
to basal levels following removal of the toxin.  This down regulatory effect was found 
to be partially blocked in a dose-dependent manner by staurosporine, indicating that 
the down-regulation of the TCR by YTX is partially modulated by the protein kinase C 
pathway and a second unknown pathway.  The expression of other cell surface 
molecules such as CD90.2 and CD40L were unaffected. 
1.3.2.4 Effect on intra-cellular calcium 
YTX has been found to cause an increase in intracellular Ca2+ levels in human 
peripheral blood lymphocytes (de la Rosa et al., 2001a, b) and mussel immunocytes 
(Malagoli et al., 2006b).  However this effect is only observed if Ca2+ is present in the 
extracellular matrix.  Compared to maitotoxin (MTX) (Fig. 2G), another polycyclic 
marine toxin, YTX was not a potent inducer of Ca2+ influx (de la Rosa et al., 2001b).  YTX 
caused intermittent influx of Ca2+ whereas MTX had a more sustained effect.  MTX also 
affected a greater number of cells than YTX.  Incubation of cells with YTX or MTX and 
various calcium channel blockers and agonists suggested that YTX and MTX are not 
acting on the same Ca2+ mediated pathway and are possibly activating more than one 
influx pathway (Malagoli et al., 2006a and b).  YTX and dsYTX do not strongly interact 
with sodium channel in membranes (Inoue et al., 2003).  In neuronal cells, blocking 
voltage sensitive calcium channels prevented calcium influx but did not stop cell death 
(Pérez-Gómez et al., 2006).  Blocking voltage sensitive sodium channels, in the same 
study, also failed to prevent cell death. 
The permeability transition pore (PTP) of mitochondria was also found to be affected 
by YTX (Bianchi et al., 2004).  YTX was found to cause an increase in the rate of state 4 
respiration in mitochondria isolated from rat liver.  However this effect was only 
observed when Ca2+ was present in the media, implicating opening of the PTP.  The 
proposed mechanism behind this effect is that Ca2+ binds to the sulphate groups of YTX 
at physiological pH 7.4, allowing YTX to then interact directly with the PTP or increase 
the hydrophobicity of YTX making it more membrane soluble.  The opening of the PTP 
may cause activation of the mitochondrial pro-apoptotic pathway.  The effect of YTX 
on the PTP, in addition to the increase in mitochondrial enzyme activity in 
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cardiomyocytes (Dell’Ovo et al., 2008) and the mitochondrial rounding seen in vivo 
(Terao et al., 1990, Aune et al., 2002, Tubaro et al., 2008) suggest that mitochondria 
may be one of the main targets of YTX. 
1.3.2.5 Effect on Cyclic AMP 
Changes in the levels of intracellular cAMP have also been seen in human peripheral 
lymphocytes (Alfonso et al., 2003) and in primary cultures of rat cardiomyocytes 
(Dell’Ovo et al., 2008).  In lymphocytes, YTX caused a decrease in the level of cAMP 
which was dependent on the presence of extracellular Ca2+ (Alfonso et al., 2003).  The 
authors suggest that YTX is increasing the rate of cAMP hydrolysis by activating 
phosphodiesterases.  A decrease in cAMP accumulation was also observed in rat 
cardiomyocytes (Dell’Ovo et al., 2008).  However, this was only seen when cAMP 
synthesis had been stimulated by prior incubation with forskolin.  YTX was not found 
to have any effect on basal or unstimulated levels of cAMP.  A decrease in cell viability 
and the beat frequency of the cardiac cells was also observed.  These effects are not 
thought to be related to the effect of YTX on cAMP as they are observed at lower 
concentrations than those required for a cAMP effect.  A transient, but significant, 
increase in the activity of mitochondrial enzymes was also observed in cardiomyocytes 
at low concentrations (first seen at 0.1 nM) of YTX. 
1.3.2.6 Effect on the cytoskeleton 
YTX appears to cause disruption of the cytoskeleton.  In MCF epithelial cells, no 
difference was observed in the level or structure of β or γ-catenins, however the 
amount of intact E-cadherin decreased after treatment with YTX (Ronzitti et al., 2004, 
Callegari et al., 2006).  Cell detachment was also observed.  Cell growth stopped 1-2 
days following treatment; however widespread cell death was not observed (Ronzitti 
et al., 2004).  In vivo, however stabilisation of E-cadherin was observed in mouse colon, 
following repeated oral administration of YTX (Callegari et al., 2006).  This effect 
appears to be reversible as no difference was detected between YTX treated and 
control mice 30 or 90 days after treatment.  YTX did not appear to affect E-cadherin in 
the lungs or kidneys, or N-cadherin.  YTX was found to disrupt the F-actin cytoskeleton 
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within 72 hours in the IPLB-LdFB insect cell line, mouse fibroblasts and primary 
cultures of myoblast and cerebellar neuronal cells (Malagoli et al., 2006a, Pérez-Gómez 
et al., 2006, Korsnes et al., 2007).  Decreased levels of native tensin and alterations to 
its distribution within cells were also observed (Korsnes et al., 2007).  The changes 
caused to the cytoskeleton by YTX may account for the changes to cell morphology 
observed in the studies mentioned in section 1.3.3 and in in vivo studies.  
1.3.2.7 Proteomic studies 
Young et al. (2009) showed that the major proteins affected by YTX in HepG2 liver cells 
were heterogeneous nuclear ribonucleoproteins (hnRNPs), lamins, cathepsins and heat 
shock proteins (HSPs).  Apoptosis was also observed in YTX treated cells.  Ingenuity 
pathways analysis (IPA) provided a possible network for the interaction between the 
proteins affected (Fig. 3A).  HnRNPs had not previously been identified as possible 
targets of YTX.  Alterations of hnRNP levels were also seen in HL60 cells treated with 
the microtubule stabilising agents; Pel A or PTX (Fig. 4) (Wilmes et al., 2011, 2012).  In 
HL60 cells treated with Pel A, IPA identified a protein network affected which was 
similar to that identified for YTX treated HepG2 cells (Fig. 3B). 
Comparison of protein changes identified in HepG2 cells treated with YTX (Young et al., 
2009) and those identified in HL60 cells in response to microtubule stabilising agents 
(Wilmes et al., 2011, 2012) revealed a number of proteins in common, although these 
were not always similarly affected (Fig. 4).  BAG2, BiP (HSP70), and hnRNP A were 
affected in both cell lines.  Lamin B1 had decreased levels in paclitaxel (PTX) treated 
HL60 cells and HepG2 cells treated with YTX.  Actin (β), β-tubulin, HSP90B1, and hnRNP 
K were affected by Pel A in HL60 cells and YTX in HepG2 cells, although changes in 
abundance were usually in opposite directions. 
 
 
Introduction 
12 
 
1.4 Desulfo-yessotoxin 
1.4.1 In vivo effects 
1.4.1.1 Lethality 
It has been suggested that di-desulfoyessotoxin (dsYTX, Fig. 1) may be formed through 
metabolism of YTX by micro-organisms in the intestine of humans following ingestion 
(Ogino et al., 1997).  Chemically prepared dsYTX, has an i.p LD50 of 301 µg/kg b.w at 48 
h (Terao et al., 1990).  In the same study YTX had an LD50 of 286 µg/kg b.w at 3 h.  
Mono-desulfated analogues, 1-desulfocarboxy-homo-YTX and 4-desulfocarboxy-homo-
YTX, have an i.p LD50 > 0.5 mg/kg b.w at 24 h, compared to YTX which was lethal to two 
out of three mice at a concentration of 0.1 mg/kg b.w at 24 h in female mice 
(Ciminiello et al., 2007). 
dsYTX is lethal to killifish (Oryzias latipes) at a concentration of 0.5 ppm (510 nM) after 
6 h (Ogino et al., 1997).  YTX was found to be non-lethal in the same study. 
1.4.1.2 Histopathology 
Histopathological analysis following administration of dsYTX to mice found changes in 
the heart, liver and pancreas, but not in the intestine (small or large), adrenal glands, 
kidneys, spleen or thymus (Terao et al., 1990).  The main effect observed was 
accumulation of fat droplets within cells of the affected organs.  The accumulation was 
slight in cardiac cells, but more pronounced in the liver, which became yellow and 
swollen within 12 h of i.p administration of 300 µg/kg b.w of dsYTX, and pancreatic 
acinar cells. 
Electron microscopy of the liver cells showed approximately 1 fat droplet formed per 
cell, in the cytoplasm, within 10 min of dsYTX administration.  However this increased 
to numerous small fat droplets within 24 h.  By 10 min after administration, 
autophagosomes were observed near the bile capillary, associated with the rough 
endoplasmic reticulum (ER).  The cytoplasm was full of large and small 
autophagosomes by 24 h.  The contents of these were found to be degenerated ER, 
vesicles and other cell debris.  At later stages after administration, autophagosomes 
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were also detected in Kupffer and Ito cells.  Mitochondria were also noted to be 
swollen and have reduced electron density (Terao et al., 1990). 
The pancreatic acinar cells contained several fat droplets in their cytoplasm.  Complete 
disappearance of zymogen granules was also observed, as well as disarrangement of 
the rough ER.  Other pancreatic cells were not affected (Terao et al., 1990).   
Lipid analysis from the same study showed that, following the administration of dsYTX, 
there was an increase in the total fat content of the liver, but not of the kidneys or 
blood.  Livers of mice treated with dsYTX contained 60 times the amount of 
triglycerides of controls or YTX treated mice, and twice the amount of phospholipids.  
A lipid peroxidation assay using thiobarbituric acid, showed double the amount in 
dsYTX mice livers compared to YTX.  This suggests the increase in fat content is due to 
an increased degradation of membrane structures within the cell. 
Oral administration of 500 µg dsYTX/kg b.w to mice 21 h prior to sacrifice, produced 
similar, but less severe, effects as i.p injection (Terao et al., 1990).  
The differences in effects of dsYTX compared with the effect of YTX in vivo (section 
1.3.1), indicates that the two toxins have different targets and mechanisms of action. 
 
1.4.2 In vitro effects 
1.4.2.1 Anti-microbial action 
Like YTX, dsYTX inhibits the growth of fungi and yeast but not bacteria (Ogino et al., 
1997).  It was found to be a more potent inhibitor of the fungus Penicillium 
funiculosum than YTX, causing inhibition at 10 µg/disc compared to YTX which caused 
inhibition at 50 µg/disc. 
1.4.2.2 Interactions with proteins 
dsYTX has been found to enhance the hemolysis caused by alamethicin I and melittin, 
α-helix containing peptides, in a dose-dependent manner (Mori et al., 2005).  In the 
same study it was also shown to decrease the amount of oligomers of glycophorin A 
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and its transmembrane peptide (both containing an α-helix), while increasing the 
number of dimers and monomers.  This suggests that the toxin has the ability to 
interact with the α-helix of these proteins and peptides.  YTX and brevetoxin B (Fig. 2B) 
were observed to have similar efficacy as dsYTX.  The tested ladder shaped polyethers 
(LSPs) were found to have 10-fold higher affinity than artificial polyethers in the 
glycophorin dissociation assay.  The authors concluded that the LSP structure can 
generally interact with α-helix motifs. 
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1.5 Aims 
The aims of this project were to use the proteomic techniques of differential in gel 
electrophoresis (DIGE) and peptide mass fingerprinting to examine the effects of YTX 
and dsYTX on Saccharomyces cerevisiae and HL60 cells, in order to elucidate the 
mechanism of action of these toxins, by identifying potential targets – either proteins 
or pathways. 
Proteomics is the study of the proteins present in cells at a given time.  Comparison of 
protein profiles from cells under different conditions can identify those proteins or 
pathways which are most affected.  These may be primary targets or a secondary 
effect. 
For this study S. cerevisiae was selected as a model organism.  As many basic biological 
structures and processes have been preserved in eukaryotes, it is possible for yeast to 
serve as indicators for the function of human genes (Kolkman et al., 2005).  S. 
cerevisiae can be readily genetically manipulated, allowing for the generation of gene 
knock-out mutant strains.  Examining the response of a mutant strain to a compound 
of interest, and comparing it with the response of the wild type strain can give an 
indication of the target or mechanism of action of that compound.  
As similarities in the proteins affected in HepG2 cells treated with YTX (Young et al., 
2009) and HL60 cells treated with microtubule stabilising agents (Wilmes et al., 2011, 
2012) were observed (section 1.3.2.7), HL60 cells were also exposed to YTX, in order to 
identify which changes seen in YTX treated HepG2 cells are toxin or cell line specific, or 
a general cell response to stress. 
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Figure 3 Networks determined by IPA to be affected by YTX in HepG2 cells (A) (Young et al., 2009) and Pel A in HL60 cells (B) (Wilmes et al., 2011).  Green and red represent 
decreases and increases respectively in the protein abundance.  The intensity of the colour reflects the magnitude of the fold change.  Grey symbols are proteins that were 
identified but did not have a significant abundance change.  Definitions of abbreviations and the symbol key are listed in Appendix A.  
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Figure 4 Venn diagram comparing the protein changes seen in HepG2 cells treated with YTX (Young et al., 2009) and HL60 cells treated with peloruside A (Pel A) 
or paclitaxel (PTX) (Wilmes et al., 2011, 2012).  Upwards pointing arrows indicate proteins which showed an increase in abundance in response to treatment.  
Downwards pointing arrows indicate proteins which decreased in abundance in response to treatment. 
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2 METHODS 
2.1 Yessotoxins 
Both YTX and dsYTX were provided by C. Miles and A.D. Hawkes, AgResearch Limited, 
Ruakura Research Centre, Hamilton, New Zealand.  These compounds were each 
dissolved in methanol (≥ 99.8% pure), giving stock concentrations of 10 μg/μL and 5 
μg/μL respectively (Appendix B). 
 
2.2 Yeast strains 
The Saccharomyces cerevisiae strains used were the haploid BY4741 mat a wild type 
strain and an ADΔ pump knock-out mutant which lacks seven of the ABC transporters 
(Lamping et al., 2007).  The latter was provided by Dr. Brian C. Monk, Department of 
Oral Sciences, University of Otago, Dunedin, New Zealand.  The ADΔ strain was 
received on agar slants.   Upon arrival stocks were made up in 10% glycerol YPD media.  
These were stored at -80°C until required. 
 
2.3 Mammalian cell lines 
HL-60 human promyelocytic leukemic blood leukocyte cells were used for mammalian 
cell work, and were acquired from Professor John H. Miller’s group, School of 
Biological Sciences, Victoria University of Wellington, Wellington, New Zealand. 
 
2.4 Yeast cell culture and protein extraction 
2.4.1 Plate culture  
S. cerevisiae strains were plated onto YPD agar plates using sterile technique.  Plates 
were incubated at 30°C for 2 days.  They were then stored at 4°C until required.
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2.4.2 Liquid culture 
Single colonies were selected from plates and transferred into 3 mL of 2% glucose YPD 
media.  These were incubated at 30°C, 225 rpm (Bioline Shaker, Edwards Instrument 
Company, Australia), until cells reached stationary phase.  Cultures were considered to 
be at stationary phase when they reached a cell density of approximately 2 x 108 
cells/mL. 
An aliquot (typically 10 μL) from these cultures was then taken and transferred into 10 
mL of 2% glucose YPD media, and incubated until cells reached either growth or 
stationary phase as required.  Cultures were considered to be at stationary phase 
when they had reached a density of approximately 2 x 108 cells/mL or an absorbance 
of 0.8-1 at 595 nm.  Cultures were considered to be at log phase when they had 
reached an absorbance of 0.4-0.5 at 595 nm. 
 
2.4.3 Determination of cell density 
The cell density of cultures was determined by cell counting using a hemocytometer.  
Ten μL of a yeast sample was diluted 1:100 with Milli-Q or High-Q water, and 10 μL of 
this was then loaded onto the hemocytometer, and observed with a phase contrast 
microscope 
For absorbance measurements, triplicate 100 μL aliquots of each sample were 
pipetted into a 96 well plate.  Absorbance readings were measured at 595 nm using a 
Molecular Devices, VERSAmax tunable microplate reader (Applied Biosystems, 
Melbourne, Australia).  YPD media containing 2% glucose was used as a blank. 
 
2.4.4 Toxin treatment 
Ten mL S. cerevisiae cultures were divided into 1.5 mL aliquots once cells had reached 
either log or stationary phase as required.  There were three conditions tested: 
untreated, methanol treated, and toxin treated (n=2).  Two µL methanol (0.13% v/v 
final concentration) was added to methanol treated controls.  Toxin treated samples 
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were treated with 2 or 20 µg of YTX or 2 µg of dsYTX.  All cultures were then incubated 
at 30°C for 24 h. 
S. cerevisiae cells from liquid cultures were harvested by centrifugation at 2300 g for 5 
min.  The supernatants were discarded and the pellets were resuspended in 1.5 mL 
Milli-Q or High-Q water before being centrifuged as before.  The supernatants were 
removed and the wash step repeated.  The supernatants were removed and the 
pellets were resuspended in 1 mL protease inhibitor solution (1 complete mini EDTA 
free protease inhibitor cocktail tablet (Catalogue number: 11 836 170 001, Roche 
Diagnostics GmbH, Mannheim, Germany) dissolved in 10 mL Milli-Q or High-Q water).  
The cell suspensions were then centrifuged as before, the supernatants were removed 
and cell pellets were stored at -80°C until required.   
 
2.4.5 Morphological analysis 
Ten μL of sample culture was diluted 1:100 with Milli-Q or High-Q distilled water.  Fifty 
μL of the diluted sample was then observed using a phase contrast microscope. 
 
2.4.6 Cell lysis and protein extraction 
Cell pellets were resuspended in 100 μL cell lysis buffer (30 mM TrisCl (pH 8.8), 7 M 
urea, 2 M thiourea, 4% w/v CHAPS) and transferred to 1.5 mL microcentrifuge tubes 
containing approximately 50 µL white quartz sand (50+70 mesh, SIGMA-ALDRICH Inc., 
St. Louis, Missouri).  The samples were then ground using mini pestles.  During this 
process the samples were kept on ice.  Following grinding, the samples were vortexed 
for 30 min at 4°C.  They were then centrifuged at 16,000 g for 15 min at 4°C.  The 
supernatants were transferred to 0.6 mL microcentrifuge tubes and stored at -20°C 
until required.  On average, 1 x 107 cells yielded approximately 20 µg of protein. 
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2.5 HL-60 cell culture and protein extraction 
2.5.1 Mammalian cell culture 
HL-60 cells were cultured in GIBCO® RPMI-1640 media containing L-glutamine and 
phenol red indicator (Invitrogen).  The media was supplemented with 10% FCS, 100 
units/mL penicillin and 100 units/mL streptomycin, at 37°C with 5% CO2 in air.  When 
cells reached approximately 80% confluency they were passaged by diluting the 
culture 1:10 or 1:20 with media.  
 
2.5.2 Determination of cell density 
The density of HL-60 cells was determined by a trypan blue live/dead exclusion assay.  
Ten μL of HL-60 cell samples were diluted 1:2 with 0.4% trypan blue.  Ten μL of this 
was then loaded onto a hemocytometer.  Live cells were considered to be those which 
were white or colourless.  Cells which displayed blue colouration were considered to 
be dead.  Only live cells were considered when calculating cell density. 
 
2.5.3 Toxin treatment 
Three x 20 mL cultures of HL-60 cells were grown to 80% confluency then combined, 
and 9 x 106 cells were then seeded into cultures of 10 mL total volume.  Ten mL 
cultures (n=4) were then treated with methanol (0.02% v/v final concentration) or 1 
μM of YTX or dsYTX.  The cultures were then incubated at 37°C with 5% CO2 in air for 
24 h. 
HL-60 replicates were then transferred to 15 mL screw top test tubes and centrifuged 
at 300 g for 5 min.  The supernatants were discarded and the pellets were 
resuspended in 10 mL ice cold PBS before being centrifuged as before.  The 
supernatants were removed and discarded.  The pellets were resuspended in 1 mL of 
PBS and transferred to 1.5 mL microcentrifuge tubes and centrifuged at 300 rpm 
(SIGMA 1-14 Laboratory Table Top Microcentrifuge).  The supernatants were discarded 
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and the pellets resuspended in 1 mL PBS/protease inhibitor solution (one complete 
mini EDTA free protease inhibitor cocktail tablet (Catalogue number: 11 836 170 001, 
Roche) in 10 mL PBS and centrifuged again.  The supernatant was removed from each 
sample as much as possible.  The pellets were then stored at -80°C until required. 
 
2.5.4 Morphological analysis 
HL60 cells were observed in culture using phase contrast microscopy. 
Images of cells were acquired using a CC12 Soft Imaging System camera connected to 
an Olympus IX51 microscope, and Olympus Cell A Imaging software. 
 
2.5.5 HL-60 cell lysis and protein extraction 
Lysis buffer was added to pellets in a ratio of 60 μL per 3.6 x 106 cells.  The pellets were 
resuspended in lysis buffer and vortexed for 30 min at 4°C.  They were then 
centrifuged at 16,000 g for 15 min at 4°C.  The supernatants were then transferred to 
0.6 mL microcentrifuge tubes and stored at -20°C until required.  On average, 
approximately 960 μg of protein were extracted per 1 x 107 cells. 
 
2.5.6 Preparation of samples for analysis by gel electrophoresis 
2.5.6.1 Protein assays 
Triplicate 1 μL aliquots from each yeast or HL-60 sample were pipetted into a 96 well 
plate.  Two hundred μL of Protein Assay, Dye Reagent concentrate (Bio-Rad, Hercules, 
California) diluted with 4 volume equivalents of Milli-Q or High-Q water was then 
added to each well.  Absorbance readings were measured at 595 nm using a Molecular 
Devices, VERSAmax tunable microplate reader (Applied Biosystems).  The protein 
concentration of samples was determined by comparison to a BSA standard curve.   
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2.5.6.2 Protein precipitation 
Proteins were precipitated using Calbiochem ProteoExtract™ Protein precipitation kit 
(Merck, Darmstadt, Germany).   One hundred μL of precipitant was added to 50-100 μL 
protein extracts from yeast samples.  For HL-60 protein extracts 4 x volume 
equivalents of precipitant were added.  The samples were then incubated at -20°C for 
at least 1 h.  Following this they were centrifuged at 13,000 g for 10 min.  The 
supernatants were discarded and 100 μL of wash buffer was added to each pellet.  The 
samples were vortexed briefly, before being centrifuged at 13,000 g for 5 min.  The 
supernatants were removed again and the wash step repeated.  The pellets were then 
allowed to dry at room temperature for 30 min before being resuspended in either 
lysis buffer or rehydration buffer. 
 
2.5.7 Gel electrophoresis 
2.5.7.1  One-dimensional electrophoresis 
Stock sample buffer was made up consisting of 2.5 μL LDS sample buffer (4x, NuPAGE®, 
Invitrogen, Carlsbad, California), 1 μL reducing agent (10x, NuPAGE®, Invitrogen) and 
5.5 μL Milli-Q or High-Q water per sample).  One μL of sample was added to 9 μL of 
sample buffer solution.  The samples were then vortexed and centrifuged briefly to 
remove air bubbles.  The samples were electrophoresed on 4-12% Bis-Tris gels 
(NuPAGE®, Invitrogen), at 200V, 400 mA for 55 min, in MOPS running buffer (MOPS 
SDS running buffer (20x) NuPAGE®, Invitrogen).  The buffer in the central chamber had 
500 µL of antioxidant (Invitrogen) added before electrophoresis began.   
2.5.7.2  Two-dimensional electrophoresis 
2.5.7.2.1 Isoelectric focusing 
Protein samples were separated by IEF on 7 cm Immoboline™ DryStrips (GE Healthcare 
Bio-Sciences A.B, Uppsala, Sweden).  Following the precipitation procedure pellets 
were resuspended in either 125 μL of rehydration buffer (2 M thiourea, 7 M urea, 2% 
DTT, 4% CHAPS, trace bromophenol blue, 2% IPG buffer (GE Healthcare)), for samples 
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to be focused on pH 3-10, pH 3-10 NL or pH 4-7 DryStrips, or 100 μL rehydration buffer 
(2 M thiourea, 7 M urea, 2.5% DTT, 2% CHAPS, 5% glycerol, 10% isopropanol, 1% IPG 
buffer) for samples to be focused on pH 6-11 DryStrips.  Samples focused on pH 3-10, 
pH 3-10 NL or pH 4-7 DryStrips were loaded onto the strips by passive loading.  This 
was done by rehydrating the strip overnight in 125 μL of sample containing 
rehydration buffer.  The pH 6-11 DryStrips always had samples loaded onto them by 
cup-loading, so were rehydrated overnight in 125 μL of rehydration buffer.  
Rehydration of DryStrips was done in an Immobiline DryStrip Reswelling tray (GE 
Healthcare).  After being placed into rehydration buffer each strip was covered with 3 
mL of mineral oil (PlusOne DryStrip cover fluid, GE Healthcare). 
IEF was carried out using a Multiphor II system (Pharmacia) connected to a power 
supply (electrophoresis power supply EPS 3500 XL, Pharmacia BioTech) and waterbath 
(Julabo).  DryStrips were run on gradient setting.  The first step was at 200 V for 1 h.  
The second step was 3500 V for 1 h 30 min.  The last step was at 3500 V for 1 h 30 min 
for pH 3-10, and 4-7 strips; and 1 h 5 min for pH 6-11 and 3-10 NL strips.  Temperature 
was kept constant at 20°C.  Total current was 2 mA and total power was 5 W.  Strips 
were either equilibrated immediately following IEF, prior to loading on second 
dimension gels or stored at -80°C until required. 
2.5.7.2.2 Equilibration 
Strips were equilibrated by 2 x 10 min incubations in 2-2.5 mL equilibration buffer (50 
mM Tris-HCl (pH 8.8), 6 M urea, 30 % v/v glycerol, 2% w/v SDS).  The first 10 min 
incubation was in 1% DTT equilibration buffer, the second in 2.5% IAA equilibration 
buffer. 
2.5.7.2.3 Electrophoresis 
Second dimension SDS-PAGE was carried out under the same conditions as for 1DE 
gels on 4-12% Bis-Tris ZOOM™ gels (NuPAGE®, Invitrogen). 
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2.5.7.2.4 Staining 
Gels were stained with Coomassie Brilliant Blue G-250 powder (Bio-Rad).  The gels 
were incubated for at least 30 min in fixing solution (50% ethanol, 3% phosphoric acid) 
before being washed for 3 x 30 min with Milli-Q or High-Q water.  Gels were then 
incubated in staining solution (34% methanol, 17% ammonium sulphate, 3% 
phosphoric acid) for at least an hour.  A small spatula tip (approximately 10 mg) of 
Coomassie was added and the gels were left to stain for at least 3 days at room 
temperature.  Gels were washed thoroughly with Milli-Q or High-Q water, at least 3 x 
30 min incubations, to remove excess Coomassie prior to image acquisition using a 
Molecular Dynamics Personal Densitometer SI. 
2.5.7.2.5 DIGE 
DIGE is proteomics tool which allows direct comparison of samples across multiple 
gels.  Protein samples are labelled with one of three CyDye fluorophores (fluors): Cy2, 
Cy3 or Cy5.  The CyDyes bind to lysine residues present in the proteins.  The CyDye 
fluors are positively charged, to replace the charge on the lysine when bound, so the 
isoelectric point of the protein is not affected.  The CyDyes are also weight matched to 
each other, so identical proteins will migrate the same distance regardless of which 
dye they are labelled with.  Each CyDye has a different excitation frequency.  This 
allows multiple samples (two) to be run on one gel, alongside an internal standard.  An 
internal standard is a pool of all the samples in a given experiment, and is run on all 
gels in the experiment.  This aids protein spot matching between gels, reducing the 
effect of gel to gel variation.  An overview of the DIGE procedure is shown in fig. 5. 
In this project, protein samples were minimally labelled with CyDye fluors.  Minimal 
labelling results in 1-2% of lysine residues being bound by CyDyes (in theory one fluor 
is bound per protein).  This gives a linear relationship between fluorescence and 
protein concentration, allowing accurate comparison of protein abundances to be 
made. 
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The protein concentration of a sample was adjusted to lie in the range 5-10 µg/µL by 
precipitating the protein, as previously described, and then resuspending the sample in 
suitable volume of lysis buffer. 
The pH of the samples was adjusted to 8.5 by the addition of a small amount (0.1-0.5 
µL) of pH 8.8 Tris-HCl buffer. 
Eighty pmol of Cy3 or Cy5 CyDyes (GE Healthcare) were added to 20 µg of protein from 
each treatment condition.  Half of the replicates from each condition were labelled 
with Cy3 and the other half were labelled with Cy5.  An internal standard was made 
consisting of 10 µg of protein from each sample, and 240 pmol of Cy2.  The samples 
were vortexed and centrifuged briefly before being incubated on ice for 30 min in the 
dark.  One µL of 10 mM lysine per 20 µg of protein was added to each solution to 
quench the reaction.  The samples were vortexed and centrifuged briefly, then 
incubated on ice for a further 15 min in the dark.  The samples were then combined so 
Figure 5 Flow diagram of DIGE procedure.  Proteins were separated by 2DE.  Image analysis 
and quantitation was carried out using DeCyder software version 6.5. (Image source: 2-D 
Electrophoresis: Principles and Methods handbook, GE Healthcare) 
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that sample mixtures contained equal amounts of internal standard, and samples from 
two different treatment conditions.  If not analysed straight away mixed sample 
solutions were stored in the dark at -20°C.  An example of a DIGE experiment design is 
shown in Appendix C. 
Samples underwent first and second dimension separation as described previously.  
Immediately after second dimension separation had been completed, 2D-DIGE gels 
were scanned using a Fujifilm Fluorescent Image Analyser FLA-5100 scanner (Fuji 
Photo Film Co. Ltd., Tokyo, Japan).  Cy2 images were scanned using a 473 nm laser and 
BPB1/530DF20 filter.  Cy3 images were scanned using a 532 nm laser and 
BPG1/570DF20 filter.  Cy5 images were scanned using a 635 nm laser and DBR1/R665 
filter.  All gels were scanned at 50 μm resolution and 16 bits.   
2.5.7.2.6 Gel Image Analysis 
DIGE gel images were acquired as TIFF files from the scanner.  These were converted 
to .gel files using IQ Tools software, version 5.2 (Molecular Dynamics).  The .gel files 
were then combined to make one multichannel image using Fluorochrome Separation 
2.2, Multicolour version (Molecular Dynamics) to make the dataset file.  The intensity 
of each CyDye signal was adjusted using IQ Tools, until it was approximately even 
between all gels, and protein spots were visible on the display.  The image was then 
cropped, before being imported into DeCyder 2D Software, version 6.5 (GE Healthcare) 
for DIGE analysis. 
The images from one experiment were all imported into DeCyder using the Image 
Loader function.  They were then all processed simultaneously using the Batch 
Processor function.  Estimated number of spots for spot detection was set to 2500.  
The Batch Processor detects and matches the spots on multiple gels automatically.  All 
gels are matched to a master gel (by default the gel assigned as the master is one on 
which the most protein spots are detected).  Matching is based on a pattern 
recognition algorithm, where a spot on one gel is matched to a spot on another gel 
based on the surrounding spots.  This process has two parts to it.  The first part 
matches large spots over the whole gel, by comparing the positions and sizes of the 
spots around it.  These matched spots are then used as landmarks.  The remaining 
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spots are matched, moving outwards from the landmarked spots.  The second part of 
the spot matching process involves transforming the spot centre detected on one gel 
to another gel.  The transformation is considered a match if the transformed co-
ordinates are close enough to the spot centre detected on the other gel.  After each 
matching step the algorithm performs a control which removes obvious mismatches. 
Following batch processing, the created workspace was opened in the DeCyder 
Biological Variation Analysis (BVA) module.  The spot matching was checked and 
corrected manually if required.  BVA was used to calculate changes in spot volume 
(average ratio) and statistics for the change (Student’s t-test, one way ANOVA).  
Proteins were labelled as being of interest if they had a t-test value ≤0.05 and an 
average ratio value ≤ -1.5 or ≥ 1.5.  Changes in protein abundance of 2-fold or greater 
(p ≤ 0.01) were considered significant.  Two biological replicates per treatment group 
were used for initial exploratory experiments.  Four biological replicates per treatment 
group were used in the final experiment to give a power of 0.8 (Karp and Lilley, 2007).   
To determine if spots of interest were true protein spots or just noise, possibly from 
dust, spots were also inspected in the 3D-view in DeCyder.  Sharp peaks, generally 
around the edge of a gel, were classed as noise.  Round peaks were classed as protein 
spots (Appendix D).  The false discovery rate (FDR) filter was used to control for type I 
errors.  Applying this filter identifies protein spots that have a change in abundance 
which is more likely to have arisen through chance, than to be a true effect of the 
treatment. 
The average ratio was calculated from the log standardised abundance of the protein 
spots.  The degree of difference in the standardised abundance was the average ratio.  
The average ratio is expressed as values from -∞ to -1 or 1 to ∞.  The abundance of a 
protein spot was quantified as a function of the internal standard.  This value is the 
standardised abundance.  The log10 of this was the log standardised abundance. 
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2.5.8 Protein identification 
Proteins were identified by peptide mass fingerprinting.  Proteins were excised from 
2D gels then subjected to tryptic digestion.  The resultant peptide fragments were then 
subjected to MALDI analysis either on a Voyager-DE PRO mass spectrometer or an AB 
Sciex TOF/TOF 5800 mass spectrometer.  The sequences acquired from this process 
were then searched against the NCBI non-redundant protein sequence database using 
either the Profound or Mascot algorithm. 
2.5.8.1 Preparation of protein spots for MALDI analysis 
Protein spots were extracted from the gels using a spot picker (OneTouch Plus 
Spot/Band picker PDM1.5, The Gel Company,  San Francisco, California) or a scalpel 
and placed in a 96 well v-bottom plate containing 100 µL destaining solution (50% 
methanol, 50 mM ammonium bicarbonate) in each well.  The plate was then left to 
destain overnight at 4°C.  The plates were then processed using an Ettan Automatic 
Digester (Amersham Biosciences) with the following programme: 3 cycles in 50% 
methanol, 50 mM ammonium bicarbonate for 20 min each, followed by air drying for 
60 min.  Trypsin (Modified Sequencing Grade, Roche); (0.05 µg/well in 20 mM 
ammonium bicarbonate) was added for 300 min, followed by the addition of 20 mM 
ammonium bicarbonate for 20 min.  The peptides were transferred to a fresh plate by 
adding a solution of 50% acetonitrile and 0.1% TFA for 3 x 20 min cycles.  The 
recovered proteins were allowed to air dry overnight in a laminar flow hood.  Once 
dry, the proteins were resuspended in 1.5 µL of CHCA matrix (10 mg/mL CHCA, 0.25% 
TFA, 50% acetonitrile, containing 0.5 µL of Calibration Mixture 2 (AB Sciex, Foster City, 
California)).  Resuspended samples were transferred onto a MALDI plate and left to dry 
overnight.   
2.5.8.2 MALDI-TOF MS Analysis 
MALDI TOF analysis was carried out using a Voyager-DE PRO mass spectrometer 
(Applied Biosystems).  The spectra were collected over the mass range 500-3500 m/z, 
with an approximate laser intensity range of 1450-1600 and 100 shots were collected 
per spectrum.  Analysis of the spectra was carried out using Data Explorer software 
version 5.1 (Applied Biosystems).   The acquired spectra were calibrated internally 
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using Calibration Mixture 2 (Applied Biosystems, Foster City, CA) ), containing a 
angiotensin I (average m/z 1297.51), adrenocorticotropic hormone (ACTH) clip 1-17 
(average m/z 2093.0867) and ACTH clip 18-39 (average m/z 2465.1989).  Trypsin peaks 
(m/z 805.4167, 1153.5740, 2163.0566) were also used for internal calibration if they 
were present in the spectrum.  The peptide masses generated were then searched 
against the NCBI non-redundant database (2009/09/01) for S. cerevisiae using the 
Profound algorithm.  Search criteria included a protein mass in the range of 0-300 kDa, 
one missed trypsin cleavage, complete cysteine modification by IAA and partial 
modification of methionine by oxidation, and a mass tolerance of 40 ppm.  Match 
criteria included at least 5 matched peptides, sequence coverage (correct cleavage 
sites – peptides end with K or R, ≥ 20% coverage), and a difference between first and 
second ranked identifications of at least 1x10-3. 
2.5.8.3 MALDI TOF-TOF MS/MS Analysis 
MALDI TOF-TOF MS/MS analysis of samples was carried out using an AB Sciex TOF/TOF 
5800 mass spectrometer (Applied Biosystems, Foster City, CA) equipped with a diode 
pulse laser (355nm, 1kHz).  The spectrometer was controlled by TOF/TOF™ Series 
Explorer™ Software.   
2.5.8.3.1 Acquisition of spectra for MS 
Spectra for MS analysis were acquired in positive reflector mode with CID off.  Peptide 
fragments were collected in the mass range 800-4000 Da.  The laser intensity was fixed 
at 3000 with a pulse rate of 400 Hz.  The laser was fired in a uniform random pattern.  
A total of 400 laser shots were collected per full spectrum. 
2.5.8.3.2 Calibration of spectra for MS 
MS spectra were internally calibrated using CalMix2 (Applied Biosystems) 
monoisotopic peaks for angiotensin I (m/z 1296.6853), adrenocorticotropic hormone 
(ACTH) clip 1-17 (m/z 2093.0867), ACTH clip 18-39 (m/z 2465.1989) and ACTH clip 7-38 
(m/z 3657.9294).  Peak matching criteria for calibration included a signal to noise ratio 
greater than or equal to 5, mass tolerance of ±0.3 m/z, a minimum of 3 matched 
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peaks, and maximum outlier error was 0.8 m/z.  A list of reference masses is shown in 
Appendix E. 
2.5.8.3.3 Precursor ion selection for MS/MS 
Selection criteria for precursors to undergo MS/MS analysis included a signal to noise 
ratio greater than or equal to 20, mass within the range 800-4000 Da, and exclusion of 
precursor ions within a resolution of 200 of the selected precursor ion.  Known adduct, 
calibration and common contaminant peaks, such as trypsin, were excluded.  A full list 
of exclusion masses is shown in Appendix F.  A maximum of 10 precursor ions were 
selected per spot.  MS/MS data were acquired from weakest precursor ion first. 
2.5.8.3.4 Acquisition of spectra for MS/MS 
Spectra for MS/MS analysis were acquired in 1kV positive reflector mode, with CID and 
metastable suppressor on.  The laser intensity was fixed at 3500 with a pulse rate of 
1000 Hz.  The laser was fired in a random uniform pattern.  Acquisition of spectra was 
stopped after 5 sub-spectra were collected.  A total of 1000 laser shots were collected 
for the final spectrum.  
2.5.8.3.5 Calibration of spectra for MS/MS 
The monoisotopic angiotensin 1 peak (1296.800 Da) was the selected precursor ion for 
calibration.  MS/MS spectra were then calibrated using known fragment ion masses 
from this precursor ion (Appendix D).  Peak matching criteria for calibration included a 
signal to noise ratio greater than or equal to 10, mass tolerance of ±0.3 m/z, a 
minimum of 3 matched peaks, and maximum outlier error of 20 ppm. 
2.5.8.3.6 Comparison of peptide sequences to NCBI database 
Peptide fingerprints and MS/MS sequences were imported into Protein Pilot™ 
software.  The MASCOT algorithm was used to search the generated peaks lists against 
the NCBI non-redundant database (2008/09/02, 21331 sequences) for S. cerevisiae 
(905409 sequences) for proteins obtained from S. cerevisiae samples, or for Homo 
sapiens (218446 sequences) for proteins from HL-60 cells.  Other search parameters 
included one missed trypsin cleavage, fixed carbamidomethyl modification of cysteine 
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by IAA, variable modification by methionine oxidation, MS/MS fragment tolerance of 
±0.1 Da, precursor tolerance of ± 0.05 Da, monoisotopic masses, and a +1 peptide 
charge. 
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3 RESULTS 
3.1 S. cerevisiae 
The effects of YTX and dsYTX were initially examined using 2D DIGE.  The goal was to 
identify proteins that changed for comparison with known effects of YTX on HepG2 
cells (Young et al., 2009).  MALDI mass fingerprinting was used to identify protein spots 
excised from 2D gels. 
 
3.1.1 Morphological analysis 
The morphology of S. cerevisiae samples was observed at 0 h and 24 h after toxin 
treatment, using phase contrast microscopy.  There were no differences in morphology 
between toxin treated cells and controls in either the wild type or pump knock-out 
mutant strain.   
 
3.1.2 2D-DIGE analysis 
The protein extracts from preliminary tests on yeast (n=2)  in stationary and log phase, 
wild type and pump knock-out mutant yeast strains, treated with either 1.2 µM or 12 
µM YTX or 1.4 µM dsYTX were analysed for changes in levels of protein expression by 
2D DIGE.  The gel images were analysed using DeCyder software (version 6.5), which 
quantified the fold change and calculated the relevant statistics.  A change in protein 
abundance ≥ 2-fold, p ≤ 0.01 was considered significant (Karp et al., 2007).  However, 
as very few protein spots matched this criterion, the decision was made to also take 
note of proteins which might be changing below the defined significance level.  The 
criteria for these proteins of interest was a fold change ≥ 1.5, p ≤ 0.05.  Tables 2 - 4 
summarise the number of protein spots of interest detected under each experimental 
condition.  These changes were only observed when the false detection rate (FDR) 
filter was not applied.  When the FDR filter was applied, no protein spots met the 
criteria for significance.  DeCyder statistics for all proteins of interest and picked 
protein spots are reported on the Supplementary Data on CD. 
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Table 2 Effects of YTX on stationary phase yeast cells.  The number of proteins from stationary phase 
BY4741 and ADΔ strains, which showed a change in possible change in abundance when analysed using 
DIGE (≥ 1.5-fold, p ≤ 0.05).  No protein changes were significant using the criteria ≥ 2-fold, p ≤ 0.01.  The 
total spots detected per gel, includes all data point matches detected by DeCyder software, including 
those which are not necessarily protein spots. 
 
All detected changes in response to 1.2 µM YTX were decreases in protein abundance 
(Table 5, Figs 6 and 7).  The two proteins that showed a change in YTX treated cells 
compared to untreated controls, did not show a change when compared to methanol 
treated controls.  The six detected changes in cells treated with 12 µM YTX compared 
to methanol controls were split equally between increasing and decreasing 
abundances.  However no changes in abundance were seen when proteins from 
treated cells were compared to those from untreated control cells. 
 
Table 3 Effects of 12 µM YTX on log phase yeast cells.  The number of proteins from log phase yeast cells, 
BY4741 and ADΔ strains, which were deemed to be of interest when comparing the different 
experimental treatments (≥ 1.5-fold, p ≤ 0.05).  No protein changes were significant using the criteria ≥ 
2-fold, p ≤ 0.01.  The total spots detected per gel, includes all data point matches detected by DeCyder 
software, including those which are not necessarily protein spots. 
 
  
Stationary phase Comparison of Change 
Strain pH 
YTX/untreated YTX/MeOH MeOH/untreated Total spots 
1.2 µM 12 µM 1.2 µM 12 µM 1.2 µM 12 µM 1.2 µM 12 µM 
BY4741 
4-7 2 0 1 6 0 0 2530 2355 
6-11 1 0 0 0 0 0 2565 2318 
ADΔ 
4-7 0 0 0 0 0 0 2062 2330 
6-11 0 0 0 0 0 0 2458 2564 
Log phase Comparison of Change 
Strain pH YTX/untreated YTX/MeOH MeOH/untreated Total spots 
BY4741 
4-7 6 0 6 2361 
6-11 6 0 7 2514 
ADΔ 
4-7 3 6 0 2324 
6-11 0 0 0 2294 
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Of the six protein spots identified as changing in the pH 4-7 log phase wild type strain 
cells in response to YTX (Table 3, Fig. 8), four were also detected as changing between 
controls.  In the pH 6-11 gels, two of the six identified as changing were also detected 
changing between controls.  All three of the protein spots identified as undergoing a 
change in ADΔ cells in response to YTX compared with untreated cells, were also 
changing when compared to methanol treated cells (Table 3, Fig. 10).  
 
Table 4 Effects of 1.4 µM dsYTX on stationary phase yeast cells.  Proteins from log phase yeast cells, 
from BY4741 and ADΔ strains, which were deemed to be of interest when comparing the different 
experimental treatments. Numbers not in brackets are the total number of spots which showed a 
possible change in abundance (≥ 1.5-fold, p ≤ 0.05).  The number in brackets is the total number of these 
spots which showed a significant change in abundance (≥ 2-fold, p ≤ 0.01).  The total spots detected per 
gel, includes all data point matches detected by DeCyder software, including those which are not 
necessarily protein spots. 
 
Four of the six protein spots identified as undergoing a change in abundance in 
response to dsYTX (pH 4-7) when compared to untreated cells in wild type BY4741 
cells, also changed when compared to methanol treated controls (Table 4, Fig. 9).  The 
protein spot detected as possibly changing on pH 6-11 gels in response to dsYTX also 
changed when compared to methanol treated cells.  The effect of dsYTX appeared to 
be similar between wild type and pump mutant strains, although it was possibly 
greater in ADΔ cells, with more protein spots showing a detectable change in 
abundance. For ADΔ cells six of the eight detected in pH 4-7, and both of the protein 
spots detected in pH 6-11 gel images, changed when compared with methanol treated 
cells as well (Table 4, Fig. 11). 
 
.
Stationary + 
dsYTX 
Comparison of Change 
Strain pH dsYTX/untreated dsYTX/MeOH MeOH/untreated Total spots 
BY4741 
4-7 6(1) 7(0) 0 2254 
6-11 1(1) 3(0) 0 2475 
ADΔ 
4-7 8(2) 26(2) 0 2403 
6-11 2(0) 5(0) 0 2200 
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Figure 6 Coomassie blue stained gels, pH 4-7 and 6-11, of proteins extracted from stationary phase wild type yeast cells treated with 1.2 µM YTX for 24 h.  Yellow = not 
changing.  Pale green = tending towards a decreasing abundance but not significant (fold change ≥ 1.5, p ≤ 0.05).   
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Figure 7  pH 4-7 Coomassie blue stained gel of proteins from 
stationary phase wild type yeast cells treated with 12 μM YTX for 
24 h.  Pale green = tending towards a decrease in response to 
YTX treatment, but not significant (fold change ≥ 1.5 p ≤ 0.05).  
Pale pink = tending towards an increase, but not significant (fold 
change ≥ 1.5 p ≤ 0.05). 
No changes in protein fold were detected between YTX treated 
and untreated cells.  No changes in protein fold were detected 
between proteins from different treatment conditions when 
separated on a pH 6-11 linear gradient. 
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Figure 8 Coomassie blue stained gels, pH 4-7 and 6-11, of proteins extracted from log phase wild type yeast cells treated with 12 μM YTX for 24 h.  Yellow = not changing.  
Pale green = tending towards a fold decrease, but not significant (fold change ≥ 1.5, p ≤ 0.05).  Pale pink = tending towards an increase, but not significant (fold change ≥ 
1.5 p ≤ 0.05).  White = proteins which underwent a fold change when methanol and untreated cell extracts were compared.   
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Figure 9  Coomassie blue stained gels, pH 4-7 and 6-11, of proteins extracted from stationary phase wild type yeast cells treated with 1.4 μM dsYTX for 24 h.  Yellow = not 
changing.  Pale green = tending towards significance (fold change ≥ 1.5, p ≤ 0.05).  Green = significant decrease (fold change ≥ 2 fold, p ≤ 0.01). Pink = tending towards an 
increase, but not significant (fold change ≥ 1.5 p ≤ 0.05).  
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Figure 10 Coomassie blue stained gels, pH 4-7 of proteins extracted 
from log phase ADΔ mutant yeast cells, treated with 12 μM YTX for 24 
h. Pale green = tending towards significance (fold change ≥ 1.5, p ≤ 
0.05).  No proteins of interest were identified amongst proteins 
separated on a pH 6-11 linear gradient. 
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Figure 11 Coomassie blue stained gels, pH 4-7 and 6-11, of proteins extracted from stationary phase ADΔ mutant yeast cells, treated with 1.4 µM dsYTX for 24 h.  Yellow = 
not changing.  Pale green = tending towards significance (fold change ≥ 1.5, p ≤ 0.05).  Pale pink = tending towards an increase, but not significant (fold change ≥ 1.5 p ≤ 
0.05).  Red = significant increase (fold change ≥ 2, p ≤ 0.01). 
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3.1.3 Protein identification by peptide mass fingerprinting 
In total 76 protein spots which had a fold change in abundance of ≥ 1.5-fold, p ≤ 0.05 
were detected.  Thirty-nine of these were not excised from the gels for MALDI analysis 
due to low abundance.  Of the remaining 37 spots, eight were identified.  A further 36 
proteins that had not changed in abundance were also identified.  These protein spots 
are numbered in Figs 6 - 11.  The DeCyder data and top ranked protein identification 
for each spot is displayed in Table 5.  Identifications which did not reach the level of 
significance for confident identification of proteins have been included, to allow for 
comparison to results from HL-60 cells.  Further identification data (including gi 
number, sequence coverage, expectation and lower ranked candidates) are reported 
in Appendix G and on the Supplementary Data CD. 
No stationary phase S. cerevisiae proteins showed a significant change in abundance 
when treated with YTX.  Two of the possible (≥ 1.5-fold, p ≤ 0.05) changes seen when 
wild type (BY4741) cells were treated with 1.2 µM YTX were identified as cytosolic 
aldehyde dehydrogenase (Spot 10, Fig. 6, Table 5) and phosphoglycerate kinase (Spot 
32, Fig. 6, Table 5). 
Spot 138 showed a significant 2.37 fold decrease in abundance in wild type cells 
treated with dsYTX when compared to untreated controls (pH 4-7, Fig. 9, Table 5).  This 
protein spot was identified as GRE1 protein.  Mitochondrial aldehyde dehydrogenase 
was also identified as showing a possible change in abundance (Spot 129, Fig. 9Table 
5). 
The four significant changes seen when proteins from ADΔ cells treated with dsYTX 
(Fig. 11) are compared with proteins from untreated or methanol treated cells 
correspond to three proteins, two of which only change when compared with one 
control.  Searching acquired spectra using MASCOT was unable to find matches to 
these spots with significant scores.  The top-ranked match for each protein spot 
returned by the search were YKR101Wp-like protein (Spot 165), Pau9p hypothetical 
protein (Spot 166), which increased approximately 2.5 and 2-fold respectively, and 
mitochondrial translational activator (Spot 200), which decreased approximately 2.3 
fold, compared to either control.  HSP90-Sba1 closed chaperone complex (chain A) 
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(Spot 168), YLL024Cp-like protein (Spot 173), ATPase involved in protein folding and 
nuclear transport (Spot 174), alcohol dehydrogenase I (Spot 211), and translational 
elongation factor 1α, showed possible changes in abundance (Fig. 11, Table 5).  
HSP90B and elongation factor 1δ had altered abundances in HepG2 cells when treated 
with YTX. 
The proteins which were identified with significant Mascot scores, but did not show 
any change in abundance by DIGE analysis are listed in Appendix H. 
A total of 212 MS spectra were collected over all S. cerevisiae experiments.  Of these 
47 were identified with a significant Mascot score.  Four of the remaining spectra did 
not provide a significant identification despite having signals and peak intensities that 
one would have expected to return a match. 
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Table 5  S. cerevisiae protein abundance changes (Av. Ratio) and associated statistics acquired from DeCyder and protein identifications of proteins of interest and picked 
protein spots as numbered in Figs. 9 - 11.  Bold statistics are significant (≥ 2-fold, p ≤ 0.01).  N/A for protein name indicates that a protein spot was not selected for 
identification, either because it was low abundance or considered not to be due to toxin.  Identifications in italics are those which did not have a significant match score.  
An absence of DeCyder statistics is indicative that a protein spot was not present in all protein spot maps.  Av. Ratio is the protein volume of the first condition compared to 
the second in the comparison.  For example negative value when comparing dsYTX/methanol (MeOH) means that the protein has undergone a decrease in abundance in 
response to dsYTX respective to the methanol treated control. 
Spot # 
Experiment pH Comparison T-test 
Av. 
Ratio 
1-way 
ANOVA 
Name 
1 BY4741 1.2 µM 
YTX 
4-7 
YTX/untreated 0.17 -1.3 0.19 
Formylglycinamidine-ribonucleotide (FGAM)-synthetase YTX/MeOH 0.52 -1.1 0.19 
MeOH/untreated 0.089 -1.18 0.19 
2 BY4741 1.2 µM 
YTX 
4-7 
YTX/untreated 0.58 -1.19 0.46 
SSE1 protein, ATPase component of Hsp90 chaperone complex YTX/MeOH 0.21 -1.39 0.46 
MeOH/untreated 0.57 1.16 0.46 
5 BY4741 1.2 µM 
YTX 
4-7 
YTX/untreated 0.001 -1.57 0.026 
Cytoplasmic tryptophanyl-tRNA synthetase 
(Protein identification score was not significant) 
YTX/MeOH 0.057 -1.59 0.026 
MeOH/untreated 0.97 1.01 0.026 
9 BY4741 1.2 µM 
YTX 
4-7 
YTX/untreated 0.49 -1.32 0.64 
Enolase II; Eno2p YTX/MeOH 0.46 -1.33 0.64 
MeOH/untreated 0.98 1.01 0.64 
10 BY4741 1.2 µM 
YTX 
4-7 
YTX/untreated 0.019 -1.51 0.085 
Cytosolic aldehyde dehydrogenase; Ald6p YTX/MeOH 0.14 -1.44 0.085 
MeOH/untreated 0.73 -1.05 0.085 
11 BY4741 1.2 µM 
YTX 
4-7 
YTX/untreated 0.4 -1.21 0.12 
cytosolic aldehyde dehydrogenase YTX/MeOH 0.13 -1.6 0.12 
MeOH/untreated 0.037 1.32 0.12 
12 BY4741 1.2 µM 
YTX 
4-7 
YTX/untreated 0.55 -1.24 0.57 
cytosolic aldehyde dehydrogenase YTX/MeOH 0.27 -1.29 0.57 
MeOH/untreated 0.81 1.05 0.57 
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Spot # 
Experiment pH Comparison T-test Av. Ratio 
1-way 
ANOVA 
Name 
15 BY4741 1.2 µM 
YTX 
4-7 
YTX/untreated 0.42 -1.18 0.41 
Threonine synthase; Thr4p YTX/MeOH 0.21 -1.24 0.41 
MeOH/untreated 0.75 1.05 0.41 
16 BY4741 1.2 µM 
YTX 
4-7 
YTX/untreated 0.9 -1.03 0.85 
Aromatic aminotransferase I; Aro8p YTX/MeOH 0.64 -1.15 0.85 
MeOH/untreated 0.73 1.12 0.85 
17 BY4741 1.2 µM 
YTX 
4-7 
YTX/untreated 0.066 -1.27 0.013 
Chain D, Crystal Structure Of Yeast Mitochondrial F1-Atpase 
(Protein identification score was not significant) 
YTX/MeOH 0.0065 -1.5 0.013 
MeOH/untreated 0.13 1.19 0.013 
18 BY4741 1.2 µM 
YTX 
4-7 
YTX/untreated 0.83 -1.07 0.71 
Enolase II; Eno2p YTX/MeOH 0.42 -1.19 0.71 
MeOH/untreated 0.6 1.11 0.71 
19 BY4741 1.2 µM 
YTX 
4-7 
YTX/untreated 0.75 -1.12 0.74 
Enolase II; Eno2p YTX/MeOH 0.45 -1.21 0.74 
MeOH/untreated 0.71 1.08 0.74 
YTX/untreated 0.79 -1.1 0.77 
Enolase II; Eno2p YTX/MeOH 0.46 -1.18 0.77 
MeOH/untreated 0.71 1.07 0.77 
20 BY4741 1.2 µM 
YTX 
4-7 
YTX/untreated 0.39 -1.47 0.6 
Enolase II; Eno2p YTX/MeOH 0.61 -1.31 0.6 
MeOH/untreated 0.7 -1.12 0.6 
22 BY4741 1.2 µM 
YTX 
4-7 
YTX/untreated 0.87 -1.03 0.86 
Fructose 1,6-bisphosphate aldolase; Fba1p YTX/MeOH 0.66 -1.11 0.86 
MeOH/untreated 0.69 1.08 0.86 
23 BY4741 1.2 µM 
YTX 
4-7 
YTX/untreated  -1.31  
Fructose 1,6-bisphosphate aldolase; Fba1p YTX/MeOH  -1.2  
MeOH/untreated  -1.1  
25 BY4741 1.2 µM 
YTX 
4-7 
YTX/untreated 0.15 -1.16 0.085 
Subunit d of the five-subunit V0 integral membrane domain of vacuolar 
H+-ATPase (V-ATPase); Vma6p 
YTX/MeOH 0.034 -1.2 0.085 
MeOH/untreated 0.61 1.04 0.085 
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Experiment pH Comparison T-test Av. Ratio 
1-way 
ANOVA 
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26 BY4741 1.2 µM 
YTX 
4-7 
YTX/untreated 0.86 1.03 0.83 
Chain A, Electrophilic Catalysis In Triosephosphase Isomerase: The Role 
Of Histidine-95 
YTX/MeOH 0.6 -1.07 0.83 
MeOH/untreated 0.61 1.11 0.83 
27 BY4741 1.2 µM 
YTX 
6-11 
YTX/untreated 0.7 -1.06 0.91 
pyruvate kinase YTX/MeOH 0.88 -1.03 0.91 
MeOH/untreated 0.77 -1.03 0.91 
28 & 
29 
BY4741 1.2 µM 
YTX 
6-11 
YTX/untreated 0.85 -1.03 0.98 
Chain A, Circularly Permuted Phosphoglycerate Kinase; Pgk P72 YTX/MeOH 0.89 -1.07 0.98 
MeOH/untreated 0.97 1.04 0.98 
32 BY4741 1.2 µM 
YTX 
6-11 
YTX/untreated 0.014 -1.75 0.046 
Chain E, Saccharomyces Cerevisiae Phosphoglycerate Mutase YTX/MeOH 0.084 -1.64 0.046 
MeOH/untreated 0.71 -1.06 0.046 
33 BY4741 1.2 µM 
YTX 
6-11 
YTX/untreated 0.93 -1.03 0.93 
Protein component of the small (40S) ribosomal subunit; Rps5p YTX/MeOH 0.78 1.07 0.93 
MeOH/untreated 0.74 -1.1 0.93 
34 
BY4741 12 µM 
YTX  
(stationary) 
4-7 
YTX/untreated 0.035 -1.38 0.0061 
N/A YTX/MeOH 0.0048 -1.71 0.0061 
MeOH/untreated 0.026 -1.34 0.012 
35 
BY4741 12 µM 
YTX 
(stationary) 
4-7 
YTX/untreated 0.048 1.34 0.016 
N/A YTX/MeOH 0.032 1.81 0.016 
MeOH/untreated 0.091 1.24 0.0061 
36 
BY4741 12 µM 
YTX 
(stationary) 
4-7 
YTX/untreated 0.032 1.43 0.0066 
N/A YTX/MeOH 0.015 1.74 0.0066 
MeOH/untreated 0.095 -1.27 0.031 
37 
BY4741 12 µM 
YTX 
(stationary) 
4-7 
YTX/untreated 0.086 1.48 0.024 
N/A YTX/MeOH 0.0036 1.78 0.024 
MeOH/untreated 0.11 -1.44 0.029 
38 
BY4741 12 µM 
YTX 
(stationary) 
4-7 
YTX/untreated 0.057 -1.42 0.023 
N/A YTX/MeOH 0.044 -1.53 0.023 
MeOH/untreated 0.35 1.08 0.012 
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39 
BY4741 12 µM 
YTX 
(stationary) 
4-7 
YTX/untreated 0.13 -1.52 0.048 
N/A YTX/MeOH 0.046 -1.92 0.048 
MeOH/untreated 0.27 -1.21 0.024 
41 
BY4741 12 µM 
YTX 
(log) 
4-7 
YTX/untreated 0.025 1.58 0.025 
Unknown 
(Protein identification score was not significant) 
YTX/MeOH 0.86 1.02 0.025 
MeOH/untreated 0.05 1.55 0.025 
43 
BY4741 12 µM 
YTX 
(log) 
4-7 
YTX/untreated 0.21 1.54 0.13 
YLL024Cp-like protein AWRI1631 YTX/MeOH 0.5 -1.1 0.13 
MeOH/untreated 0.12 1.7 0.13 
44 
BY4741 12 µM 
YTX 
(log) 
4-7 
YTX/untreated 0.16 1.44 0.077 
ATPase; Ssa1p YTX/MeOH 0.31 -1.11 0.077 
MeOH/untreated 0.083 1.6 0.077 
45 
BY4741 12 µM 
YTX 
(log) 
4-7 
YTX/untreated 0.013 1.63 0.0072 
Unknown 
(Protein identification score was not significant) 
YTX/MeOH 0.79 1.02 0.0072 
MeOH/untreated 0.013 1.59 0.0072 
48 
BY4741 12 µM 
YTX 
(log) 
4-7 
YTX/untreated 0.017 1.5 0.025 
N/A YTX/MeOH 0.65 -1.06 0.025 
MeOH/untreated 0.042 1.59 0.025 
49 
BY4741 12 µM 
YTX 
(log) 
4-7 
YTX/untreated 0.0015 1.75 0.0043 
Chain A, The Structure Of Tap42 Alpha4 Subunit 
(Protein identification score was not significant) 
YTX/MeOH 0.55 -1.06 0.0043 
MeOH/untreated 0.015 1.86 0.0043 
58 
BY4741 12 µM 
YTX 
(log) 
4-7 
YTX/untreated 0.018 1.51 0.013 
No hit YTX/MeOH 0.99 1 0.013 
MeOH/untreated 0.022 1.5 0.013 
60 
BY4741 12 µM 
YTX 
(log) 
4-7 
YTX/untreated 0.057 -1.53 0.019 
N/A YTX/MeOH 0.1 1.09 0.019 
MeOH/untreated 0.038 -1.66 0.019 
62 
BY4741 12 µM 
YTX 
(log) 
4-7 
YTX/untreated 0.31 -1.13 0.72 
YLL024Cp-like protein AWRI1631 YTX/MeOH 0.92 1.01 0.72 
MeOH/untreated 0.56 -1.14 0.72 
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66 
BY4741 12 µM 
YTX 
(log) 
4-7 
YTX/untreated 0.026 -1.5 0.027 
No hit YTX/MeOH 0.54 1.06 0.027 
MeOH/untreated 0.053 -1.6 0.027 
72 
BY4741 12 µM 
YTX 
(log) 
6-11 
YTX/untreated 0.047 1.63 0.018 
Hypothetical protein identified by homology; Pau9p 
(Protein identification score was not significant) 
YTX/MeOH 0.85 -1.02 0.018 
MeOH/untreated 0.015 1.66 0.018 
81 
BY4741 12 µM 
YTX 
(log) 
6-11 
YTX/untreated 0.096 1.44 0.041 
N/A YTX/MeOH 0.49 -1.08 0.041 
MeOH/untreated 0.033 1.55 0.041 
88 
BY4741 12 µM 
YTX 
(log) 
6-11 
YTX/untreated 0.0057 -1.56 0.0049 
Ics2p 
(Protein identification score was not significant) 
YTX/MeOH 0.19 -1.1 0.0049 
MeOH/untreated 0.025 -1.42 0.0049 
89 
BY4741 12 µM 
YTX 
(log) 
6-11 
YTX/untreated 0.023 -1.55 0.036 
N/A YTX/MeOH 0.68 -1.06 0.036 
MeOH/untreated 0.059 -1.46 0.036 
92 
BY4741 12 µM 
YTX 
(log) 
6-11 
YTX/untreated 0.027 -1.52 0.041 
YNL022Cp-like protein AWRI1631 
(Protein identification score was not significant) 
YTX/MeOH 0.96 -1.01 0.041 
MeOH/untreated 0.058 -1.51 0.041 
93 
BY4741 12 µM 
YTX 
(log) 
6-11 
YTX/untreated 0.061 -1.45 0.033 
N/A YTX/MeOH 0.72 1.04 0.033 
MeOH/untreated 0.04 -1.51 0.033 
95 
BY4741 12 µM 
YTX 
(log) 
6-11 
YTX/untreated 0.012 -1.62 0.033 
N/A YTX/MeOH 0.47 -1.12 0.033 
MeOH/untreated 0.084 -1.45 0.033 
96 
BY4741 12 µM 
YTX 
(log) 
6-11 
YTX/untreated 0.066 -1.19 0.077 
Nucleoside diphosphate kinase; Ynk1p YTX/MeOH 0.84 1.01 0.077 
MeOH/untreated 0.11 -1.2 0.077 
98 
BY4741 12 µM 
YTX 
(log) 
6-11 
YTX/untreated 0.063 -1.75 0.026 
Thymidylate synthase; Cdc21p 
(Protein identification score was not significant) 
YTX/MeOH 0.54 1.05 0.026 
MeOH/untreated 0.048 -1.83 0.026 
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113 
BY4741 12 µM 
YTX 
(log) 
6-11 
YTX/untreated 0.029 -1.57 0.01 
Ydr381wp 
(Protein identification score was not significant) 
YTX/MeOH 0.11 -1.02 0.01 
MeOH/untreated 0.033 -1.54 0.01 
114 
BY4741 12 µM 
YTX 
(log) 
6-11 
YTX/untreated 0.064 -1.55 0.032 
N/A YTX/MeOH 1 1 0.032 
MeOH/untreated 0.044 -1.55 0.032 
115 
BY4741 12 µM 
YTX 
(log) 
6-11 
YTX/untreated 0.063 -1.94 0.036 
N/A YTX/MeOH 0.78 -1.04 0.036 
MeOH/untreated 0.036 -1.86 0.036 
123 
BY4741 dsYTX 4-7 
dsYTX/untreated 0.89 -1.01 0.88 
Hsp90 cochaperone; Sti1p dsYTX/MeOH 0.61 -1.02 0.88 
MeOH/untreated 0.8 1.01 0.88 
124 
BY4741 dsYTX 4-7 
dsYTX/untreated 0.032 -1.36 0.03 N/A 
dsYTX/MeOH 0.044 -1.58 0.03 
MeOH/untreated 0.29 1.16 0.03 
127 
BY4741 dsYTX 4-7 
dsYTX/untreated 0.0079 1.51 0.0024 
Thymidylate synthase; Cdc21p 
(Protein identification score was not significant) 
dsYTX/MeOH 0.01 1.39 0.0024 
MeOH/untreated 0.11 1.09 0.0024 
129 
BY4741 dsYTX 4-7 
YTX/untreated 0.028 -1.59 0.012 
Mitochondrial aldehyde dehydrogenase; Ald4p YTX/MeOH 0.012 -1.67 0.012 
MeOH/untreated 0.64 1.05 0.012 
135 
BY4741 dsYTX 4-7 
dsYTX/untreated 0.077 1.36 0.025 
N/A dsYTX/MeOH 0.031 1.59 0.025 
MeOH/untreated 0.17 -1.17 0.025 
136 
BY4741 dsYTX 4-7 
dsYTX/untreated 0.6 -1.02 0.89 
Phosphomannomutase; Sec53p dsYTX/MeOH 0.94 -1 0.89 
MeOH/untreated 0.78 -1.01 0.89 
137 
BY4741 dsYTX 4-7 
YTX/untreated 0.29 -1.12 0.4 
Egd2p 
 
YTX/MeOH 0.91 1.01 0.4 
MeOH/untreated 0.25 -1.13 0.4 
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138 
BY4741 dsYTX 4-7 
dsYTX/untreated 0.0046 -2.37 0.0039 
protein GRE1 RM11-1a dsYTX/MeOH 0.021 -1.84 0.0039 
MeOH/untreated 0.11 -1.28 0.0039 
142 
BY4741 dsYTX 4-7 
dsYTX/untreated 0.0086 -1.52 0.0061 
Hypothetical protein identified by homology; Pau9p 
(Protein identification score was not significant) 
dsYTX/MeOH 0.017 -1.39 0.0061 
MeOH/untreated 0.26 -1.09 0.0061 
143 
BY4741 dsYTX 4-7 
dsYTX/untreated 0.056 -1.56 0.027 
N/A dsYTX/MeOH 0.043 -1.54 0.027 
MeOH/untreated 0.86 -1.02 0.027 
147 
BY4741 dsYTX 4-7 
dsYTX/untreated 0.94 -1.01 0.32 
Chain A, H48c Yeast Cu(Ii)ZN SUPEROXIDE DISMUTASE Structure dsYTX/MeOH 0.27 1.26 0.32 
MeOH/untreated 0.24 -1.28 0.32 
150 
BY4741 dsYTX 4-7 
dsYTX/untreated 0.046 1.34 0.18 
Chain G, Yeast Cytochrome Bc1 Complex With Bound Substrate 
Cytochrome C 
dsYTX/MeOH 0.29 1.18 0.18 
MeOH/untreated 0.5 1.13 0.18 
151 
BY4741 dsYTX 4-7 
dsYTX/untreated 0.0025 -1.54 0.00081 
N/A dsYTX/MeOH 0.0057 -1.55 0.00081 
MeOH/untreated 0.88 1 0.00081 
154 
BY4741 dsYTX 4-7 
dsYTX/untreated 0.026 -2.08 0.018 
Chain O, Structure Of The Ribosomal 80s-Eef2-Sordarin Complex 
(Protein identification score was not significant) 
dsYTX/MeOH 0.038 -1.63 0.018 
MeOH/untreated 0.2 -1.27 0.018 
155 
BY4741 dsYTX 6-11 
dsYTX/untreated 0.06 -1.66 0.032 
N/A dsYTX/MeOH 0.042 -1.8 0.032 
MeOH/untreated 0.53 1.09 0.032 
156 
BY4741 dsYTX 6-11 
YTX/untreated 0.0061 -2.13 0.024 
N/A YTX/MeOH 0.046 -2.33 0.024 
MeOH/untreated 0.74 1.09 0.024 
157 
BY4741 dsYTX 6-11 
dsYTX/untreated 0.051 -1.87 0.024 
N/A dsYTX/MeOH 0.044 -2.28 0.024 
MeOH/untreated 0.23 1.22 0.024 
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1-way 
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158 ADΔ 12 µM YTX 
(log) 
4-7 
YTX/untreated 0.034 -1.58 0.009 
N/A YTX/MeOH 0.018 -1.78 0.009 
MeOH/untreated 0.15 1.13 0.009 
159 ADΔ 12 µM YTX 
(log) 
4-7 
YTX/untreated 0.085 -1.38 0.028 
N/A YTX/MeOH 0.036 -1.53 0.028 
MeOH/untreated 0.19 1.11 0.028 
160 ADΔ 12 µM YTX 
(log) 
4-7 
YTX/untreated 0.013 -1.69 0.0024 
N/A YTX/MeOH 0.0018 -1.74 0.0024 
MeOH/untreated 0.59 1.03 0.0024 
161 ADΔ 12 µM YTX 
(log) 
4-7 
YTX/untreated 0.1 -1.9 0.045 
N/A YTX/MeOH 0.018 -2.18 0.045 
MeOH/untreated 0.53 1.15 0.045 
162 ADΔ 12 µM YTX 
(log) 
4-7 
YTX/untreated 0.07 -1.67 0.041 
N/A YTX/MeOH 0.036 -1.79 0.041 
MeOH/untreated 0.68 1.07 0.041 
163 ADΔ 12 µM YTX 
(log) 
4-7 
YTX/untreated 0.02 -2.17 0.02 
N/A YTX/MeOH 0.042 -1.99 0.02 
MeOH/untreated 0.62 -1.09 0.02 
164 
ADΔ dsYTX 4-7 
dsYTX/untreated 0.095 1.75 0.066 
Phosphatidylinositol transfer protein (PITP); Pdr16p 
(Protein identification score was not significant) 
dsYTX/MeOH 0.011 1.68 0.066 
MeOH/untreated 0.82 1.04 0.066 
165 
ADΔ dsYTX 4-7 
dsYTX/untreated 0.021 2.41 0.0059 
YKR101Wp-like protein AWRI1631 
(Protein identification score was not significant) 
dsYTX/MeOH 0.0099 2.5 0.0059 
MeOH/untreated 0.79 -1.04 0.0059 
166 
ADΔ dsYTX 4-7 
dsYTX/untreated 0.0063 2.04 0.02 
Hypothetical protein identified by homology; Pau9p 
(Protein identification score was not significant) 
dsYTX/MeOH 0.043 2.06 0.02 
MeOH/untreated 0.91 -1.01 0.02 
168 
ADΔ dsYTX 4-7 
dsYTX/untreated 0.065 1.61 0.045 
Chain A, Crystal Structure Of An Hsp90-Sba1 Closed Chaperone Complex dsYTX/MeOH 0.045 1.66 0.045 
MeOH/untreated 0.85 -1.03 0.045 
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170 
ADΔ dsYTX 4-7 
dsYTX/untreated 0.027 1.78 0.014 
Chain A, Crystal Structure Analysis Of Sse1, A Yeast Hsp110 
(Protein identification score was not significant) 
dsYTX/MeOH 0.026 1.89 0.014 
MeOH/untreated 0.61 -1.06 0.014 
172 
ADΔ dsYTX 4-7 
dsYTX/untreated 0.14 1.42 0.035 
N/A dsYTX/MeOH 0.013 1.85 0.035 
MeOH/untreated 0.2 -1.31 0.035 
173 
ADΔ dsYTX 4-7 
dsYTX/untreated 0.1 1.85 0.049 
YLL024Cp-like protein AWRI1631 dsYTX/MeOH 0.036 2.04 0.049 
MeOH/untreated 0.67 -1.1 0.049 
174 
ADΔ dsYTX 4-7 
dsYTX/untreated 0.087 1.62 0.052 
ATPase involved in protein folding and nuclear localisation signal (NLS)-
directed nuclear transport; Ssa1p 
dsYTX/MeOH 0.023 1.58 0.052 
MeOH/untreated 0.81 1.03 0.052 
175 
ADΔ dsYTX 4-7 
dsYTX/untreated 0.074 1.32 0.034 
N/A dsYTX/MeOH 0.042 1.66 0.034 
MeOH/untreated 0.18 -1.26 0.034 
176 
ADΔ dsYTX 4-7 
dsYTX/untreated 0.054 1.56 0.024 
N/A dsYTX/MeOH 0.012 1.56 0.024 
MeOH/untreated 0.98 -1 0.024 
177 
ADΔ dsYTX 4-7 
dsYTX/untreated 0.024 1.95 0.021 
Hypothetical protein identified by homology; Pau9p 
(Protein identification score was not significant) 
dsYTX/MeOH 0.05 1.82 0.021 
MeOH/untreated 0.64 1.07 0.021 
179 
ADΔ dsYTX 4-7 
dsYTX/untreated 0.06 1.51 0.036 
N/A dsYTX/MeOH 0.025 1.61 0.036 
MeOH/untreated 0.66 -1.07 0.036 
181 
ADΔ dsYTX 4-7 
dsYTX/untreated 0.012 1.5 0.013 
Hypothetical protein identified by homology; Pau9p 
(Protein identification score was not significant) 
dsYTX/MeOH 0.03 1.66 0.013 
MeOH/untreated 0.33 -1.1 0.013 
184 
ADΔ dsYTX 4-7 
dsYTX/untreated 0.074 1.6 0.029 
One of six ATPases of the 19S regulatory particle of the 26S proteasome; 
Rpt6p (Protein identification score was not significant) 
dsYTX/MeOH 0.047 1.82 0.029 
MeOH/untreated 0.22 -1.14 0.029 
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186 
ADΔ dsYTX 4-7 
dsYTX/untreated 0.19 -1.19 0.034 
N/A dsYTX/MeOH 0.036 -1.5 0.034 
MeOH/untreated 0.085 1.26 0.034 
188 
ADΔ dsYTX 4-7 
dsYTX/untreated 0.062 1.31 0.042 
YLL024Cp-like protein AWRI1631 dsYTX/MeOH 0.09 1.26 0.042 
MeOH/untreated 0.38 1.04 0.042 
190 
ADΔ dsYTX 4-7 
dsYTX/untreated 0.13 1.27 0.072 
actin dsYTX/MeOH 0.042 1.36 0.072 
MeOH/untreated 0.52 -1.08 0.072 
191 
ADΔ dsYTX 4-7 
dsYTX/untreated 0.044 1.63 0.019 
YGL071Wp-like protein AWRI1631 
(Protein identification score was not significant) 
dsYTX/MeOH 0.015 1.65 0.019 
MeOH/untreated 0.94 -1.01 0.019 
195 
ADΔ dsYTX 4-7 
dsYTX/untreated 0.022 -1.33 0.003 
N/A dsYTX/MeOH 0.0078 -1.58 0.003 
MeOH/untreated 0.031 1.19 0.003 
196 
ADΔ dsYTX 4-7 
dsYTX/untreated 0.08 -1.22 0.0063 
N/A dsYTX/MeOH 0.011 -1.59 0.0063 
MeOH/untreated 0.023 1.3 0.0063 
198 
ADΔ dsYTX 4-7 
dsYTX/untreated 0.053 -1.42 0.036 
N/A dsYTX/MeOH 0.029 -1.5 0.036 
MeOH/untreated 0.65 1.06 0.036 
199 
ADΔ dsYTX 4-7 
dsYTX/untreated 0.067 -1.44 0.019 
N/A dsYTX/MeOH 0.035 -1.66 0.019 
MeOH/untreated 0.065 1.15 0.019 
200 
ADΔ dsYTX 4-7 
dsYTX/untreated 0.0005 -2.26 0.00027 
Mitochondrial translational activator YJM789 
(Protein identification score was not significant) 
dsYTX/MeOH 0.0023 -2.36 0.00027 
MeOH/untreated 0.43 1.04 0.00027 
201 
ADΔ dsYTX 4-7 
dsYTX/untreated 0.45 1.16 0.54 
conserved protein YJM789 dsYTX/MeOH 0.36 1.15 0.54 
MeOH/untreated 0.94 1.01 0.54 
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204 
ADΔ dsYTX 4-7 
dsYTX/untreated 0.011 -1.34 0.0083 
N/A dsYTX/MeOH 0.021 -1.51 0.0083 
MeOH/untreated 0.18 1.12 0.0083 
205 
ADΔ dsYTX 4-7 
dsYTX/untreated 0.028 -1.7 0.02 
Putative protein of unknown function; Ylr146w-ap 
(Protein identification score was not significant) 
dsYTX/MeOH 0.023 -1.81 0.02 
MeOH/untreated 0.68 1.06 0.02 
206 
ADΔ dsYTX 4-7 
dsYTX/untreated 0.019 -1.37 0.005 One of six subunits of the RNA polymerase III transcription initiation factor 
complex (TFIIIC); Tfc1p 
(Protein identification score was not significant) 
dsYTX/MeOH 0.0056 -1.53 0.005 
MeOH/untreated 0.19 1.11 0.005 
207 
ADΔ dsYTX 4-7 
dsYTX/untreated 0.69 1.06 0.52 
Chain G, Yeast Cytochrome Bc1 Complex With Bound Substrate 
Cytochrome C 
dsYTX/MeOH 0.37 1.12 0.52 
MeOH/untreated 0.29 -1.07 0.52 
208 
ADΔ dsYTX 4-7 
dsYTX/untreated 0.011 -1.28 0.027 YGR254Wp-like protein AWRI1631 
dsYTX/MeOH 0.046 -1.42 0.027 
MeOH/untreated 0.33 1.11 0.027 
209 
ADΔ dsYTX 4-7 
dsYTX/untreated 0.002 -1.45 0.029 
YGR254Wp-like protein AWRI1631 dsYTX/MeOH 0.052 -1.65 0.029 
MeOH/untreated 0.4 1.14 0.029 
210 
ADΔ dsYTX 4-7 
dsYTX/untreated  -1.72  
Enolase II; Eno2p dsYTX/MeOH  -1.57  
MeOH/untreated  -1.1  
211 
ADΔ dsYTX 4-7 
dsYTX/untreated 0.0025 -1.49 0.022 
dehydrogenase isozyme I, alcohol dsYTX/MeOH 0.049 -1.54 0.022 
MeOH/untreated 0.8 1.03 0.022 
213 
ADΔ dsYTX 6-11 
dsYTX/untreated 0.02 1.41 0.0036 
N/A dsYTX/MeOH 0.0058 1.58 0.0036 
MeOH/untreated 0.11 -1.13 0.0036 
214 
ADΔ dsYTX 6-11 
dsYTX/untreated 0.067 1.82 0.027 
N/A dsYTX/MeOH 0.036 1.95 0.027 
MeOH/untreated 0.57 -1.07 0.027 
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Spot # 
Experiment pH Comparison T-test Av. Ratio 
1-way 
ANOVA 
Name 
215 
ADΔ dsYTX 6-11 
dsYTX/untreated 0.11 1.69 0.037 
Translational elongation factor EF-1 alpha; Tef2p, TEF1 dsYTX/MeOH 0.026 2.1 0.037 
MeOH/untreated 0.3 -1.24 0.037 
217 
ADΔ dsYTX 6-11 
dsYTX/untreated 0.014 -2.09 0.02 
Unnamed protein product 
(Protein identification score was not significant) 
dsYTX/MeOH 0.044 -2.14 0.02 
MeOH/untreated 0.95 1.02 0.02 
218 
ADΔ dsYTX 6-11 
dsYTX/untreated 0.42 -1.11 0.43 
pyruvate kinase dsYTX/MeOH 0.13 -1.14 0.43 
MeOH/untreated 0.81 1.03 0.43 
219 
ADΔ dsYTX 6-11 
dsYTX/untreated 0.0016 -1.59 0.017 
Alcohol dehydrogenase isoenzyme V; Adh5p 
(Protein identification score was not significant) 
dsYTX/MeOH 0.038 -1.82 0.017 
MeOH/untreated 0.39 1.15 0.017 
220 
ADΔ dsYTX 6-11 
dsYTX/untreated 0.2 -1.33 0.093 
pyruvate kinase 
 
dsYTX/MeOH 0.014 -1.49 0.093 
MeOH/untreated 0.47 1.12 0.093 
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3.2 HL-60 cells 
HL60 cells were cultured until they were approximately 80% confluent.  The cells were 
then divided into 10 mL cultures containing 9 x 106 cells.  Samples were then treated 
with 1 μM of YTX or dsYTX.  Control samples were treated with methanol (0.02% v/v 
final concentration).   
 
3.2.1 Morphological analysis 
The morphology of all HL60 samples was observed at 0 h and 24 h after incubation 
with toxin or methanol control.  No obvious morphological differences were observed 
in flasks of cells treated with YTX or control samples (Fig. 12).  After 24 h of incubation 
flasks of cells treated with dsYTX had clumps of floating cells (Fig. 13).  Staining of the 
cells with trypan blue indicated that cells in these clumps were dead.   
 
Figure 12 HL60 cells in culture at 0 and 24 h after addition of toxin at 20x magnification.  No 
morphological differences were observed in flasks of cells treated with toxin compared with control cells 
treated with methanol, with the exception of clumps forming in dsYTX treated cultures. 
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Analysis of trypan blue staining gave a percentage cell viability of 86.1% at 0 h.  After 
24 h of incubation the percentage cell viability was 91.7% for control samples 
incubated with methanol, and 79.0% and 67.7% for samples incubated YTX and dsYTX 
respectively. 
 
3.2.2 2D-DIGE analysis 
The effects of YTX and dsYTX on HL60 cells were examined using 2D DIGE.  The goal 
was to identify proteins that changed for comparison with known effects of YTX on 
HepG2 cells (Young et al., 2009), and to the microtubule stabilising agent Pel A on HL60 
cells (Wilmes et al., 2012).  The protein extracts treated with 1 μM YTX or dsYTX and 
control samples (0.02% methanol) were analysed for changes in levels of protein 
expression by 2D DIGE.  A change in protein abundance ≥ 2-fold, p ≤ 0.01 was again 
considered significant.  MALDI mass fingerprinting was used to identify protein spots 
excised from 2D gels. 
Table 6 Protein spots detected as changing by DeCyder analysis, in HL60 cells in response to YTX or 
dsYTX.  The numbers in brackets are the number of protein spots which match the fold and p-value 
criteria when the FDR filter was not applied.   
 Comparison of change 
 YTX/MeOH dsYTX/MeOH dsYTX/YTX 
Total 
spots  
≥ 1.5-fold,  
p ≤ 0.05 
≥ 2-fold, 
 p ≤ 0.01 
≥ 1.5-fold,  
p ≤ 0.05 
≥ 2-fold, 
 p ≤ 0.01 
≥ 1.5-fold,  
p ≤ 0.05 
≥ 2-fold, 
 p ≤ 0.01 
pH 4-7 2(51) 1(16) 61(86) 0(26) 0(6) 0(0) 2413 
pH 6-11 0(12) 0(0) 0(22) 0(6) 0(2) 0(0) 2439 
 
  
Figure 13 HL60 cells after 24 h incubation with 
dsYTX at 10x magnification.  Arrows indicate 
aggregated cells.  
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2D-DIGE analysis detected a total of 119 protein spots undergoing a change in 
abundance by comparing all conditions (when the FDR filter was not applied).  Thirty-
eight protein spots were identified as changing significantly (≥ 2-fold, p ≤ 0.01) when 
comparing toxin treated cells to controls.  Ten protein spots showed significant 
changes in abundance in response to both toxins, six changed only in YTX treated cells 
and 22 changed in cells treated with dsYTX.  Of the six significant YTX specific changes, 
four were also possibly changing in response to dsYTX (≥ 1.5-fold (but less than 2), p ≤ 
0.05).  Of the 22 dsYTX specific changes, 13 were also possibly changing with YTX.  
Potential changes (≥ 1.5-fold (but less than 2-fold), p ≤ 0.05) were also detected in an 
additional 80 proteins.  Eight were specific to YTX, 46 were specific to dsYTX and 26 
were detected in both.  Figure 14 shows the location of protein spots identified by 
DIGE analysis as undergoing a change in abundance, on pH 4-7 and 6-11 Coomassie 
stained polyacrylamide gels.  Figures 15 and 16 summarise protein changes in 
response to toxin treatment (when the FDR filter was not or was applied, respectively). 
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Figure 14 Coomassie blue stained gel with protein spots of interest from HL60 cells treated with YTX or dsTYX.  Black numbers are protein spots which did not undergo a 
change of abundance in response to toxin treatment but were extracted and successfully identified by MALDI analysis.  Red represents increase in abundance of at least 2-
fold, p ≤ 0.01.  Pink represents an increase in abundance of between 1.5 and 2-fold, p ≤ 0.05.  Green represents a decrease in abundance of at least 2-fold, p ≤ 0.01.  Pale 
green represents a decrease in abundance between 1.5 and 2-fold, p ≤ 0.05.  
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Figure 15 Distribution of protein changes detected by 2D DIGE for toxin vs. methanol when the FDR was not applied.  Red numbers are those that underwent an increase 
in abundance in response to toxin.  Green numbers are those proteins whose abundance decreased in response to toxin.  Proteins almost always responded in the same 
direction in response to either YTX or dsYTX.  The one exception to this is spot number 58.  * Denotes proteins which also showed a difference in abundance in dsYTX 
treated cells compared to YTX.   Numbers 1-92 are proteins in the pH 4-7 range.  Numbers 93-119 are proteins in the pH 6-11 range. 
 
R
esu
lts 
  
 
6
1 
  
Figure 16 Distribution of protein changes detected by 2D DIGE for toxin vs. methanol when the FDR was applied.  Red numbers are those that underwent 
an increase in abundance in response to toxin.  Green numbers are those proteins whose abundance decreased in response to toxin.  Numbers 1-92 are 
proteins in the pH 4-7 range.  Numbers 93-119 are proteins in the pH 6-11 range. 
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Protein spots which changed in response to both toxins seemed to be affected 
similarly by YTX and dsYTX.  In almost all such cases a protein which had an increased 
abundance in YTX treated cells also had an increased abundance in dsYTX treated cells 
and vice versa.  Of the 53 proteins with at least a 1.5-fold change in abundance (p ≤ 
0.05), 36 showed similar fold changes with either toxin.  Seventeen changed at least 2-
fold (p ≤ 0.01) with only one toxin, while changing between 1.5 and 2-fold with the 
other toxin.   
The only exception to proteins being affected in the same way was protein spot 58.  
Although neither toxin caused a change in abundance meeting the required cut off 
criteria (≥ 1.5-fold, p ≤ 0.05), a possible decrease was detected in dsYTX treated cells 
compared to those treated with YTX (-1.65 fold, t = 0.0016).  YTX caused an apparent 
increase of 1.49 fold (t = 0.033).  DsYTX did not cause a change in abundance (-1.11 
fold compared to methanol control, t = 0.54). 
When the FDR filter was applied (Fig. 16) 62 protein spots were identified as 
potentially changing.  The majority (60 spots) of these were at the p ≤ 0.05 level only, 
and in response to dsYTX (59 spots).  Protein spot 82 had a significant change in 
abundance (≥ 2-fold, p ≤ 0.01) in response to YTX treatment but only reached the p ≤ 
0.05 level for dsYTX treatment. 
 
3.2.3 Protein identification by peptide mass fingerprinting 
Sixty-four of the 119 protein spots identified as changing by 2D-DIGE analysis were 
extracted from gels for identification by MALDI-TOF/TOF for peptide mass 
fingerprinting.  Thirteen of these were successfully identified with a significant score at 
the p ≤ 0.05 level.  An additional 13 protein spots which showed no change in 
abundance were also identified.  Tables 7 and 8 list the results of the DIGE analysis and 
the identity of the protein spots. 
Four identified proteins were similarly affected by YTX and dsYTX in HL60 cells.  Stress 
response proteins GRP78 (BiP) precursor and HSP60 (chaperonin) showed significant 
increases in abundance in dsYTX treated cells (approximately 2 and 2.5 fold 
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respectively, p ≤ 0.01, Table 7).  However when the FDR filter was applied they only 
reached the p ≤ 0.05 level.  An apparent increase was seen in these proteins in YTX 
treated cells, but did not reach the 2-fold criterion for significance.  The mitochondrial 
glycoprotein p32/tat-associated protein (chain A) and protein disulfide isomerase 
related protein 5 showed apparent changes in both YTX and dsYTX treated HL60, but 
these did not make the criteria for significance (≥ 2-fold, p ≤ 0.01).  When the FDR filter 
was applied, both of the detected changes remained at the ≥ 1.5-fold, p ≤ 0.05 level. 
Actin, hnRNP A, and BiP all appeared to have increased abundances in dsYTX treated 
HL60 cells, with actin having a significant increase (Table 7).  These proteins all 
decreased in abundance in YTX treated HepG2 cells (Fig. 17, Young et al., 2009).  No 
identified proteins showed changes in abundance in both YTX treated HL60 and HepG2 
cells. 
Spots number 2 and 106 showed a possible increase in abundance when treated with 
dsYTX compared to controls.  These were identified as tumour rejection antigen (gp96) 
1 and nucleolin, respectively (Table 7).  The levels of the gp96 precursor have been 
shown to be affected by YTX in HepG2 cells (Young et al., 2009).  Application of the 
FDR filter resulted in the change detected in nucleolin no longer reaching the p-value 
cut-off criteria.  The gp96 precursor change still met the ≥ 1.5-fold, p ≤ 0.05 cut-off. 
Spot 96 showed an apparent decrease in HL60 cells treated with YTX.  This was 
matched by MASCOT to an unnamed protein, containing a K-homology domain (type 
1).  This domain is found in a range of proteins of the ribosome and in transcription 
factors.  A BLAST search of the top ranked protein match indicated that this protein 
may be the far upstream element binding protein 1 (Supplementary Data CD).  This 
protein is involved in c-myc expression.  C-myc was one of the predicted hub molecules 
identified in the pathway affected by Pel A in HL60 cells detected by IPA. 
No identified proteins were changing in common between HL60 cells treated with YTX, 
Pel A, or PTX (Fig. 18).  Actin and possibly tumour rejection antigen 1 increased in 
abundance in HL60 cells treated with dsYTX or Pel A (Fig. 19).  BiP appeared to increase 
in abundance in dsYTX and Pel A treated cells.  In PTX treated HL60 cells and YTX 
treated HepG2 cells however it decreased (Wilmes et al., 2012; Young et al., 2009).  
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HnRNP A showed an apparent increase in response to dsYTX.  It was also found to 
increase in Pel A or PTX treated HL60 cells (Wilmes et al., 2011, 2012).  In YTX treated 
HepG2 cells however it was shown to decrease (Young et al., 2009). 
Spot 82 still met the criteria for a significant change in abundance in response to YTX 
compared with controls, when the FDR filter was applied.  The top-ranked match for 
this protein was the signal recognition particle; however the identification did not have 
a significant Mascot score. 
A total of 288 spots were picked from HL60 gels.  Twenty-four of these were identified 
with a significant Mascot score.  Thirty-one had MS spectra of comparable quality to 
those that were identified, but did not provide a significant match. 
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Table 7 HL60 Protein abundance change (Av. Ratio) and associated statistics acquired from DeCyder and protein identification where applicable of proteins of interest and 
picked protein spots as numbered in Figs. 14-16.  N/A for the protein name indicates that a protein spot was not selected for identification due to low abundance.  An 
absence of DeCyder statistics is indicative that a protein spot was not present in all protein spot maps.  Av. Ratio is the protein volume of the first condition compared to 
the second in the comparison.  For example negative value when comparing dsYTX/untreated means that the protein has undergone a decrease in abundance in response 
to dsYTX respective to the untreated control.  * Indicates protein identification is not the top-ranked match. 
 
Spot # pH Comparison T-test 
Av. 
Ratio 
1-way 
ANOVA 
Name 
1 
4-7 
YTX/MeOH 9.50E-05 1.87 2.20E-05 
Immunoglobulin heavy chain variable region  
(protein identification score was not significant) 
dsYTX/MeOH 0.00056 2.13 2.20E-05 
dsYTX/YTX 0.11 1.14 2.20E-05 
2 
4-7 
YTX/MeOH 0.063 1.27 0.0014 
tumour rejection antigen (gp96) 1 dsYTX/MeOH 0.00047 1.63 0.0014 
dsYTX/YTX 0.033 1.28 0.0014 
3 
4-7 
YTX/MeOH 0.0089 -1.74 0.0049 
N/A dsYTX/MeOH 0.01 -1.89 0.0049 
dsYTX/YTX 0.58 -1.08 0.0049 
4 
4-7 
YTX/MeOH 0.019 1.4 0.003 
opioid growth factor receptor and/or S100 calcium-binding protein A8  
(protein identification score was not significant) 
dsYTX/MeOH 0.0053 1.55 0.003 
dsYTX/YTX 0.21 1.1 0.003 
5 
4-7 
YTX/MeOH 0.081 1.61 0.0089 
MHC class I antigen  
(protein identification score was not significant) 
dsYTX/MeOH 0.00051 2.02 0.0089 
dsYTX/YTX 0.21 1.26 0.0089 
6 
4-7 
YTX/MeOH 0.018 1.5 0.0046 
N/A dsYTX/MeOH 0.013 1.65 0.0046 
dsYTX/YTX 0.23 1.1 0.0046 
7 
4-7 
YTX/MeOH 0.001 2.37 8.30E-05 
hCG2015481  
(protein identification score was not significant) 
dsYTX/MeOH 0.00017 2.9 8.30E-05 
dsYTX/YTX 0.21 1.22 8.30E-05 
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Spot # pH Comparison T-test 
Av. 
Ratio 
1-way 
ANOVA 
Name 
8 4-7 
YTX/MeOH 0.0023 1.88 0.00019 
hCG2044129 
(protein identification score was not significant) 
dsYTX/MeOH 0.00064 2.31 0.00019 
dsYTX/YTX 0.12 1.23 0.00019 
9 4-7 
YTX/MeOH 0.0044 1.65 0.00018 
GRP78 precursor 
dsYTX/MeOH 0.00046 2.07 0.00018 
dsYTX/YTX 0.045 1.25 0.00018 
10 4-7 
YTX/MeOH 0.013 1.49 0.0006 
dsYTX/MeOH 0.00061 1.82 0.0006 
dsYTX/YTX 0.064 1.22 0.0006 
11 4-7 
YTX/MeOH 0.043 1.44 0.0042 
dsYTX/MeOH 0.002 1.7 0.0042 
dsYTX/YTX 0.15 1.18 0.0042 
12 4-7 
YTX/MeOH 0.054 1.54 0.0096 
BiP protein dsYTX/MeOH 0.0033 1.8 0.0096 
dsYTX/YTX 0.28 1.17 0.0096 
13 4-7 
YTX/MeOH 0.022 1.99 0.0032 
PRO1095 
(protein identification score was not significant) 
dsYTX/MeOH 0.0038 2.57 0.0032 
dsYTX/YTX 0.18 1.3 0.0032 
14 4-7 
YTX/MeOH 0.11 1.58 0.021 
N/A dsYTX/MeOH 0.0046 2.01 0.021 
dsYTX/YTX 0.24 1.28 0.021 
15 4-7 
YTX/MeOH 0.001 -1.76 0.001 
N/A dsYTX/MeOH 0.0062 -1.71 0.001 
dsYTX/YTX 0.87 1.03 0.001 
16 4-7 
YTX/MeOH 0.18 -1.23 0.015 
N/A dsYTX/MeOH 0.017 -1.61 0.015 
dsYTX/YTX 0.043 -1.3 0.015 
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Spot # pH Comparison T-test 
Av. 
Ratio 
1-way 
ANOVA 
Name 
17 4-7 
YTX/MeOH 0.044 -1.41 0.0078 
N/A dsYTX/MeOH 0.0069 -1.66 0.0078 
dsYTX/YTX 0.18 -1.18 0.0078 
18 4-7 
YTX/MeOH 0.0038 -1.62 0.00071 
Unnamed protein product (highly similar to absent in melanoma 1 protein) 
(protein identification score was not significant) 
dsYTX/MeOH 0.0024 -1.95 0.00071 
dsYTX/YTX 0.11 -1.2 0.00071 
19 4-7 
YTX/MeOH 0.034 -1.37 0.0029 
unnamed protein product {contains Ribosomal L3 superfamily domain; highly similar to 
mitochondrial 39s ribosomal protein L3}  
(protein identification score was not significant) 
dsYTX/MeOH 0.006 -1.7 0.0029 
dsYTX/YTX 0.034 -1.24 0.0029 
20 4-7 
YTX/MeOH 0.0033 -1.63 0.00027 
hCG2040114, isoform CRA_b 
(protein identification score was not significant) 
dsYTX/MeOH 0.0012 -2.04 0.00027 
dsYTX/YTX 0.043 -1.25 0.00027 
21 4-7 
YTX/MeOH 0.003 -1.59 0.00029 
hCG2042223  
(protein identification score was not significant) 
dsYTX/MeOH 0.00029 -1.63 0.00029 
dsYTX/YTX 0.86 -1.02 0.00029 
22 4-7 
YTX/MeOH 0.014 -2.81 0.0019 
translation initiation factor eIF-4gamma  
(protein identification score was not significant) 
dsYTX/MeOH 0.0061 -2.58 0.0019 
dsYTX/YTX 0.36 1.09 0.0019 
23 4-7 
YTX/MeOH 0.0013 -2.68 0.00015 
cytotoxic T-lymphocyte-associated protein 4 
(protein identification score was not significant) 
dsYTX/MeOH 0.00037 -2.55 0.00015 
dsYTX/YTX 0.63 1.05 0.00015 
24 4-7 
YTX/MeOH 0.12 1.49 0.026 
ferritin light polypeptide 
(protein identification score was not significant) 
dsYTX/MeOH 0.015 2.1 0.026 
dsYTX/YTX 0.18 1.41 0.026 
25 4-7 
YTX/MeOH 0.056 1.65 0.007 
immunoglobulin lambda chain variable region 
(protein identification score was not significant) 
dsYTX/MeOH 0.0046 2.38 0.007 
dsYTX/YTX 0.12 1.44 0.007 
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Spot # pH Comparison T-test 
Av. 
Ratio 
1-way 
ANOVA 
Name 
26 4-7 
YTX/MeOH 0.0075 1.76 0.0059 
N/A dsYTX/MeOH 0.0093 1.67 0.0059 
dsYTX/YTX 0.74 -1.06 0.0059 
27 4-7 
YTX/MeOH 0.012 -1.45 0.0083 
N/A dsYTX/MeOH 0.014 -1.54 0.0083 
dsYTX/YTX 0.53 -1.07 0.0083 
28 4-7 
YTX/MeOH 0.00038 2.05 4.20E-05 
hCG2012006  
(protein identification score was not significant) 
dsYTX/MeOH 0.00026 2.55 4.20E-05 
dsYTX/YTX 0.11 1.24 4.20E-05 
29 4-7 
YTX/MeOH 0.0012 2.12 6.20E-05 
heat shock 60kDa protein 1 (chaperonin), isoform CRA_c  
(protein identification score was not significant) 
dsYTX/MeOH 0.0004 2.89 6.20E-05 
dsYTX/YTX 0.037 1.36 6.20E-05 
30 4-7 
YTX/MeOH 0.0034 1.86 9.30E-05 
heat shock 60kDa protein 1 (chaperonin), isoform CRA_c dsYTX/MeOH 0.00032 2.54 9.30E-05 
dsYTX/YTX 0.021 1.37 9.30E-05 
31 4-7 
YTX/MeOH 0.03 1.53 0.0014 
immunoglobulin heavy chain variable region 
(protein identification score was not significant) 
dsYTX/MeOH 0.00093 2 0.0014 
dsYTX/YTX 0.056 1.31 0.0014 
32 4-7 
YTX/MeOH 0.3 1.22 0.026 
unnamed protein product {GroEL/chaperonin type I/II/chaperonin like domain.} 
 (protein identification score was not significant) 
dsYTX/MeOH 0.0028 1.57 0.026 
dsYTX/YTX 0.12 1.28 0.026 
33 4-7 
YTX/MeOH 0.22 1.23 0.049 
N/A dsYTX/MeOH 0.0092 1.51 0.049 
dsYTX/YTX 0.23 1.23 0.049 
34 4-7 
YTX/MeOH 0.0031 1.75 0.00021 
hCG2030305, isoform CRA_a  
(protein identification score was not significant) 
dsYTX/MeOH 0.00074 2.1 0.00021 
dsYTX/YTX 0.093 1.2 0.00021 
  R
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Spot # pH Comparison T-test 
Av. 
Ratio 
1-way 
ANOVA 
Name 
35 4-7 
YTX/MeOH 0.096 1.31 0.01 
calreticulin precursor variant 
(protein identification score was not significant) 
dsYTX/MeOH 0.0062 1.56 0.01 
dsYTX/YTX 0.095 1.19 0.01 
36 4-7 
YTX/MeOH 0.034 -1.72 0.037 
N/A dsYTX/MeOH 0.031 -1.62 0.037 
dsYTX/YTX 0.7 1.06 0.037 
37 4-7 
YTX/MeOH 0.045 1.39 0.0068 
N/A dsYTX/MeOH 0.0062 1.58 0.0068 
dsYTX/YTX 0.18 1.14 0.0068 
38 4-7 
YTX/MeOH 0.13 1.34 0.0083 
N/A dsYTX/MeOH 0.00089 1.77 0.0083 
dsYTX/YTX 0.1 1.32 0.0083 
39 4-7 
YTX/MeOH 0.012 -1.76 0.0065 NOS1 protein  
(protein identification score was not significant) dsYTX/MeOH 0.0017 -1.79 0.0065 
dsYTX/YTX 0.98 -1.02 0.0065 
40 4-7 
YTX/MeOH 0.051 1.56 0.0095 
N/A dsYTX/MeOH 0.0009 1.8 0.0095 
dsYTX/YTX 0.34 1.16 0.0095 
41 4-7 
YTX/MeOH 0.029 -1.57 0.014 unnamed protein product {non-specific BLAST hit to NAD-dependent glycerol-3-
phosphate dehydrogenase C-terminus domain}  
(protein identification score was not significant) 
dsYTX/MeOH 0.013 -1.77 0.014 
dsYTX/YTX 0.45 -1.13 0.014 
42 4-7 
YTX/MeOH 0.046 -1.5 0.0085 
N/A dsYTX/MeOH 0.01 -1.8 0.0085 
dsYTX/YTX 0.14 -1.2 0.0085 
43 4-7 
YTX/MeOH 0.059 -1.57 0.042 
N/A dsYTX/MeOH 0.034 -1.79 0.042 
dsYTX/YTX 0.49 -1.14 0.042 
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Spot # pH Comparison T-test 
Av. 
Ratio 
1-way 
ANOVA 
Name 
44 4-7 
YTX/MeOH 0.025 -2 0.018 
N/A dsYTX/MeOH 0.02 -1.96 0.018 
dsYTX/YTX 0.86 1.02 0.018 
45 4-7 
YTX/MeOH 0.0018 2.02 3.20E-05 
KRT8 protein 
(protein identification score was not significant) 
dsYTX/MeOH 5.70E-05 2.81 3.20E-05 
dsYTX/YTX 0.026 1.39 3.20E-05 
46 4-7 
YTX/MeOH 0.052 2.34 0.0095 
zinc finger protein 441  
(protein identification score was not significant) 
dsYTX/MeOH 0.0099 3.55 0.0095 
dsYTX/YTX 0.16 1.51 0.0095 
47 4-7 
YTX/MeOH 0.065 -1.38 0.011 
N/A dsYTX/MeOH 0.004 -1.61 0.011 
dsYTX/YTX 0.27 -1.17 0.011 
48 4-7 
YTX/MeOH 0.04 -1.5 0.016 
N/A dsYTX/MeOH 0.0094 -1.55 0.016 
dsYTX/YTX 0.88 -1.04 0.016 
49 4-7 
YTX/MeOH 0.0029 2.45 0.00074 
N/A dsYTX/MeOH 0.0004 2.16 0.00074 
dsYTX/YTX 0.62 -1.13 0.00074 
50 4-7 
YTX/MeOH 0.00097 2.53 8.50E-05 
tyrosine hydroxylase  
(protein identification score was not significant) 
dsYTX/MeOH 0.00055 2.42 8.50E-05 
dsYTX/YTX 0.73 -1.05 8.50E-05 
51 4-7 
YTX/MeOH 0.0039 2.03 0.00052 
unnamed protein product{nonspecific BLAST hit to BACK domain}  
(protein identification score was not significant) 
dsYTX/MeOH 0.0021 2.03 0.00052 
dsYTX/YTX 0.94 -1 0.00052 
52 4-7 
YTX/MeOH 0.024 1.62 0.0048 
protein disulfide isomerase-related protein 5 dsYTX/MeOH 0.0072 1.73 0.0048 
dsYTX/YTX 0.45 1.07 0.0048 
53 4-7 
YTX/MeOH 0.095 -1.28 0.0073 
N/A dsYTX/MeOH 0.004 -1.64 0.0073 
dsYTX/YTX 0.077 -1.28 0.0073 
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Spot # pH Comparison T-test 
Av. 
Ratio 
1-way 
ANOVA 
Name 
54 
4-7 
YTX/MeOH 0.19 1.71 0.061 
unnamed protein product {specific BLAST hit to actin} 
dsYTX/MeOH 0.0092 2.27 0.061 
55 β-actin* 
dsYTX/YTX 0.33 1.32 0.061 
56 4-7 
YTX/MeOH 0.21 2.12 0.049 
unnamed protein product{specific hit to actin domain}  
(protein identification score was not significant) 
dsYTX/MeOH 0.0061 3.19 0.049 
dsYTX/YTX 0.27 1.51 0.049 
57 4-7 
YTX/MeOH 0.0064 -1.83 0.0053 
N/A dsYTX/MeOH 0.046 -1.46 0.0053 
dsYTX/YTX 0.082 1.26 0.0053 
58 4-7 
YTX/MeOH 0.033 1.49 0.0074 
N/A dsYTX/MeOH 0.54 -1.11 0.0074 
dsYTX/YTX 0.0016 -1.65 0.0074 
59 4-7 
YTX/MeOH 0.013 -1.57 0.0036 
N/A dsYTX/MeOH 0.0059 -1.82 0.0036 
dsYTX/YTX 0.25 -1.16 0.0036 
60 4-7 
YTX/MeOH 0.03 1.54 0.012 
N/A dsYTX/MeOH 0.0098 1.75 0.012 
dsYTX/YTX 0.42 1.14 0.012 
61 4-7 
YTX/MeOH 0.09 -1.4 0.044 
N/A dsYTX/MeOH 0.034 -1.68 0.044 
dsYTX/YTX 0.31 -1.19 0.044 
62 4-7 
YTX/MeOH 0.022 -1.26 0.00018 
N/A dsYTX/MeOH 0.00044 -1.56 0.00018 
dsYTX/YTX 0.0017 -1.24 0.00018 
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Spot # pH Comparison T-test 
Av. 
Ratio 
1-way 
ANOVA 
Name 
63   
4-7 
YTX/MeOH 0.092 -1.32 0.033 
zinc finger protein 441  
(protein identification score was not significant) 
64 
dsYTX/MeOH 0.0042 -1.56 0.033 tyrosine hydroxylase  
(protein identification score was not significant) dsYTX/YTX 0.42 -1.18 0.033 
65 4-7 
YTX/MeOH 0.0096 -1.41 0.002 
immunoglobulin heavy chain variable region  
(protein identification score was not significant) 
dsYTX/MeOH 0.0017 -1.59 0.002 
dsYTX/YTX 0.27 -1.13 0.002 
YTX/MeOH 0.084 -1.24 0.02 
dsYTX/MeOH 0.02 -1.38 0.02 
dsYTX/YTX 0.15 -1.12 0.02 
66 4-7 
YTX/MeOH 0.0038 1.76 0.002 
N/A dsYTX/MeOH 0.0072 1.92 0.002 
dsYTX/YTX 0.58 1.09 0.002 
67 4-7 
YTX/MeOH 0.052 -1.41 0.021 N/A 
dsYTX/MeOH 0.008 -1.51 0.021 
dsYTX/YTX 0.67 -1.07 0.021 
68 4-7 
YTX/MeOH 0.027 1.61 0.0053 
Chain A, Crystal Structure Of Human P32, A Doughnut-Shaped Acidic Mitochondrial 
Matrix Protein 
dsYTX/MeOH 0.0058 1.75 0.0053 
dsYTX/YTX 0.39 1.09 0.0053 
69 4-7 
YTX/MeOH 0.055 -1.3 0.0064 
unnamed protein product {match to Zn finger 285A protein} 
(protein identification score was not significant) 
dsYTX/MeOH 0.0059 -1.52 0.0064 
dsYTX/YTX 0.1 -1.16 0.0064 
70 4-7 
YTX/MeOH 0.011 -1.44 0.0016 
immunoglobulin heavy chain variable region  
(protein identification score was not significant) 
dsYTX/MeOH 0.0015 -1.52 0.0016 
dsYTX/YTX 0.52 -1.06 0.0016 
71 4-7 
YTX/MeOH 0.00061 2.35 0.00013 
N/A dsYTX/MeOH 0.0069 1.64 0.00013 
dsYTX/YTX 0.0041 -1.43 0.00013 
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Spot # pH Comparison T-test 
Av. 
Ratio 
1-way 
ANOVA 
Name 
72 4-7 
YTX/MeOH 0.0016 -2.26 0.00025 
similar to RIKEN cDNA 1700016G05, isoform CRA_c 
(protein identification score was not significant) 
dsYTX/MeOH 0.002 -1.88 0.00025 
dsYTX/YTX 0.082 1.2 0.00025 
73 4-7 
YTX/MeOH 0.019 1.32 0.0021 
N/A dsYTX/MeOH 0.0035 1.57 0.0021 
dsYTX/YTX 0.08 1.19 0.0021 
74 4-7 
YTX/MeOH 0.13 -1.25 0.0081 
CALD1 protein 
(protein identification score was not significant) 
dsYTX/MeOH 0.0078 -1.57 0.0081 
dsYTX/YTX 0.027 -1.26 0.0081 
75 4-7 
YTX/MeOH 0.01 1.73 0.0027 
N/A dsYTX/MeOH 0.0029 1.7 0.0027 
dsYTX/YTX 0.97 -1.02 0.0027 
76 4-7 
YTX/MeOH 0.018 1.51 0.009 
N/A dsYTX/MeOH 0.037 1.42 0.009 
dsYTX/YTX 0.24 -1.06 0.009 
77 4-7 
YTX/MeOH 0.0079 -1.26 2.30E-05 
STK35 protein 
(protein identification score was not significant) 
dsYTX/MeOH 0.00011 -1.66 2.30E-05 
dsYTX/YTX 0.00093 -1.32 2.30E-05 
78 4-7 
YTX/MeOH 0.00044 2.91 5.50E-05 
complement receptor  
(protein identification score was not significant) 
dsYTX/MeOH 0.012 1.63 5.50E-05 
dsYTX/YTX 0.00019 -1.79 5.50E-05 
79 4-7 
YTX/MeOH 0.0044 3.14 0.0021 
CDC28 protein kinase regulatory subunit 1B  
(protein identification score was not significant) 
dsYTX/MeOH 0.037 1.91 0.0021 
dsYTX/YTX 0.013 -1.64 0.0021 
80 4-7 
YTX/MeOH 2.40E-05 2.12 3.90E-05 T cell receptor V alpha 9.1=specific for mycobacterial heat shock protein 60-derived 
peptide P1 {clone 2.4, complementarity-determining region 3} [human, peripheral blood 
T cells, Peptide Partial, 29 aa] (protein identification score was not significant) 
dsYTX/MeOH 0.12 1.22 3.90E-05 
dsYTX/YTX 0.00096 -1.74 3.90E-05 
81 4-7 
YTX/MeOH 0.012 -1.73 0.006 
N/A dsYTX/MeOH 0.026 -1.53 0.006 
dsYTX/YTX 0.19 1.13 0.006 
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Spot # pH Comparison T-test 
Av. 
Ratio 
1-way 
ANOVA 
Name 
82 4-7 
YTX/MeOH 2.70E-06 3.26 2.60E-07 
signal recognition particle 9kDa, isoform CRA_c  
(protein identification score was not significant) 
dsYTX/MeOH 0.00014 2.1 2.60E-07 
dsYTX/YTX 0.0006 -1.55 2.60E-07 
83 4-7 
YTX/MeOH 0.00019 1.98 3.90E-05 
N/A dsYTX/MeOH 0.0098 1.34 3.90E-05 
dsYTX/YTX 0.0015 -1.47 3.90E-05 
84 4-7 
YTX/MeOH 0.00073 2.17 0.00022 
unnamed protein product  
(protein identification score was not significant) 
dsYTX/MeOH 0.027 1.43 0.00022 
dsYTX/YTX 0.0014 -1.51 0.00022 
85 4-7 
YTX/MeOH 0.00014 1.81 3.90E-05 
N/A dsYTX/MeOH 0.00073 1.52 3.90E-05 
dsYTX/YTX 0.057 -1.19 3.90E-05 
86 4-7 
YTX/MeOH 0.0033 1.66 0.0021 
N/A dsYTX/MeOH 0.0026 1.57 0.0021 
dsYTX/YTX 0.68 -1.06 0.0021 
87 4-7 
YTX/MeOH 0.11 -1.28 0.0036 
N/A dsYTX/MeOH 0.0032 -1.72 0.0036 
dsYTX/YTX 0.02 -1.34 0.0036 
88 4-7 
YTX/MeOH 0.0016 1.83 0.00035 
N/A dsYTX/MeOH 0.0021 1.61 0.00035 
dsYTX/YTX 0.19 -1.14 0.00035 
89 4-7 
YTX/MeOH 0.13 -1.21 0.011 
Unknown {specific BLAST hit to α crystalline domain found in small HSPαB crystalline.} 
(protein identification score was not significant) 
dsYTX/MeOH 0.012 -1.53 0.011 
dsYTX/YTX 0.05 -1.26 0.011 
90 4-7 
YTX/MeOH 0.24 -1.26 0.02 
Full=MIF4G domain-containing protein; AltName: Full=SLBP-interacting protein 1; 
Short=hSLIP1 (protein identification score was not significant) 
dsYTX/MeOH 0.019 -1.66 0.02 
dsYTX/YTX 0.015 -1.31 0.02 
91 4-7 
YTX/MeOH 0.0059 -2.13 0.00055 
N/A dsYTX/MeOH 0.0002 -2.69 0.00055 
dsYTX/YTX 0.31 -1.26 0.00055 
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Spot # pH Comparison T-test 
Av. 
Ratio 
1-way 
ANOVA 
Name 
92 4-7 
YTX/MeOH 0.0025 1.74 4.30E-05 
immunoglobulin heavy chain variable region  
(protein identification score was not significant) 
dsYTX/MeOH 0.00012 2.17 4.30E-05 
dsYTX/YTX 0.022 1.24 4.30E-05 
93 6-11 
YTX/MeOH 0.031 1.65 0.024 
N/A dsYTX/MeOH 0.086 1.32 0.024 
dsYTX/YTX 0.088 -1.26 0.024 
94 6-11 
YTX/MeOH 0.012 -1.57 0.014 
N/A dsYTX/MeOH 0.066 -1.34 0.014 
dsYTX/YTX 0.18 1.17 0.014 
95 6-11 
YTX/MeOH 0.0015 -1.62 0.00046 
N/A dsYTX/MeOH 0.018 -1.33 0.00046 
dsYTX/YTX 0.0048 1.22 0.00046 
96 6-11 
YTX/MeOH 0.012 -1.7 0.0076 
unnamed protein product {specific BLAST hit K homology RNA-binding domain, type I.  
KH binds ss RNA/DNA} 
dsYTX/MeOH 0.071 -1.39 0.0076 
dsYTX/YTX 0.027 1.22 0.0076 
97 6-11 
YTX/MeOH 0.024 1.27 0.038 
N/A dsYTX/MeOH 0.037 1.55 0.038 
dsYTX/YTX 0.27 1.22 0.038 
98 6-11 
YTX/MeOH 0.029 2.04 0.024 
N/A dsYTX/MeOH 0.034 2.09 0.024 
dsYTX/YTX 0.97 1.03 0.024 
99 6-11 
YTX/MeOH 0.0046 1.63 0.0018 
N/A dsYTX/MeOH 0.0032 1.7 0.0018 
dsYTX/YTX 0.75 1.04 0.0018 
100 6-11 
YTX/MeOH 0.039 2.23 0.016 
hCG1647242 {specific BLAST hit to Bel/Pao family of RNase HI in long-term repeat 
retroelements}  (protein identification score was not significant) 
dsYTX/MeOH 0.0071 3.06 0.016 
dsYTX/YTX 0.29 1.37 0.016 
101 6-11 
YTX/MeOH 0.014 1.92 0.0018 
hCG2042223  
(protein identification score was not significant) 
dsYTX/MeOH 0.0012 2.47 0.0018 
dsYTX/YTX 0.2 1.29 0.0018 
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Spot # pH Comparison T-test 
Av. 
Ratio 
1-way 
ANOVA 
Name 
102 6-11 
YTX/MeOH 0.055 1.68 0.013 
tyrosine hydroxylase  
(protein identification score was not significant) 
dsYTX/MeOH 0.0028 2.13 0.013 
dsYTX/YTX 0.28 1.27 0.013 
103 6-11 
YTX/MeOH 0.28 1.19 0.047 
N/A dsYTX/MeOH 0.027 1.5 0.047 
dsYTX/YTX 0.12 1.26 0.047 
104 6-11 
YTX/MeOH 0.082 -1.38 0.011 
N/A dsYTX/MeOH 0.0027 -1.89 0.011 
dsYTX/YTX 0.16 -1.36 0.011 
105 6-11 
YTX/MeOH 0.15 -1.55 0.031 
N/A dsYTX/MeOH 0.046 -2.42 0.031 
dsYTX/YTX 0.046 -1.56 0.031 
106 6-11 
YTX/MeOH 0.052 1.63 0.025 
nucleolin, isoform CRA_c dsYTX/MeOH 0.02 1.72 0.025 
dsYTX/YTX 0.69 1.05 0.025 
107 6-11 
YTX/MeOH 0.074 1.41 0.0075 
HNRPA1 protein dsYTX/MeOH 0.0011 1.7 0.0075 
dsYTX/YTX 0.17 1.21 0.0075 
108 6-11 
YTX/MeOH 0.003 1.62 0.00034 
N/A dsYTX/MeOH 0.00025 1.77 0.00034 
dsYTX/YTX 0.37 1.09 0.00034 
109 6-11 
YTX/MeOH 0.01 1.79 0.00052 
N/A dsYTX/MeOH 0.0015 2.22 0.00052 
dsYTX/YTX 0.035 1.24 0.00052 
110 6-11 
YTX/MeOH 0.02 2.32 0.024 
N/A dsYTX/MeOH 0.072 1.84 0.024 
dsYTX/YTX 0.23 -1.26 0.024 
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Spot # pH Comparison T-test 
Av. 
Ratio 
1-way 
ANOVA 
Name 
111 6-11 
YTX/MeOH 0.38 1.11 0.01 
N/A dsYTX/MeOH 0.013 1.57 0.01 
dsYTX/YTX 0.017 1.41 0.01 
112 6-11 
YTX/MeOH 0.0007 1.85 9.50E-05 
N/A dsYTX/MeOH 0.00096 1.61 9.50E-05 
dsYTX/YTX 0.1 -1.15 9.50E-05 
113 6-11 
YTX/MeOH 0.1 -1.21 0.00022 
N/A dsYTX/MeOH 0.00013 -1.76 0.00022 
dsYTX/YTX 0.0031 -1.46 0.00022 
114 6-11 
YTX/MeOH 0.009 -1.43 0.0024 
transgelin 2, isoform CRA_a  
(protein identification score was not significant) 
dsYTX/MeOH 0.0044 -1.71 0.0024 
dsYTX/YTX 0.14 -1.19 0.0024 
115 6-11 
YTX/MeOH 0.074 -1.38 0.047 
apolipoprotein M, isoform CRA_b  
(protein identification score was not significant) 
dsYTX/MeOH 0.031 -1.54 0.047 
dsYTX/YTX 0.5 -1.11 0.047 
116 6-11 
YTX/MeOH 0.017 -1.41 0.0022 
N/A dsYTX/MeOH 0.0031 -1.65 0.0022 
dsYTX/YTX 0.13 -1.17 0.0022 
117 6-11 
YTX/MeOH 0.037 -1.33 0.00075 
N/A dsYTX/MeOH 0.0012 -1.75 0.00075 
dsYTX/YTX 0.012 -1.32 0.00075 
118 6-11 
YTX/MeOH 0.27 1.26 0.0046 unnamed protein product {gene region Rossmann-fold NADP(+)-binding protein; highly 
similar to pyruvate dehydrogenase regulatory subunit, mRNA} (protein identification 
score was not significant) 
dsYTX/MeOH 0.0072 2.23 0.0046 
dsYTX/YTX 0.0026 1.77 0.0046 
119 6-11 
YTX/MeOH 0.054 2.05 0.026 
N/A dsYTX/MeOH 0.036 2.09 0.026 
dsYTX/YTX 0.82 1.02 0.026 
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Table 8 HL60 protein abundance changes (Av. Ratio) and associated statistics acquired from DeCyder and protein identification for picked protein spots which did not show 
a change in abundance, as numbered in Fig. 14.  Av. Ratio is the protein volume of the first condition compared to the second in the comparison.  For example negative 
value when comparing dsYTX/untreated means that the protein has undergone a decrease in abundance in response to dsYTX respective to the untreated control. 
* Indicates protein identification is not the top-ranked match. 
 
Spot # pH Comparison T-test 
Av. 
Ratio 
1-way 
ANOVA 
Name 
01 4-7 
YTX/MeOH 0.53 1.23 0.22 
MTHSP75* 
dsYTX/MeOH 0.0062 1.43 0.22 
dsYTX/YTX 0.38 1.16 0.22 
YTX/MeOH 0.93 1.06 0.61 
dsYTX/MeOH 0.099 1.2 0.61 
dsYTX/YTX 0.48 1.14 0.61 
02 4-7 
YTX/MeOH 0.27 -1.24 0.38 
heat shock 70kDa protein 8 isoform 1 variant* dsYTX/MeOH 0.21 -1.13 0.38 
dsYTX/YTX 0.5 1.1 0.38 
03 4-7 
YTX/MeOH 0.42 -1.12 0.36 
unnamed protein product {BLAST matches to protein disulfide isomerise (PDI) a, a’, b, b’ 
families; ER} 
dsYTX/MeOH 0.49 1.09 0.36 
dsYTX/YTX 0.22 1.22 0.36 
04 4-7 
YTX/MeOH 0.85 -1 0.18 
Chaperonin (HSP60) dsYTX/MeOH 0.022 1.26 0.18 
dsYTX/YTX 0.16 1.26 0.18 
05 4-7 
YTX/MeOH 0.67 1.05 0.2 
Chain A, TapasinERP57 HETERODIMER dsYTX/MeOH 0.087 1.2 0.2 
dsYTX/YTX 0.17 1.14 0.2 
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Spot # pH Comparison T-test 
Av. 
Ratio 
1-way 
ANOVA 
Name 
06 4-7 
YTX/MeOH 0.64 -1.06 0.64 
unnamed protein product {specific BLAST hit to β tubulin} dsYTX/MeOH 0.25 -1.16 0.64 
dsYTX/YTX 0.71 -1.1 0.64 
07 4-7 
YTX/MeOH 0.38 -1.14 0.48 
unnamed protein product {specific BLAST hit to β tubulin} dsYTX/MeOH 0.22 -1.18 0.48 
dsYTX/YTX 0.87 -1.04 0.48 
08 4-7 
YTX/MeOH 0.49 1.23 0.45 
unnamed protein product {specific BLAST hit to α tubulin}* dsYTX/MeOH 0.13 1.35 0.45 
dsYTX/YTX 0.64 1.1 0.45 
09 4-7 
YTX/MeOH 0.13 -1.32 0.14 
unnamed protein product {specific BLAST hit to α tubulin} dsYTX/MeOH 0.041 -1.38 0.14 
dsYTX/YTX 0.89 -1.05 0.14 
010 4-7 
YTX/MeOH 0.53 -1.12 0.71 
unnamed protein product {specific BLAST hit to actin} dsYTX/MeOH 0.4 -1.16 0.71 
dsYTX/YTX 0.94 -1.04 0.71 
011 4-7 
YTX/MeOH 0.28 -1.25 0.42 
unnamed protein product {specific BLAST hit to actin} dsYTX/MeOH 0.17 -1.28 0.42 
dsYTX/YTX 0.96 -1.02 0.42 
012 6-11 
YTX/MeOH 0.16 1.32 0.13 
Chain A, Crystal Structure Of Human Phosphoglycerate Kinase Bound To D-
Adp/phosphoglycerate kinase 1, isoform CRA_b 
dsYTX/MeOH 0.89 -1.03 0.13 
dsYTX/YTX 0.037 -1.36 0.13 
YTX/MeOH 0.82 -1.03 0.93 
dsYTX/MeOH 0.71 -1.06 0.93 
dsYTX/YTX 0.92 -1.03 0.93 
013 6-11 
YTX/MeOH 0.23 -1.09 0.16 
17 kDa cyclophilin A (internal fragment) dsYTX/MeOH 0.11 -1.21 0.16 
dsYTX/YTX 0.33 -1.1 0.16 
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  Figure 17 Proteins identified as changing in HL60 cells treated with YTX or dsYTX with MeOH as control, compared to changes found in HepG2 cells following 24 h 
incubation with YTX (Young et al., 2009).  * denotes a 2 fold change, 0.01 (dsYTX or YTX only).  Upwards pointing arrows indicate proteins which increased in 
abundance in response to treatment.  Downwards pointing arrows indicate proteins which decreased in response to treatment. 
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Figure 18 Proteins identified as changing in HL60 cells treated with either YTX with MeOH as control, or peloruside A (Pel A) or paclitaxel (PTX) (Wilmes et al., 
2010, 2011).  * denotes a 2 fold change, 0.01 (dsYTX or YTX only).  Upwards pointing arrows indicate proteins which increased in abundance in response to 
treatment.  Downwards pointing arrows indicate proteins which decreased in response to treatment. 
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 Figure 19 Proteins identified as changing in HL60 cells treated with dsYTX with MeOH as control, or peloruside A (Pel A) or paclitaxel (PTX) (Wilmes et al., 
2011, 2012).  * denotes a 2 fold change, 0.01 (dsYTX or YTX only).  Upwards pointing arrows indicate proteins which increased in abundance in response to 
treatment.  Downwards pointing arrows indicate proteins which decreased in response to treatment. 
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4 DISCUSSION 
4.1  S. cerevisiae 
In initial experiments wild type S. cerevisiae cells were exposed to 1.2 µM YTX.  This 
concentration was selected to be comparable to the amount used by Young et al., in 
HepG2 cells. 
The effects of YTX or dsYTX on yeast cell proteins were small and did not meet the 
criteria for significant change (Karp et al., 2007).  These small changes were only 
observed when the FDR filter was not applied.  The changes are reported, however, for 
comparison with effects seen in mammalian cells. 
DIGE analysis showed no significant changes, using the ≥ 2-fold, p ≤ 0.01 criteria, in 
response to 1.2 µM YTX.  Of four protein spots showing a possible change (≥ 1.5 fold, p 
≤ 0.05) in abundance, two were identified with significant Mascot scores.  Cytosolic 
aldehyde dehydrogenase showed a possible 1.51-fold decrease in abundance (spot 10) 
in YTX treated cells compared to untreated controls.  S. cerevisiae phosphoglycerate 
mutase showed a possible 1.75-fold decrease in YTX treated cells when compared with 
untreated cells, but not methanol treated (spot 32).  Spot 5 and Spot 17 also possibly 
decreased in abundance when treated with YTX compared with untreated or methanol 
treated controls respectively. 
Yeast cells often require a higher toxin dose to have an effect than is seen with 
mammalian cells due to the presence of the yeast cell wall and a number of export 
pumps.  Therefore in order to test if the small number of changes was due to the 
concentration of YTX used being too low, the effect of a 10-fold higher concentration 
on wild type stationary phase yeast cells was tested.  This resulted in an increase in the 
number of changes detected when proteins from YTX treated cells were compared 
with those from methanol treated cells.  These differences in abundance did not reach 
the criteria for significance and were not observed when toxin treated proteins were 
compared to those from untreated cells. 
Log phase wild type cells were then exposed to YTX, as they can be more susceptible 
than stationary phase cells to the chemical effects.  No significant changes in
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abundance were observed using the defined criteria.  Seven of the 12 possible (≥1.5-
fold, p ≤ 0.05) changes detected when YTX treated proteins were compared to 
untreated control samples also changed when the methanol treated and untreated 
controls were compared with each other.  The fact that the changes were detected 
when controls were compared suggests that these differences in abundance were 
artefacts and not effects of the toxin.   
The ABC transporter pump knock-out mutant, ADΔ, was used to examine whether the 
small number of changes observed was due to the toxin being removed from the cell 
before it had a chance to exert an effect.  No changes were detected in stationary 
phase cells treated with 1.2 or 12 µM YTX.  Basic proteins from log phase cells treated 
with YTX also showed no differences from controls.  While no significant protein 
changes were detected, three protein spots showed possible decreases in abundance 
(Spots 158, 160 and 163, Table 5) when compared with methanol treated or untreated 
controls.  Three other protein spots showed apparent decreases in response to YTX 
when compared with methanol treated cells only.  No changes were detected between 
the two control groups.  Due to the small number of changes and the fact that the 
majority of the changing protein spots were low abundance, these protein spots were 
not excised from gels for identification.  
YTX did not appear to have an effect on S. cerevisiae cells; however inhibition of yeast 
growth by YTX has been observed previously (Ogino et al., 1997).  However in that 
study, YTX was applied at a much higher concentration (50 µM), than was used in this 
project.  It was also applied on a disk to Candida rugosa plate cultures, rather than 
administered in liquid cultures. 
Significant changes in protein abundance were only detected in yeast cells treated with 
dsYTX.  In wild type cells, GRE1 was identified as undergoing a 2.37-fold decrease in 
abundance in response to dsYTX compared with untreated controls.  GRE1 is a 
hydrophillin induced in response to stress, and is regulated by the (HOG) MAPK-
pathway.  Spot 156 showed a 2.13-fold decrease, but was too low in abundance to be 
extracted for MALDI TOF/TOF MSMS analysis.  A possible, but not significant, change in 
abundance was also detected in mitochondrial aldehyde dehydrogenase.  However 
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Mascot scores for these identifications were below the significance threshold (score > 
56, p ≤ 0.05).  These proteins were not identified as undergoing a change in abundance 
in HepG2 cells treated with YTX.  The greater effect seen with dsYTX is consistent with 
dsYTX being a more potent inhibitor of yeast growth than YTX (Ogino et al., 1997).   
DIGE analysis detected more changes in protein abundance in pump knock-out mutant 
cells exposed to dsYTX compared with wild type.  Three protein spots showed 
significant changes in cells exposed to toxin.  Spots 165 and 166 showed 2.5 and 2-fold 
increases in response to dsYTX treatment respectively.  Spot 200 showed an 
approximately 2.3-fold decrease when exposed to dsYTX.  Unfortunately mass 
spectrometry analysis of these protein spots did not yield significant matches.  The 
top-ranked match for each spot in order was YKR101Wp-like protein, Pau9 
hypothetical protein product, and mitochondrial translational activator.  Possible (≥ 
1.5-fold, p ≤ 0.05) increases in abundance were detected in protein spots identified as 
HSP90-Sba1 closed chaperone complex (chain A, spot 168, Table 5), YLL024Cp-like 
protein (spot 173), ATPase (involved in nuclear localisation signal directed nuclear 
transport), and translational elongation factor EF-1α (spot 215).  A possible decrease 
was detected in alcohol dehydrogenase isozyme I (spot 211).  HSP90B1 and elongation 
factor 1δ were shown to decrease and increase respectively, in HepG2 cells exposed to 
YTX. 
There did not seem to be any common pattern to the protein changes seen in S. 
cerevisiae.  The exception was spots 38 and 159 (Figs. 7 and 10) which migrated to 
similar positions on their respective gels so may be the same protein.  Both spots, in 
stationary wild type cells or log phase pump mutant cells respectively, showed a 
possible decrease when exposed to 12 µM YTX.  They are also possibly the same as 
spot 26 (Fig. 6), which was identified as triosephosphate isomerase, chain A.  Spot 26 
did not have a change in abundance in stationary wild type cells exposed to 1.2 µM 
YTX. 
Twenty-three proteins, which showed no change in protein abundance, were 
identified with significant Mascot scores (Appendix H).  These included fructose-1,6-
aldolase, pyruvate kinase, actin, and SSE1 (ATPase component of the HSP90 co-
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chaperone complex) and the HSP90 co-chaperone protein.  Changes in abundance 
were seen in proteins similar to these in HepG2 cells treated with YTX (Young et al., 
2009).  These were aldolase A, pyruvate kinase 3 (isoform 1), β-actin, and HSP90B1. 
Possible reasons for the lack of a strong effect seen with YTX or dsYTX on S. cerevisiae 
cells include poor penetration of the toxins through the yeast cell wall, removal of the 
toxin by efflux pumps other than the ABC transporters, or lack of proteins in S. 
cerevisiae structurally homologous to targets in mammalian cells.  For example, 
although there are proteins functionally homologous to hnRNPs in yeast, they are not 
structurally identical to those in mammalian cells (Matunis et al., 1994, Denisenko et 
al., 2001, Jimeno et al., 2006). 
 
4.1.1 Summary  
Few changes were seen in S. cerevisiae cells treated with YTX.  Significant changes in 
protein abundance were only observed in cells treated with dsYTX, with a possibly 
greater effect seen in the pump knock-out mutant strain.  However, these changes 
were non-significant when the FDR filter was applied.  A slight increase in the number 
of affected proteins was also seen in log phase cells from the mutant strain when 
treated with YTX.   A significant decrease was seen in the abundance of GRE1 in YTX 
treated cells compared to untreated controls.  Apparent increases were detected in 
the HSP90-Sba1 closed chaperone complex (chain A) and translational elongation 
factor EF-1α, when cells were exposed to dsYTX, compared to methanol treated 
controls.  These proteins were also affected by YTX in HepG2 cells (Young et al., 2009).  
No change in abundance was detected in fructose-1,6-aldolase, pyruvate kinase, actin, 
and SSE1 (ATPase component of the HSP90 co-chaperone complex) and the HSP90 co-
chaperone protein.  However in HepG2 cells treated with YTX, changes in abundance 
were detected in protein similar to these.  These were: aldolase A, pyruvate kinase 3 
(isoform 1), β-actin, and HSP90B1 (Young et al., 2009). 
The greater effect seen with dsYTX is consistent with previous research which showed 
dsYTX was a more potent inhibitor of yeast growth than YTX (Ogino et al., 1997). 
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The slightly higher number of protein changes detected in the pump knock-out mutant 
implies that the ABC transporters may be involved in export of the toxin. 
As only a small number of changes in protein abundance were observed in S. cerevisiae 
cells exposed to YTXs, the planned chemical genetics experiments could not be carried 
out. 
 
4.2 HL60 cells 
4.2.1 Morphological changes 
Following 24 h exposure to YTX, no differences in morphology were observed in HL60 
cells compared to controls.  However trypan blue staining showed a 12.7% decrease in 
the number of live cells.  Exposure to dsYTX, caused cells to aggregate into clumps of 
various sizes.  Trypan blue staining showed that the cells in these clumps were dead.  A 
24% decrease in the number of live cells was also seen. 
 
4.2.2 Protein changes 
4.2.2.1 DeCyder Analysis 
A greater number of protein changes was observed in HL60 cells treated with YTX, 
than was seen in yeast.  Sixteen protein spots were identified as undergoing a 
significant change in response to YTX.  As was seen in yeast, dsYTX seemed to have a 
greater effect (Table 6, Figs. 15 and 16), with 32 proteins showing a significant change 
(Table 6).  Of the 119 spots identified as changing, 33 showed a significant increase in 
abundance.  Five showed a significant decrease in abundance. 
When protein abundances from dsYTX treated cells were compared to those from YTX 
treated cells no significant differences were detected.  DeCyder analysis showed that 
protein abundances seemed to be affected in a similar way by either toxin.  Eight 
protein spots did, however, show a possible difference (between 1.5 and 2-fold 
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change, p ≤ 0.05) between the two toxins, but no identification was attained for these 
proteins. 
4.2.2.2 Protein identifications and comparison to HepG2, Pel A, and PTX 
4.2.2.2.1 YTX vs. dsYTX in HL60 cells 
Four identified proteins changed in both YTX and dsYTX treated HL60 cells.  Two of 
these were stress response proteins (HSP60 (chaperonin), GRP78 (BiP) precursor), one 
was a mitochondrial glycoprotein (chain A, p32/tat associated protein), the fourth was 
protein disulfide isomerase-related protein 5.  In HepG2 cells treated with YTX the 
protein disulfide isomerase precursor was found to be affected in HepG2 cells (Young 
et al., 2009).  The two stress response proteins both showed a significant increase 
(approximately 2 and 2.5-fold for GRP78 precursor and HSP60, respectively, p ≤ 0.01) 
in abundance in response to dsYTX.  Apparent increases were also observed in 
response to YTX.  Protein disulfide isomerase-related protein 5 and p32 (chain A) both 
showed possible increases of approximately 1.6 and 1.7-fold in response to YTX and 
dsYTX respectively.  When the FDR filter was applied all four of these proteins no 
longer met the p ≤ 0.01 cut-off but were significant at p ≤ 0.05. 
An unnamed protein, containing a K homology RNA binding, type 1 domain was 
identified as possibly decreasing (1.7-fold) in response to YTX.  This domain is found in 
wide range of proteins, including proteins of the ribosome and transcription factors, 
including hnRNP K, and is involved in binding single stranded RNA and DNA.  A BLAST 
search of the top ranked protein identification suggests that it may be far upstream 
element-binding protein 1, which is involved in c-myc expression.   Myc was identified 
as a hub protein in the IPA network analysis of proteins affected by Pel A (Wilmes et 
al., 2011). 
Nucleolin and tumour rejection antigen 1 (gp96) showed increases in abundance, or 
1.72 and 1.63 fold respectively, in HL60 cells treated with dsYTX compared to controls.  
The gp96 precursor underwent an increase in abundance in HepG2 cells following 24 h 
incubation with YTX (Young et al., 2009).  When the FDR filter was applied the gp96 
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precursor change still met the ≥ 1.5-fold, p ≤ 0.05 cut-off.  Nucleolin did not meet this 
criteria. 
4.2.2.2.2 YTX and dsYTX in HL60 cells vs. HepG2 cells treated with YTX 
Identified proteins changing in HL60 cells when incubated with YTX or dsYTX for 24 h 
were compared with those previously found to be changing in HepG2 treated with YTX 
after 24 h of incubation (Fig. 17). 
Actin (β), hnRNP A, and BiP were found to be affected by dsYTX in HL60 cells and YTX in 
HepG2 cells.  HnRNP A and BiP showed increases of 1.7 and 1.8-fold respectively.  Actin 
(β) showed a significant 2.27 fold increase.  In HepG2 cells treated with YTX these 
proteins all decreased in abundance (Fig. 17, Young et al., 2009).   
4.2.2.2.3 Comparison of identified protein changes in HL60 cells 
No identified proteins were found to be changing in common between HL60 cells 
treated with PTX or Pel A and YTX. (Fig. 18) 
BiP and hnRNP A were found to be changing in HL60 cells treated with PTX, Pel A or 
dsYTX.  In almost all cases these proteins increased in abundance.  The only exception 
was in PTX treated cells, where BiP underwent a decrease in abundance (Fig. 19). 
Two identified proteins were affected by both Pel A and dsYTX.  These were actin and 
tumour rejection antigen 1.  Both proteins had an increase (actin: ≥2-fold, 0.01 in 
dsYTX treated) in abundance compared to controls.   
No identified proteins were found to be affected by both PTX and dsYTX, but not Pel A 
in HL60 cells. 
4.2.2.2.4 Other proteins 
No changes in abundance were detected in response to either toxin for mitochondrial 
HSP75, HSP 70 kDa protein 8 isoform 1 variant, tapasin/ERP57 heterodimer (chain A),  
phosphoglycerate kinase (chain A), cylcophilin A (17 kDa fragment), or unnamed 
products with specific BLAST search hits to α- or β-tubulin.  An unnamed protein 
product had a BLAST search match to protein disulfide isomerase a, a’, b and b’ 
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families.  This contrasts to the results obtained for HL60 cells treated with PTX or Pel A 
(Wilmes et al., 2011, 2012) and HepG2 cells treated with YTX (Young et al., 2009).  
Tubulin decrease in abundance in HepG2 cells treated with YTX and increased in HL60 
cells treated with Pel A.  α-tubulin abundance increased in HL60 cells when treated 
with PTX (α-tubulin 1A), or when treated with PTX or Pel A (α-tubulin 1C). 
 
4.2.3 Summary 
YTX and dsYTX were more potent against mammalian HL60 cells than yeast.  No 
change in morphology was observed in cells exposed to YTX for 24 h, however trypan 
blue staining showed a 12.7% decrease in the number of live cells present.  DsYTX may 
be affecting cell-cell adhesion in some way as when cells were exposed to it for 24 h, 
they aggregated into clumps of dead cells.  A 24% decrease in the number of live cells 
was also observed. It is not clear whether cell death occurred prior to or after cluster 
formation.  Only a small number of the detected protein changes were able to be 
successfully identified.  Of these hnRNP A and BiP (GRP78, HSP70) were identified as 
changing in response to treatment with dsYTX, Pel A or PTX in HL60 cells, and in 
response to YTX in HepG2 cells.  Actin (β) was affected by dsYTX and Pel A in HL60 
cells, and YTX in HepG2 cells. 
HSP60, GRP78 precursor, p32/tat associated protein, and protein disulfide isomerase-
related protein 5, underwent a change in abundance in response to YTX treatment and 
to dsYTX treatment.  These proteins are mostly related to stress response. 
Unexpectedly, none of the identified proteins which changed with response to YTX in 
HL60 cells were also changing in YTX treated HepG2 cells or in Pel A or PTX treated 
HL60 cells.  However as the number of proteins identified was limited, this does not 
mean that there are no similar protein changes.  This means that we were unable to 
distinguish toxin specific protein changes from those which are cell line specific. 
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4.3 Conclusions 
The small number of protein identifications limits the formation of a comprehensive 
conclusion.  No significant changes in protein abundance or cell morphology were 
observed in S. cerevisiae cells treated with YTX.  This suggests that YTX does not exert 
any significant effect on S. cerevisiae cells at the concentration used in either 
stationary or log phase.  Significant changes in abundance were detected when 
stationary phase cells were exposed to dsYTX.  This suggests that dsYTX is potentially 
more toxic to yeast than YTX.  This disulfated compound may have greater penetration 
through the cell wall or a different mechanism of action or protein target than YTX 
which makes it more toxic to yeast.  
A greater effect of both toxins was seen in mammalian cells compared with yeast.  
HL60 cells showed no morphological differences from controls when treated with YTX, 
however dsYTX treated cells aggregated into clumps of dead cells.  Actin (β), hnRNP A, 
and BiP were found to be affected by both YTX and dsYTX in HL60 cells.  These proteins 
were also affected in YTX treated HepG2 cells (Young et al., 2009).  These proteins 
increased in abundance in HL60 cells but were reported to decrease in HepG2 cells 
(Young et al., 2009).  BiP and hnRNP A also showed an increase in HL60 cells treated 
with Pel A or PTX (Wilmes et al., 2011, 2012).  This suggests that these proteins are a 
general response of HL60 cells to stress.  No identified proteins were detected as 
changing in response to YTX in both HL60 and HepG2 cells.  However, due to the small 
number of significant protein identifications it cannot be concluded that there were no 
similarities.   
A greater number of changes in protein levels appeared to be produced by dsYTX 
compared with YTX in HL60 cells.  However when the DIGE analyses of the two toxins 
were compared, there were few differences in abundance detected, even for protein 
spots which showed a change in abundance response to only one of the toxins.  
Proteins which underwent a change in abundance in response to treatment with either 
toxin were changed similarly.  For example a protein spot which underwent an 
increase in abundance in response to YTX would also show an increase in response to 
dsYTX, although the fold-change in abundance could be different.  
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4.4 Future directions 
Further proteomic analysis of effects in HL60 cells could use either larger gels, which 
allow the application of greater protein loads than 7cm gels, or gel-free shotgun 
proteomics methods.  The advantage of the gel-based approach is that it allows the 
ready detection of protein isoforms formed from different post-translational 
modifications.  Protein identifications should be validated by Western Blot analysis.  
Once a larger set of protein identifications is obtained IPA should then be used to 
identify the possible target pathways of YTX and dsYTX.  These should then be 
compared to each other, and to those obtained by Young et al. (2009), in YTX treated 
HepG2 cells, and Wilmes et al. (2011) in HL60 cells treated with Pel A. 
Observation of the cells over the course of exposure to the toxin could provide insight 
into how the toxic effects of each compound progresses.  In particular it would be 
useful to learn more about the development of the cell aggregation seen with dsYTX 
treatment.  Comparison of protein profiles from different time points would also be 
interesting to carry out, to observe any time dependent effects on protein expression.  
Annexin V/PI staining should also be carried out to determine if the cell death 
observed is apoptosis or necrosis. 
If larger amounts of toxin are available, the effect of higher toxin concentrations on S. 
cerevisiae and HL60 cells could be investigated.  Determination of the LC50 and IC50 of 
YTX and dsYTX in these cell lines could help to determine the optimal concentration to 
use to observe toxin specific effects, with the least amount of general stress and cell 
death responses. 
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Appendix A 
Symbol key for IPA networks 
Function 
Circle     Other 
Circle (double)   Group/complex 
Diamond    Enzyme 
Hexagon    Translation regulator 
Oval     Transcription regulator 
Rectangle (dotted)   Ion channel 
Rectangle (solid)   G-protein nuclear receptor 
Square     Cytokine 
Trapezium    Transporter 
Triangle (downward pointing) Kinase 
Triangle (upward pointing)  Phosphatase 
 
Interaction 
Arrow, solid line Direct action (protein acts on another to influence 
expression) 
Arrow, dotted line   Indirect association 
Dotted line    Indirect action 
Solid line    Binding  
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Gene abbreviations 
HepG2 cells and YTX  
ACTB   β-actin 
AHCY   S-adenosylhomocysteine hydrolase 
ALDOA  aldolase A 
BAG2   BCL2-associated anthanogene 2 
CCN2   calponin 2 
DNAJC3  DNA J (Hsp40) homologue, subfamily C, member 3 
HNRNPA2B1  hnRNP A2/B1 
HNRNPL  hnRNP L 
HNRNPK  hnRNP K 
HSP90B1  heat shock protein 90 kDa β (Grp94), member 1 
HSPA8   heat shock 70 kDa protein 8 
HSPA9   heat shock 70 kDa protein 9 (mortalin) 
PCBP1   hnRNP E1 
PKM2   pyruvate kinase, muscle 
XRCC5 X-ray repair complementing defective repair in Chinese hamster  
cells 5 
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HL60 cells and Pel A  
ACAT2     acetyl-coenzyme A acetyltransferase 2 
BIK     BCL2-interacting killer  
CAPZB     F-actin-capping subunit β 
CLIC4     chloride intracellular channel 4 
COTL1     coactosin-like 1  
DSTN     destrin 
EEF1D     eukaryotic translation elongation factor 1δ  
EIF3D eukaryotic translation initiation factor 3, subunit 
D 
EIF3F     eukaryotic translation initiation factor 3, subunit F 
EIF4E     eukaryotic translation initiation factor 4E 
ERN1     ER to nucleus signalling 1 protein 
GARS     glycyl-tRNA synthetase 
HNRNPC    heterogeneous nuclear ribonucleoprotein C 
HSP90AA2    heat shock protein 90 kDa α, class A member 2 
HSPA1B    heat shock protein 1B 
IFI6     interferon, alpha-inducible protein 6 
IGK@     immunoglobulin kappa locus 
IKBKE inhibitor of kappa light polypeptide gene 
enhancer in B cells, kinase epsilon 
Immunoproteasome Pa28/20s proteasome activator subunit 1 (PA28 alpha) 
KHSRP     KH-type splicing regulatory protein 
LMNB2    lamin B2 
MSR1     macrophage scavenger receptor 1 
MYC v-myc myelocytomatosis viral oncogene homolog 
(avian) 
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MYH9    myosin 
PDGFB    platelet derived growth factor, B polypeptide 
PRDX3    peroxiredoxin 3 
Proteasome PA700/20s proteasome activator subunit 1 (PA28 alpha) 
PSMA1   proteasome subunit, alpha type 1 
PSMB4   proteasome subunit, beta type, 4 
PSMC4    proteasome 26s subunit 
SDHA succinate dehydrogenase complex, subunit A, 
flavoprotein 
SRXN1    sulfiredoxin 1 homolog (S. cerevisiae) 
STMN1   stathmin 1/oncoprotein 18 
TNF    tumour necrosis factor (TNF superfamily, member 2) 
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Appendix B 
LC-MS analysis of the compounds was carried out by Andy Selwood of the Cawthron 
Institute, Nelson, New Zealand.  The analysis determined that the stock solutions of 
each compound were pure.  The YTX stock contained no detectable traces of other YTX 
analogues.  The dsYTX stock contained only trace (ca 1%) amounts of YTX. 
The YTX and dsYTX samples sent for analysis were supposed to contain 100 µg and 25 
µg of toxin respectively.  LC-MS-MS analysis determined the amount of YTX to be 50 
µg.  UV comparison of the dsYTX sample to the Cawthron Institute’s dsYTX standard 
determined the quantity of toxin present to be 19 µg.  This means there is potentially 
some difference between the intended concentration of toxin used to treat samples, 
and the actual.  However since only small samples (10 µL and 5 µL for YTX and dsYTX 
respectively), it is also possible that some may have evaporated in transit between 
Wellington and Nelson. 
 
  
UV spectrum of YTX Positive ion MS spectrum of YTX 
LC-MS negative ion of YTX LC-MS negative ions MS spectrum of YTX 
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UV spectrum of dsYTX Positive ion MS spectrum of dsYTX 
LC-MS negative ions MS spectrum of dsYTX 
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Appendix C 
 Example template for a DIGE experiment (n=4, 3 treatment conditions) 
  
PROTEIN LOAD: 20 µg/dye/strip  
DYE/PROTEIN: 80 pmols/20 µg 
WORKING DYE SOL’N.: 1.2 µL dye + 4.8 (5) µL DMF (1 pH range) 
                                           2.4 µL dye + 9,6 (10) µL DMF (2 pH ranges) 
STRIPS: 7cm; 4-7/6-11 
CHECK pH SAMPLES (>8) 
LABELLING 
Cy3 SAMPLE 
µg 
prot. 
µL 
lysate 
µL 
Dye 
µL 
lysine 
Tot 
volume 
tube 1 MeOH 1 20 2.46 1 1 4.46 
tube 2 MeOH 4 20 2.06 1 1 4.06 
tube3  YTX 6 20 2.99 1 1 4.99 
tube 4 YTX 7 20 2.45 1 1 4.45 
tube 5 dsYTX 10 20 3.02 1 1 5.02 
tube 6 dsYTX 11 20 2.66 1 1 4.66 
 TOTAL Cy3 480 pmol/ 120 µg protein 
Cy5 SAMPLE 
µg 
prot. 
µL 
lysate 
µL 
Dye 
µL 
lysine 
Tot 
volume 
tube 7 MeOH 2 20 2.04 1 1 4.04 
tube 8 MeOH 3 20 2.70 1 1 4.70 
tube 9 YTX 5 20 2.27 1 1 4.27 
tube 10 YTX 8 20 2.41 1 1 4.41 
tube 11 dsYTX 9 20 2.18 1 1 4.18 
tube 12 dsYTX 12 20 2.46 1 1 4.46 
 TOTAL Cy5 480 pmol/ 120 µg protein 
 INTERNAL ST. 
µg 
prot. 
µL 
lysate 
µL 
Dye 
µL 
lysine 
Tot 
volume 
tube 13   
120        14.85 
10/sample     6            6           26.85 
 TOTAL Cy2 480 pmol/120 µg prot. 
  
 SAMPLE MIX 
1 tube 1  +  tube 9  +  4.47  µL i.s 
2 tube 2  +  tube 12  +   4.47   µL  i.s 
3 tube 3  +  tube 7  +   4.47   µL  i.s 
4 tube 4  +  tube 11  +   4.47   µL  i.s 
5 tube 5  +  tube 8  +   4.47   µL  i.s 
6 tube 6  +  tube 10  +   4.47   µL  i.s 
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 EXPERIMENT DESIGN 
µL R.B. 
pH 4-7 pH 6-11 
   Cy3  MeOH 1   
1 strip#  11347 Cy5  YTX 5 125 100 
   i.s.Cy2   
   Cy3  MeOH 4   
2 strip#  11349 Cy5  dsYTX 12 125 100 
   i.s.Cy2   
   Cy3  YTX 6   
3 strip#  11350 Cy5  MeOH 2 125 100 
   i.s.Cy2   
   Cy3  YTX 7   
4 strip#  11350 Cy5  dsYTX 9 125 100 
   i.s.Cy2   
   Cy3  dsYTX 10   
5 strip#  11350 Cy5  MeOH 3 125 100 
   i.s.Cy2   
   Cy3  dsYTX 11   
6 strip#  11350 Cy5  YTX 8 125 100 
   i.s.Cy2   
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Appendix D 
 
Example of “noise” 3D view Example of dust 3D view 
Example of a protein spot 3D view 
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Appendix E 
Reference masses for MS internal reflector positive procedural method 
 
 
 
 
Reference masses for MS/MS internal reflector positive procedural method 
 
  
m/z monoisotopic NAME TYPE CHARGE 
904.4680 des-Arg1-bradykinin r +1 
1296.6850 Angiotensin 1 r +1 
1570.6770 Glu1-fibrinopeptide r +1 
2093.0870 ACTH (1-17) r +1 
2465.1990 ACTH (18-39) r +1 
3657.9294 ACTH (7-38) r +1 
m/z monoisotopic NAME TYPE CHARGE 
255.1090 B2-17(-NH3) fragment ion r +1 
354.1780 B3-17(-NH3) fragment ion r +1 
784.4110 B6 fragment ion r +1 
1181.6580 Angiotensin Y9 fragment ion r +1 
1183.6010 Angiotensin fragment ion r +1 
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Appendix F 
Exclusion masses for MALDI TOF/TOF MS/MS 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Keller et al., 2008 
  
  
m/z monoisotopic NAME TOLERANCE (m/z) 
659.384 Trypsin 0.03 
805.417 Trypsin 0.03 
861.060 CHCA 0.10 
877.000 Polyethylene glycol 0.10 
906.505 Trypsin 0.03 
1020.503 Trypsin 0.03 
1153.574 Trypsin 0.03 
1175.523 Trypsin 0.03 
1296.680 Angiotensin 1 0.03 
1433.721 Trypsin 0.03 
1493.599 Trypsin 0.03 
1676.777 Trypsin 0.03 
1774.851 Trypsin 0.03 
2093.080 ACTH (clip 1-17) 0.03 
2163.057 Trypsin 0.03 
2193.003 Trypsin 0.03 
2193.995 Trypsin 0.03 
2273.160 Trypsin 0.03 
2289.155 Trypsin 0.03 
2305.150 Trypsin 0.03 
2465.190 ACTH (clip 18-39) 0.03 
2514.339 Trypsin 0.03 
2550.233 Trypsin 0.03 
2612.181 Trypsin 0.03 
2613.350 Trypsin 0.03 
3211.475 Trypsin 0.03 
3227.40 Trypsin 0.03 
  
 
1
1
0 
Appendix G 
The top ranked protein identification for each picked protein spot from S. cerevisiae experiments.  Match scores greater than 56 are significant, p = 0.05 and are in bold.  Fold 
changes in bold are significant (≥ 2-fold, p ≤ 0.01).  Identifications without a score were identified using Data Explorer and searched through Profound. Profound scores were not 
determined (n.d.).  Protein identifications acquired through Profound were considered significant if there were at least 5 matched peptides, sequence coverage ≥ 20% and a 
difference between first and second ranked identifications of at least 1x10
-3
. 
  
Spot 
# 
Expt Name gi # 
Calc. Mw 
(kDa) 
Calc. 
pI 
Score Expect. 
Seq. 
cov. 
(%) 
Matched /total 
Fold change 
YTX/
un 
YTX/ 
MeOH 
MeOH/
un 
1 
BY4741 1.2 μM, 
4-7 
Formylglycinamidine-ribonucleotide 
(FGAM)-synthetase, catalyses a step in 
the 'de novo' purine nucleotide 
biosynthetic pathway; Ade6p 
gi|6321498 150.14 5.1 n.d. 8.9×10
-7
 26 27/131 -1.3 -1.1 -1.18 
2 
BY4741 1.2 μM, 
4-7 
SSE1 protein gi|533365 77.68 5.1 n.d. 3.4×10
-5
 36 21/93 -1.19 -1.39 1.16 
5 
BY4741 1.2 μM, 
4-7 
Cytoplasmic tryptophanyl-tRNA 
synthetase, aminoacylates 
tryptophanyl-tRNA; Wrs1p 
gi|6324475 49.661 6.35 28 31 12 5/45 -1.57 -1.59 1.01 
9 
BY4741 1.2 μM, 
4-7 
Enolase II, catalyses the conversion of 
2-phosphoglycerate to 
phosphoenolpyruvate during glycolysis 
and the reverse reaction during 
gluconeogenesis; Eno2p 
gi|6321968 46.942 5.67 198 3.4e-016 19 10/75 -1.32 -1.33 1.01 
10 
BY4741 1.2 μM, 
4-7 
Cytosolic aldehyde dehydrogenase, 
activated by Mg2+ and utilizes NADP+ 
as the preferred coenzyme; required 
for conversion of acetaldehyde to 
acetate; constitutively expressed; 
locates to the mitochondrial outer 
surface upon oxidative stress; Ald6p 
gi|6325196 54.80 5.3 n.d. 6.7×10-4 33 15/132 -1.51 -1.44 -1.05 
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Spot 
# 
Expt Name gi # 
Calc. Mw 
(kDa) 
Calc. 
pI 
Score Expect. 
Seq. 
cov. 
(%) 
Matched /total 
Fold change 
YTX/
un 
YTX/ 
MeOH 
MeOH/
un 
11 
BY4741 1.2 μM, 
4-7 
cytosolic aldehyde dehydrogenase gi|1336076 54.96 5.4 n.d. 8.9×10-7 49 23/99 -1.21 -1.6 1.32 
12 
BY4741 1.2 μM, 
4-7 
cytosolic aldehyde dehydrogenase gi|1336076 54.96 5.4 n.d. 5.7×10-7 49 23/117 -1.24 -1.29 1.05 
15 
BY4741 1.2 μM, 
4-7 
Threonine synthase, conserved 
protein, catalyses formation of 
threonine from 0-
phosphohomoserine; Thr4p 
gi|6319901 57.553 5.46 97 4.4e-006 17 10/64 -1.18 -1.24 1.05 
16 
BY4741 1.2 μM, 
4-7 
Aromatic aminotransferase I; Aro8p gi|6321236 56.371 5.68 143 1.1e-010 15 11/75 -1.03 -1.15 1.12 
18 
BY4741 1.2 μM, 
4-7 
Enolase II, catalyses the conversion of 
2-phosphoglycerate to 
phosphoenolpyruvate during 
glycolysis and the reverse reaction 
during gluconeogenesis; Eno2p 
gi|6321968 46.942 5.67 194 8.5e-016 18 11/75 -1.07 -1.19 1.11 
19 
BY4741 1.2 μM, 
4-7 
Enolase II, catalyses the conversion of 
2-phosphoglycerate to 
phosphoenolpyruvate during 
glycolysis and the reverse reaction 
during gluconeogenesis; Eno2p 
gi|6321968 46.942 5.67 
433 1.1e-039 30 15/75 -1.12 -1.21 1.08 
429 2.7e-039 34 18/75 -1.1 -1.18 1.07 
20 
BY4741 1.2 μM, 
4-7 
Enolase II, catalyses the conversion of 
2-phosphoglycerate to 
phosphoenolpyruvate during 
glycolysis and the reverse reaction 
during gluconeogenesis; Eno2p 
gi|6321968 46.942 5.67 315 6.7e-028 29 15/75 -1.47 -1.31 -1.12 
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Spot 
# 
Expt Name gi # 
Calc. Mw 
(kDa) 
Calc. 
pI 
Score Expect. 
Seq. 
cov. 
(%) 
Matched /total 
Fold change 
YTX/
un 
YTX/ 
MeOH 
MeOH/
un 
23 
BY4741 1.2 μM, 
4-7 
Fructose 1,6-bisphosphate aldolase, 
required for glycolysis and 
gluconeogenesis; catalyses conversion 
of fructose 1,6 bisphosphate to 
glyceraldehyde-3-P and 
dihydroxyacetone-P; locates to 
mitochondrial outer surface upon 
oxidative stress; Fba1p 
gi|6322790 39.881 5.51 123 1.1e-008 14 8/75 -1.31 -1.2 -1.1 
25 
BY4741 1.2 μM, 
4-7 
Subunit d of the five-subunit V0 
integral membrane domain of 
vacuolar H+-ATPase (V-ATPase), an 
electrogenic proton pump found in 
the endomembrane system; stabilizes 
VO subunits; required for V1 domain 
assembly on the vacuolar membrane; 
Vma6p 
gi|6323480 40.12 4.5 n.d. 6.2×10
-3
 32 8/90 -1.16 -1.2 1.04 
26 
BY4741 1.2 μM, 
4-7 
Chain A, Electrophilic Catalysis In 
Triosephosphase Isomerase: The Role 
Of Histidine-95 
gi|349951 26.75 5.6 n.d. 3.2×10
-4
 47 11/87 1.03 -1.07 1.11 
28 
BY4741 1.2 μM, 
6-11 
Chain A, Circularly Permuted 
Phosphoglycerate Kinase; Pgk P72 
gi|157876436 44.595 7.71 401 1.7e-036 40 18/75 -1.03 -1.07 1.04 
29 
BY4741 1.2 μM, 
6-11 
Chain A, Circularly Permuted 
Phosphoglycerate Kinase; Pgk P72 
gi|157876436 44.595 7.71 369 2.7e-033 44 18/75    
32 
BY4741 1.2 μM, 
6-11 
Chain E, Saccharomyces Cerevisiae 
Phosphoglycerate Mutase 
gi|157884466 26.687 8.27 335 6.7e-030 44 15/75 -1.75 -1.64 -1.06 
33 
BY4741 1.2 μM, 
6-11 
Protein component of the small (40S) 
ribosomal subunit, the least basic of 
the non-acidic ribosomal proteins; 
phosphorylated in vivo; essential for 
viability; Rps5p 
gi|6322583 25.080 8.63 345 6.7e-031 35 16/75 -1.03 1.07 -1.1 
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Spot 
# 
Expt Name gi # 
Calc. Mw 
(kDa) 
Calc. 
pI 
Score Expect. 
Seq. 
cov. 
(%) 
Matched 
/total 
Fold change 
(ds)YTX
/un 
(ds)YTX
/MeOH 
MeOH/
un 
41 
BY4741 12 μM, 
4-7, log 
unknown gi|825555 22.362 5.10 37 4.6 17 5/23 1.58 1.02 1.55 
43 
BY4741 12 μM, 
4-7, log 
YLL024Cp-like protein, AWRI1631 gi|207343245 59.805 7.00 494 8.5e-046 28 21/75 1.54 -1.1 1.7 
45 
BY4741 12 μM, 
4-7, log 
unknown gi|825555 22.362 5.10 22 1.4e+002 17 6/56 1.63 1.02 1.59 
49 
BY4741 12 μM, 
4-7, log 
Chain A, The Structure Of Tap42 Alpha4 
Subunit 
gi|152149535 27.360 5.58 20 2.3e+002 9 4/69 1.75 -1.06 1.86 
58 
BY4741 12 μM, 
4-7, log 
No hit        1.51 1 1.5 
66 
BY4741 12 μM, 
4-7, log 
No hit        -1.5 1.06 -1.6 
72 
BY4741 12 μM, 
6-11, log 
hypothetical protein identified by 
homology. See FEBS Letters [2000] 
487:31-36.; Pau9p 
gi|13129151 4.521 9.52 23 1.1e+002 52 2/75 1.63 -1.02 1.66 
88 
BY4741 12 μM, 
6-11, log 
Ics2p gi|30267748 3.320 10.29 32 12 90 3/59 -1.56 -1.1 -1.42 
92 
BY4741 12 μM, 
6-11, log 
YNL022Cp-like protein AWRI1631 gi|207341631 56.825 9.02 27 40 17 7/70 -1.52 -1.01 -1.51 
98 
BY4741 12 μM, 
6-11, log 
Thymidylate synthase, required for de 
novo biosynthesis of pyrimidine 
deoxyribonucleotides; expression is 
induced at G1/S; Cdc21p 
gi|83578104 35.310 6.67 26 52 19 7/67 -1.75 1.05 -1.83 
113 
BY4741 12 μM, 
6-11, log 
Ydr381wp gi|849202 11.932 10.72 26 56 42 6/75 -1.57 -1.02 -1.54 
123 
BY4741 dsYTX, 
4-7 
Hsp90 cochaperone, interacts with the 
Ssa group of the cytosolic Hsp70 
chaperones; activates the ATPase 
activity of Ssa1p; homolog of 
mammalian Hop protein; Sti1p 
gi|6324601 66.395 5.45 93 1.1e-005 19 12/61 -1.01 -1.02 1.01 
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Spot 
# 
Expt Name gi # 
Calc. Mw 
(kDa) 
Calc. 
pI 
Score Expect. 
Seq. 
cov. 
(%) 
Matched 
/total 
Fold change 
dsYTX/
un 
dsYTX/ 
MeOH 
MeOH/
un 
127 
BY4741 dsYTX, 
4-7 
Thymidylate synthase, required for de 
novo biosynthesis of pyrimidine 
deoxyribonucleotides; expression is 
induced at G1/S; Cdc21p 
gi|83578104 35.310 6.67 30 20 22 8/75 1.51 1.39 1.09 
136 
BY4741 dsYTX, 
4-7 
Phosphomannomutase, involved in 
synthesis of GDP-mannose and 
dolichol-phosphate-mannose; 
required for folding and glycosylation 
of secretory proteins in the ER lumen; 
Sec53p 
gi|14318474 29.216 5.14 124 8.5e-009 32 14/75 -1.02 -1 -1.01 
138 
BY4741 dsYTX, 
4-7 
protein GRE1 RM11-1a gi|190407740 18.926 4.60 113 1.1e-007 42 8/75 -2.37 -1.84 -1.28 
142 
BY4741 dsYTX, 
4-7 
hypothetical protein identified by 
homology. See FEBS Letters [2000] 
487:31-36.; Pau9p 
gi|13129151 4.521 9.52 24 77 52 2/61 -1.52 -1.39 -1.09 
147 
BY4741 dsYTX, 
4-7 
Chain A, H48c Yeast Cu(Ii)ZN 
superoxide dismutase room 
temperature (298k) Structure 
gi|6730103 15.851 5.48 555 6.7e-052 60 13/75 -1.01 1.26 -1.28 
150 
BY4741 dsYTX, 
4-7 
Chain G, Yeast Cytochrome Bc1 
Complex With Bound Substrate 
Cytochrome C 
gi|20151124 14.482 
5.63 
 
68 0.0035 28 6/75 1.34 1.18 1.13 
164 ADΔ dsYTX, 4-7 
Phosphatidylinositol transfer protein 
(PITP) controlled by the multiple drug 
resistance regulator Pdr1p, localizes to 
lipid particles and microsomes, controls 
levels of various lipids, may regulate 
lipid synthesis, homologous to Pdr17p; 
Pdr16p 
gi|6324098 40.802 7.72 21 1.9e+002 13 5/67 1.75 1.68 1.04 
165 ADΔ dsYTX, 4-7 YKR101Wp-like protein AWRI1631 gi|207343311 69.792 9.04 19 2.4e+002 12 6/69 2.41 2.5 -1.04 
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Spot 
# 
Expt Name gi # 
Calc. Mw 
(kDa) 
Calc. 
pI 
Score Expect. 
Seq. 
cov. 
(%) 
Matched 
/total 
Fold change 
dsYTX/
un 
dsYTX/
MeOH 
MeOH/
un 
166 ADΔ dsYTX, 4-7 
hypothetical protein identified by 
homology. See FEBS Letters [2000] 
487:31-36.; Pau9p 
gi|13129151 4.521 9.52 24 85 52 2/64 2.04 2.06 -1.01 
168 ADΔ dsYTX, 4-7 
Chain A, Crystal Structure Of An 
Hsp90-Sba1 Closed Chaperone 
Complex 
gi|99031945 77.927 5.06 95 6.6e-006 8 8/75 1.61 1.66 -1.03 
170 ADΔ dsYTX, 4-7 
Chain A, Crystal Structure Analysis Of 
Sse1, A Yeast Hsp110 
gi|159795398 73.710 5.17 24 89 5 4/70 1.78 1.89 -1.06 
173 ADΔ dsYTX, 4-7 YLL024Cp-like protein AWRI1631 gi|207343245 59.805 7.00 280 2.1e-024 23 16/75 1.85 2.04 -1.1 
177 ADΔ dsYTX, 4-7 
hypothetical protein identified by 
homology. See FEBS Letters [2000] 
487:31-36.; Pau9p 
gi|13129151 4.521 9.52 23 1.1e+002 52 2/75 1.95 1.82 1.07 
181 ADΔ dsYTX, 4-7 
hypothetical protein identified by 
homology. See FEBS Letters [2000] 
487:31-36.; Pau9p 
gi|13129151 4.521 9.52 23 1.1e+002 52 2/75 1.5 1.66 -1.1 
184 ADΔ dsYTX, 4-7 
One of six ATPases of the 19S 
regulatory particle of the 26S 
proteasome involved in the 
degradation of ubiquitinated 
substrates; bound by ubiquitin-protein 
ligases Ubr1p and Ufd4p; localized 
mainly to the nucleus throughout the 
cell cycle; Rpt6p 
gi|6321390 45.471 9.09 19 2.5e+002 14 4/72 1.6 1.82 -1.14 
188 ADΔ dsYTX, 4-7 YLL024Cp-like protein AWRI1631 gi|207343245 59.805 7.00 92 1.3e-005 13 11/74 1.31 1.26 1.04 
190 ADΔ dsYTX, 4-7 actin gi|3328 41.907 5.53 98 3.3e-006 14 9/52 1.27 1.36 -1.08 
191 ADΔ dsYTX, 4-7 YGL071Wp-like protein AWRI1631 gi|207345331 51.776 5.74 31 16 14 9/75 1.63 1.65 -1.01 
200 ADΔ dsYTX, 4-7 
mitochondrial translational activator 
[Saccharomyces cerevisiae YJM789] 
gi|151944573 57707 9.18 25 67 15% 7/75 -2.26 -2.36 1.04 
201 ADΔ dsYTX, 4-7 conserved protein YJM789 gi|151942578 18.896 4.60 168 3.4e-013 34 8/63 1.16 1.15 1.01 
205 ADΔ dsYTX, 4-7 
Putative protein of unknown function; 
Ylr146w-ap 
gi|82795259 7.130 4.75 24 87 37 4/75 -1.7 -1.81 1.06 
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Spot 
# 
Expt Name gi # 
Calc. Mw 
(kDa) 
Calc. 
pI 
Score Expect. 
Seq. 
cov. 
(%) 
Matched 
/total 
Fold change 
dsYTX/
un 
dsYTX/ 
MeOH 
MeOH/
un 
206 ADΔ dsYTX, 4-7 
One of six subunits of the RNA 
polymerase III transcription initiation 
factor complex (TFIIIC); part of the 
TauA globular domain of TFIIIC that 
binds DNA at the BoxA promoter sites 
of tRNA and similar genes; human 
homolog is TFIIIC-63; Tfc1p 
gi|6319600 73.678 5.23 24 85 14 8/71 -1.37 -1.53 1.11 
207 ADΔ dsYTX, 4-7 
Chain G, Yeast Cytochrome Bc1 
Complex With Bound Substrate 
Cytochrome C 
gi|20151124 14.482 5.63 79 0.00026 28 6/75 1.06 1.12 -1.07 
208 ADΔ dsYTX, 4-7 YGR254Wp-like protein AWRI1631 gi|207344913 41.740 6.23 94 8.1e-006 8 3/75 -1.28 -1.42 1.11 
209 ADΔ dsYTX, 4-7 YGR254Wp-like protein AWRI1631 gi|207344913 41.740 6.23 120 2.1e-008 4 2/31 -1.45 -1.65 1.14 
211 ADΔ dsYTX, 4-7 
dehydrogenase isozyme I, alcohol 
 
gi|223142 31.954 6.38 84 8.1e-005 12 6/75 -1.49 -1.54 1.03 
215 
ADΔ dsYTX, 6-
11 
Translational elongation factor EF-1 
alpha; also encoded by TEF1; functions 
in the binding reaction of aminoacyl-
tRNA (AA-tRNA) to ribosomes; Tef2p 
gi|6319594 50.400 9.14 112 1.3e-007 13 10/75 1.69 2.1 -1.24 
217 
ADΔ dsYTX, 6-
11 
unnamed protein product gi|395245 12.862 10.33 20 2.3e+002 21 3/75    
218 
ADΔ dsYTX, 6-
11 
pyruvate kinase gi|4180 54.964 8.00 197 4.3e-016 14 14/75 -1.11 -1.14 1.03 
219 
ADΔ dsYTX, 6-
11 
Alcohol dehydrogenase isoenzyme V; 
involved in ethanol production; Adh5p 
gi|6319621 38.194 5.94 31 15 5 3/72 -1.59 -1.82 1.15 
220 
ADΔ dsYTX, 6-
11 
pyruvate kinase gi|4180 54.964 8.00 341 1.7e-030 17 19/75 -1.33 -1.49 1.12 
 117 
 
Appendix H 
Proteins identified as not having a significant change of abundance by 2D-DIGE analysis 
of YTX in S. cerevisiae. 
 
Experiment Protein name 
Spot 
number(s) 
BY4741, 1.2 µM YTX FGAM-synthetase 1 
BY4741, 1.2 µM YTX SSE1 protein (ATPase component of HSP90 cochaperone complex) 2 
BY4741, 1.2 µM YTX Enolase II 9, 18-20 
BY4741, 1.2 µM YTX Cytosolic aldehyde dehydrogenase 11, 12 
BY4741, 1.2 µM YTX Threonine synthase 15 
BY4741, 1.2 µM YTX Aromatic aminotransferase I 16 
BY4741, 1.2 µM YTX Fructose 1,6-biphosphate aldolase 22 
BY4741, 1.2 µM YTX V0 integral membrane domain of vacuolar H
+
-ATPase, subunit d 25 
BY4741, 1.2 µM YTX Electrophilic catalysis in triosephophate isomerase, chain A 26 
BY4741, 1.2 µM YTX; 
ADΔ dsYTX 
Pyruvate kinase 
27, 218, 
220 
BY4741, 1.2 µM YTX Circularly permuted phosphoglycerate kinase, chain A 28, 29 
BY4741, 1.2 µM YTX Protein component of small ribosomal subunit 33 
BY4741, 12 µM YTX, 
log phase; 
ADΔ dsYTX 
YYL024Cp-like protein 
43, 62, 
188 
BY4741, 12 µM YTX, 
log phase 
ATPase 44 
BY4741, 12 µM YTX, 
log phase 
Nucleoside diphosphate kinase 96 
BY4741 dsYTX HSP90 cochaperone 123 
BY4741 dsYTX Phosphomannomutase 136 
BY4741 dsYTX Egd2p 137 
BY4741 dsYTX Yeast Cu(Li)Zn superoxide dismutase 147 
BY4741 dsYTX; 
ADΔ dsYTX 
Cytochrome Bcl complex 150, 207 
ADΔ dsYTX Actin 190 
ADΔ dsYTX Conserved protein, YJM789 201 
ADΔ dsYTX YGR254Wp-like protein 208, 209 
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Appendix I 
The top ranked protein identification for each picked protein spots from HL60 experiment which showed at least a 1.5-fold change in abundance, p-value = 0.05.  Match scores 
greater than 66 are significant, p = 0.05 and are in bold.  *Indicates a protein identification which is the best match overall (including Mw, pI), but is not the top-ranked 
identification.  Fold changes in bold are significant (≥ 2-fold, p ≤ 0.01). 
  
Spot 
# 
pH Name gi # 
Calc. Mw 
(kDa) 
Calc. 
pI 
Score Expect. 
Seq. cov. 
(%) 
Matched 
/total 
Fold change 
YTX/ 
MeOH 
dsYTX/ 
MeOH 
dsYTX/ 
YTX 
1 4-7 
Immunoglobulin heavy chain 
variable region 
gi|112699019 10.962 7.88 34 95 40% 3/65 1.87 2.13 1.14 
2 4-7 
tumour rejection antigen (gp96) 1 gi|61656607 92.567 4.77 71 0.018 10% 14/75 
1.27 1.63 1.28 heat shock protein 90kDa beta, 
member 1  
gi|4507677 92.696 4.76 71 0.018 10% 14/75 
4 4-7 
opioid growth factor receptor 
and/or S100 calcium-binding 
protein A8  
gi|66347254 11.600 5.54 44 9.3 32% 5/75 
1.4 1.55 1.1 
gi|21614544 10.885 6.51 36 62 43% 6/75 
5 4-7 MHC class I antigen gi|85815622 10.392 5.30 35 76 46% 4/64 1.61 2.02 1.26 
7 4-7 hCG2015481 gi|119618893  7.512 9.04 24 7.9e+002 43% 3/75 2.37 2.9 1.22 
8 4-7 
hCG2044129 {region: DUF132, 
contains SGF29 tudor-like domain; 
pfam07039; poss RNA binding} 
gi|119572656 6.273 6.31 36 50 24% 2/7 1.88 2.31 1.23 
9, 
10, 
11 
4-7 GRP78 precursor gi|386758 72.185 5.03 446 5.5e-040 30% 23/75 
1.65 2.07 1.25 
1.49 1.82 1.22 
1.44 1.7 1.18 
12 4-7 BiP protein gi|6470150 71.002 5.23 145 6.9e-010 16% 12/75 1.54 1.8 1.17 
13 4-7 
PRO1095 {predicted protein 
product of HQ1095} 
gi|11493413 4.854 9.59 29 2.8e+002 57% 4/42 1.99 2.57 1.3 
18 4-7 unnamed protein product gi|193786969 99.132 7.32 39 26 4% 5/12 -1.62 1.95 -1.2 
19 4-7 
unnamed protein product {contains 
Ribosomal L3 superfamily domain; 
highly similar to mitochondrial 39s 
ribosomal protein L3} 
gi|194376318 27.262 9.64 48 3.8 16% 4/14 -1.37 -1.7 -1.24 
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Spot 
# 
pH Name gi # 
Calc. Mw 
(kDa) 
Calc. 
pI 
Score Expect. 
Seq. cov. 
(%) 
Matched 
/total 
Fold change 
YTX/ 
MeOH 
dsYTX/ 
MeOH 
dsYTX/YTX 
20 4-7 
hCG2040114, isoform CRA_b 
{ch/some 2} 
gi|119620565 15.179 8.56 31 1.8e+002 29% 3/34 -1.63 -2.04 -1.25 
21 4-7 hCG2042223 {ch/some 1} gi|119615331 8.095 11.92 50 2 38% 3/11 -1.59 -1.63 -1.02 
22 4-7 
translation initiation factor eIF-
4gamma 
gi|510307 79.884 5.44 35 6 5% 4/11 -2.81 -2.58 1.09 
23 4-7 
cytotoxic T-lymphocyte-associated 
protein 4 
gi|553245 4.397 9.61 39 29 50% 4/44 -2.68 -2.55 1.05 
24 4-7 ferritin light polypeptide gi|171702799 5.863 5.74 31 1.9e+002 44% 4/75 1.49 2.1 1.41 
25 4-7 
immunoglobulin lambda chain 
variable region 
gi|3153364 11.031 9.07 44 8.9 43% 3/41 1.65 2.38 1.44 
28 4-7 hCG2012006 {ch/some 2} gi|119590542 3.398 9.39 34 85 51% 3/62 2.05 2.55 1.24 
29 4-7 
heat shock 60kDa protein 1 
(chaperonin), isoform CRA_c 
gi|119590557 41.067 5.09 47 4.8 16% 7/75 2.12 2.89 1.36 
30 4-7 
heat shock 60kDa protein 1 
(chaperonin), isoform CRA_c 
gi|119590557 41.067 5.09 67 0.04   21% 11/75 1.86 2.54 1.37 
31 4-7 
immunoglobulin heavy chain 
variable region 
gi|11137459 11.216 10.01 34 81 58% 5/66 1.53 2 1.31 
32 4-7 
unnamed protein product 
{GroEL/chaperonin type 
I/II/chaperonin like domain.  
Chaperonins are involved in 
productive folding of proteins} 
gi|221041730 58.705 5.82 52 1.2 7% 10/75 1.22 1.57 1.28 
34 4-7 
hCG2030305, isoform CRA_a 
{ch/some 6} 
gi|119568344 6.997 9.77 29 3e+002 24% 2/15 1.75 2.1 1.2 
35 4-7 calreticulin precursor variant gi|62897681 47.061 4.30 31 1.8e+002 11% 9/75 1.31 1.56 1.19 
39 4-7 NOS1 protein gi|118600892 10.454 5.08 40 25 45% 4/41 -1.76 -1.79 -1.02 
41 4-7 
unnamed protein product {non-
specific hit to NAD-dependent 
glycerol-3-phosphate 
dehydrogenase C-terminus 
domain} 
gi|193785041 13.475 7.63 35 66  18% 4/42 -1.57 -1.77 -1.13 
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Spot 
# 
pH Name gi # 
Calc. Mw 
(kDa) 
Calc. pI Score Expect. 
Seq. cov. 
(%) 
Matched 
/total 
Fold change 
YTX/ 
MeOH 
dsYTX/ 
MeOH 
dsYTX/YTX 
45 4-7 KRT8 protein gi|14198278  30.802 5.02 26 5.5e+002 21% 4/31 2.02 2.81 1.39 
46 4-7 zinc finger protein 441 gi|119604646 78.130 8.95 38 32 9% 6/20 2.34 3.55 1.51 
50 4-7 tyrosine hydroxylase gi|548153 3.717 8.31 36 55 73% 3/15 2.53 2.42 -1.05 
51 4-7 
unnamed protein product 
{nonspecific hit to BACK domain} 
gi|221044806 23.358 6.88 34 91 11% 3/14 2.03 2.03 -1 
52 4-7 
protein disulfide isomerase-
related protein 5 
gi|1710248 46.512 4.95 161 1.7e-011 14% 8/75 1.62 1.73 1.07 
54 
4-7 
unnamed protein product 
{specific hit to actin} 
gi|194376310 38.950 5.19 116 5.5e-007 18% 8/75 
1.71 2.27 1.32 
55 ACTB protein* gi|15277503 40.536 5.55 84 0.00081 10 5/75 
56 4-7 
unnamed protein product {specific 
hit to actin domain} 
gi|194376310 38.950 5.19 65 0.069 15% 6/48 2.12 3.19 1.51 
63 
4-7 
zinc finger protein 441  gi|119604646 78.130 8.95 52 1.3 9% 6/17 
-1.32 -1.56 -1.18 
64 tyrosine hydroxylase gi|548153 3.717 8.31 35 63 73% 3/16 
65 4-7 
immunoglobulin heavy chain 
variable region 
gi|27650504 8.847 8.07 30 2.4e+002 23% 4/75 -1.41 -1.59 -1.13 
68 4-7 
Chain A, Crystal Structure Of 
Human P32, A Doughnut-Shaped 
Acidic Mitochondrial Matrix 
Protein 
gi|4930073 23.844 4.32 141 1.7e-009 32% 6/75 1.61 1.75 1.09 
69 4-7 
unnamed protein product {match 
to Zn finger 285A protein} 
gi|16550013 51.777 8.85 35 68 8% 4/16 -1.3 -1.52 -1.16 
70 4-7 
immunoglobulin heavy chain 
variable region 
gi|21999882 6.980 5.04 37 41 56% 4/75 -1.44 -1.52 -1.06 
72 4-7 
similar to RIKEN cDNA 
1700016G05, isoform CRA_c 
gi|119604393 25.383 9.19 34 89 15% 3/15 -2.26 -1.88 1.2 
74 4-7 CALD1 protein gi|116283250 17.756 9.69 39 30 20% 4/15 -1.25 -1.57 -1.26 
77 4-7 STK35 protein gi|84798766 28.027 7.78 33 1.1e+002 16% 8/74 -1.26 -1.66 -1.32 
78 4-7 complement receptor gi|395334 3.082 9.22 37 47 44% 2/14 2.91 1.63 -1.79 
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Spot 
# 
pH Name gi # 
Calc. Mw 
(kDa) 
Calc. pI Score Expect. 
Seq. cov. 
(%) 
Matched 
/total 
Fold change 
YTX/ 
MeOH 
dsYTX/ 
MeOH 
dsYTX/YTX 
79 4-7 
CDC28 protein kinase regulatory 
subunit 1B 
gi|55960117 8.079 5.88 47 4 38% 3/16 3.14 1.91 -1.64 
80 4-7 
T cell receptor V alpha 9.1=specific 
for mycobacterial heat shock 
protein 60-derived peptide P1 
{clone 2.4, complementarity-
determining region 3} [human, 
peripheral blood T cells, Peptide 
Partial, 29 aa] 
gi|1086967 3.287 10.05 33 1.1e+002 75% 3/75 2.12 1.22 -1.74 
82 4-7 
signal recognition particle 9kDa, 
isoform CRA_c 
gi|119590159 5.570 6.54 31 1.8e+002 34% 2/21 3.26 2.1 -1.55 
84 4-7 unnamed protein product gi|194380768 19.682 11.21 32 1.5e+002 17% 5/75 2.17 1.43 -1.51 
89 4-7 
Unknown {specific hit to α 
crystalline domain found in small 
HSPαB crystalline. sHSPs are 
molecular chaperones, protect 
against cell stress} 
gi|2852648 22.435 7.18 36 62 15% 3/14 -1.21 -1.53 -1.26 
90 4-7 
Full=MIF4G domain-containing 
protein; AltName: Full=SLBP-
interacting protein 1; Short=hSLIP1 
gi|189081938 25.749 5.23 30 2.4e+002 9% 2/5 -1.26 -1.66 -1.31 
92 4-7 
immunoglobulin heavy chain 
variable region 
gi|112698573 11.110 9.10 42 13 32% 3/19 1.74 2.17 1.24 
96 6-11 
unnamed protein product {specific 
hit K homology RNA-binding 
domain, type I.  KH binds ss 
RNA/DNA} 
gi|194377024 70.150 9.47 67 0.043 8% 8/12 -1.7 -1.39 1.22 
100 6-11 
hCG1647242 {specific hit to 
Bel/Pao family of RNase HI in long-
term repeat retroelements}  
gi|119612025 58.863 9.16 26 5.9e+002 17% 4/50 2.23 3.06 1.37 
101 6-11 hCG2042223 {ch/some 1} gi|119615331 8.095 11.92 45 6.8 38% 3/16 1.92 2.47 1.29 
102 6-11 tyrosine hydroxylase gi|548153 3.717 8.31 32 1.3e+002 73% 2/21 1.68 2.13 1.27 
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Spot 
# 
pH Name gi # 
Calc. Mw 
(kDa) 
Calc. pI Score Expect. 
Seq. cov. 
(%) 
Matched 
/total 
Fold change 
YTX/ 
MeOH 
dsYTX/ 
MeOH 
dsYTX/YTX 
106 6-11 nucleolin, isoform CRA_c gi|119591368 58.576 4.57 208 3.5e-016 18% 14/75 1.63 1.72 1.05 
107 6-11 HNRNPA1 protein gi|75517570 29.482 9.19 131 1.7e-008 26% 9/75 1.41 1.7 1.21 
114 6-11 transgelin 2, isoform CRA_a gi|119573144 19.458 8.87 49 2.9 35% 7/75 -1.43 -1.71 -1.19 
115 6-11 apolipoprotein M, isoform CRA_b gi|119623867 18.021 8.52 43 10 22% 7/75 -1.38 -1.54 -1.11 
118 6-11 
unnamed protein product {gene 
region Rossmann-fold NADP(+)-
binding protein; highly similar to 
pyruvate dehydrogenase regulatory 
subunit, mRNA} 
gi|193788467 32.249 
9.61 
 
30 
2e+002 
 
15% 
 
2/7 1.26 2.23 1.77 
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Appendix J 
The top ranked protein identification for each picked protein spots from HL60 experiment which had a significant match score, but were not identified as changing by 2D-DIGE 
analysis. *Indicates a protein identification which is the best match (including Mw, pI), but is not the top-ranked identification. 
 
  
Spot 
# 
pH Name gi # 
Calc. Mw 
(kDa) 
Calc. pI Score Expect. 
Seq. cov. 
(%) 
Matched 
/total 
Fold change 
YTX/ 
MeOH 
dsYTX/ 
MeOH 
dsYTX/YTX 
01 4-7 
unnamed protein product {hits to 
DNA K molecular chaperone, highly 
similar to HSP70 mitochondrial 
protein} 
gi|221039760 47504 6.20 253 1.1e-020 32% 19/75 1.23 1.43 1.16 
MTHSP75*  gi|292059 74019 5.97 229 2.8e-018 21% 19/75 1.06 1.2 1.14 
02 4-7 
Chain A, Crystal Structure Of 
Hsc70BAG1 IN COMPLEX WITH ATP 
gi|225698069 42120 6.38 154 8.7e-011 21% 11/75 
-1.24 -1.13 1.1 
heat shock 70kDa protein 8 isoform 
1 variant* 
gi|62897129 71083 5.28 151 1.7e-010 15% 13/75 
03 4-7 
unnamed protein product {matches 
to protein disulfide isomerise (PDI) 
a, a’, b, b’ families; ER} 
gi|194373909 51620 4.77 186 5.5e-014 21% 14/75 -1.12 1.09 1.22 
04 4-7 Chaperonin (HSP60) gi|31542947 61187 5.70 220 2.2e-017 31% 20/75 -1 1.26 1.26 
05 4-7 
Chain A, TapasinERP57 
heterodimer (nb: ERP is part of PDI 
family) 
gi|220702506 54541 5.61 301 1.7e-025 24% 19/75 1.05 1.2 1.14 
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Spot 
# 
pH Name gi # 
Calc. Mw 
(kDa) 
Calc. pI Score Expect. 
Seq. 
cov. 
(%) 
Matched 
/total 
Fold change 
YTX/ 
MeOH 
dsYTX/ 
MeOH 
dsYTX/Y
TX 
06 4-7 
unnamed protein product {specific 
hit to β tubulin} 
gi|221045918 46936 4.83 118 3.5e-007 30% 21/75 -1.06 -1.16 -1.1 
07 4-7 
unnamed protein product {specific 
hit to β tubulin} 
gi|221045918 46936 4.83 99 2.6e-005 27% 19/75 -1.14 -1.18 -1.04 
08 4-7 
unnamed protein product {from 
tubulin Ftsz region} 
gi|194387512 20259 4.39 74 0.0095 19% 3/75 
1.23 1.35 1.1 
unnamed protein product {specific 
hit to α tubulin} 
gi|221039556 58636 4.94 71 0.017 9% 3/75 
09 4-7 
unnamed protein product^ 
{specific hit to α tubulin} 
gi|221039556 58636 4.94 91 0.00018 5% 2/75 -1.32 -1.38 -1.05 
010 4-7 
unnamed protein product 
{specific hit to actin} 
gi|194375299 37667 5.49 239 2.8e-019 19% 5/20 -1.12 -1.16 -1.04 
011 4-7 
unnamed protein product {specific 
hit to actin} 
gi|194375299 37667 5.49 226 5.5e-018 33% 14/75 -1.25 -1.28 -1.02 
012 6-11 
Chain A, Crystal Structure Of 
Human Phosphoglycerate Kinase 
Bound To D-Adp/phosphoglycerate 
kinase 1, isoform CRA_b 
gi|193506632 45266 8.32 288 3.5e-024 24% 13/75 
1.32 -1.03 -1.36 
-1.03 -1.06 -1.03 
013 6-11 
17 kDa cyclophilin A {internal 
fragment} [human, first trimester 
decidual and placental tissue, 
Peptide Partial, 29 aa] 
gi|1041969 3190 4.10 127 4.4e-008 62% 2/75 -1.09 -1.21 -1.1 
